id	sid	tid	token	lemma	pos
dpc-1935	1	1	dermatology	dermatology	NOUN
dpc-1935	1	2	:	:	PUNCT
dpc-1935	1	3	practical	practical	ADJ
dpc-1935	1	4	and	and	CCONJ
dpc-1935	1	5	conceptual	conceptual	ADJ
dpc-1935	1	6	original	original	ADJ
dpc-1935	1	7	article	article	NOUN
dpc-1935	1	8	|	|	ADV
dpc-1935	1	9	dermatol	dermatol	ADJ
dpc-1935	1	10	pract	pract	NOUN
dpc-1935	1	11	concept	concept	NOUN
dpc-1935	1	12	.	.	PUNCT
dpc-1935	2	1	2022;12(2):e2022081	2022;12(2):e2022081	NUM
dpc-1935	2	2	1	1	NUM
dpc-1935	2	3	should	should	AUX
dpc-1935	2	4	mammography	mammography	NOUN
dpc-1935	2	5	be	be	AUX
dpc-1935	2	6	a	a	DET
dpc-1935	2	7	prerequisite	prerequisite	NOUN
dpc-1935	2	8	prior	prior	ADV
dpc-1935	2	9	to	to	ADP
dpc-1935	2	10	initiation	initiation	NOUN
dpc-1935	2	11	of	of	ADP
dpc-1935	2	12	biological	biological	ADJ
dpc-1935	2	13	agents	agent	NOUN
dpc-1935	2	14	in	in	ADP
dpc-1935	2	15	patients	patient	NOUN
dpc-1935	2	16	with	with	ADP
dpc-1935	2	17	psoriasis	psoriasis	NOUN
dpc-1935	2	18	?	?	PUNCT
dpc-1935	3	1	funda	funda	PROPN
dpc-1935	3	2	tamer1	tamer1	PROPN
dpc-1935	3	3	,	,	PUNCT
dpc-1935	3	4	ayla	ayla	ADJ
dpc-1935	3	5	gulekon1	gulekon1	NOUN
dpc-1935	3	6	1	1	NUM
dpc-1935	3	7	gazi	gazi	PROPN
dpc-1935	3	8	university	university	PROPN
dpc-1935	3	9	school	school	NOUN
dpc-1935	3	10	of	of	ADP
dpc-1935	3	11	medicine	medicine	PROPN
dpc-1935	3	12	department	department	PROPN
dpc-1935	3	13	of	of	ADP
dpc-1935	3	14	dermatology	dermatology	NOUN
dpc-1935	3	15	,	,	PUNCT
dpc-1935	3	16	ankara	ankara	PROPN
dpc-1935	3	17	,	,	PUNCT
dpc-1935	3	18	turkey	turkey	PROPN
dpc-1935	3	19	key	key	ADJ
dpc-1935	3	20	words	word	NOUN
dpc-1935	3	21	:	:	PUNCT
dpc-1935	3	22	biological	biological	ADJ
dpc-1935	3	23	agents	agent	NOUN
dpc-1935	3	24	,	,	PUNCT
dpc-1935	3	25	breast	breast	NOUN
dpc-1935	3	26	cancer	cancer	NOUN
dpc-1935	3	27	,	,	PUNCT
dpc-1935	3	28	mammography	mammography	NOUN
dpc-1935	3	29	,	,	PUNCT
dpc-1935	3	30	psoriasis	psoriasis	NOUN
dpc-1935	3	31	citation	citation	NOUN
dpc-1935	3	32	:	:	PUNCT
dpc-1935	3	33	tamer	tame	ADJ
dpc-1935	3	34	f	f	NOUN
dpc-1935	3	35	,	,	PUNCT
dpc-1935	3	36	gulekon	gulekon	PROPN
dpc-1935	3	37	a.	a.	PROPN
dpc-1935	3	38	should	should	AUX
dpc-1935	3	39	mammography	mammography	NOUN
dpc-1935	3	40	be	be	AUX
dpc-1935	3	41	a	a	DET
dpc-1935	3	42	prerequisite	prerequisite	NOUN
dpc-1935	3	43	prior	prior	ADV
dpc-1935	3	44	to	to	ADP
dpc-1935	3	45	initiation	initiation	NOUN
dpc-1935	3	46	of	of	ADP
dpc-1935	3	47	biological	biological	ADJ
dpc-1935	3	48	agents	agent	NOUN
dpc-1935	3	49	in	in	ADP
dpc-1935	3	50	patients	patient	NOUN
dpc-1935	3	51	with	with	ADP
dpc-1935	3	52	psoriasis	psoriasis	NOUN
dpc-1935	3	53	?	?	PUNCT
dpc-1935	4	1	dermatol	dermatol	NOUN
dpc-1935	4	2	pract	pract	NOUN
dpc-1935	4	3	concept	concept	NOUN
dpc-1935	4	4	.	.	PUNCT
dpc-1935	5	1	2022;12(2):e2022081	2022;12(2):e2022081	X
dpc-1935	5	2	.	.	PUNCT
dpc-1935	6	1	doi	doi	NOUN
dpc-1935	6	2	:	:	PUNCT
dpc-1935	6	3	https://doi.org/10.5826/dpc.1202a81	https://doi.org/10.5826/dpc.1202a81	NOUN
dpc-1935	6	4	accepted	accept	VERB
dpc-1935	6	5	:	:	PUNCT
dpc-1935	6	6	september	september	PROPN
dpc-1935	6	7	21	21	NUM
dpc-1935	6	8	,	,	PUNCT
dpc-1935	6	9	2021	2021	NUM
dpc-1935	6	10	;	;	PUNCT
dpc-1935	6	11	published	publish	VERB
dpc-1935	6	12	:	:	PUNCT
dpc-1935	6	13	april	april	PROPN
dpc-1935	6	14	2022	2022	NUM
dpc-1935	7	1	copyright	copyright	NOUN
dpc-1935	7	2	:	:	PUNCT
dpc-1935	7	3	©	©	PROPN
dpc-1935	7	4	2022	2022	NUM
dpc-1935	7	5	tamer	tamer	ADV
dpc-1935	7	6	et	et	PROPN
dpc-1935	7	7	al	al	PROPN
dpc-1935	7	8	.	.	PUNCT
dpc-1935	8	1	this	this	PRON
dpc-1935	8	2	is	be	AUX
dpc-1935	8	3	an	an	DET
dpc-1935	8	4	open	open	ADJ
dpc-1935	8	5	-	-	PUNCT
dpc-1935	8	6	access	access	NOUN
dpc-1935	8	7	article	article	NOUN
dpc-1935	8	8	distributed	distribute	VERB
dpc-1935	8	9	under	under	ADP
dpc-1935	8	10	the	the	DET
dpc-1935	8	11	terms	term	NOUN
dpc-1935	8	12	of	of	ADP
dpc-1935	8	13	the	the	DET
dpc-1935	8	14	creative	creative	ADJ
dpc-1935	8	15	commons	common	NOUN
dpc-1935	8	16	attribution	attribution	NOUN
dpc-1935	8	17	-	-	PUNCT
dpc-1935	8	18	noncommercial	noncommercial	ADJ
dpc-1935	8	19	license	license	NOUN
dpc-1935	8	20	(	(	PUNCT
dpc-1935	8	21	by	by	ADP
dpc-1935	8	22	-	-	PUNCT
dpc-1935	8	23	nc-4.0	nc-4.0	NOUN
dpc-1935	8	24	)	)	PUNCT
dpc-1935	8	25	,	,	PUNCT
dpc-1935	8	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1935	8	27	,	,	PUNCT
dpc-1935	8	28	which	which	PRON
dpc-1935	8	29	permits	permit	VERB
dpc-1935	8	30	unrestricted	unrestricted	ADJ
dpc-1935	8	31	noncommercial	noncommercial	ADJ
dpc-1935	8	32	use	use	NOUN
dpc-1935	8	33	,	,	PUNCT
dpc-1935	8	34	distribution	distribution	NOUN
dpc-1935	8	35	,	,	PUNCT
dpc-1935	8	36	and	and	CCONJ
dpc-1935	8	37	reproduction	reproduction	NOUN
dpc-1935	8	38	in	in	ADP
dpc-1935	8	39	any	any	DET
dpc-1935	8	40	medium	medium	NOUN
dpc-1935	8	41	,	,	PUNCT
dpc-1935	8	42	provided	provide	VERB
dpc-1935	8	43	the	the	DET
dpc-1935	8	44	original	original	ADJ
dpc-1935	8	45	authors	author	NOUN
dpc-1935	8	46	and	and	CCONJ
dpc-1935	8	47	source	source	NOUN
dpc-1935	8	48	are	be	AUX
dpc-1935	8	49	credited	credit	VERB
dpc-1935	8	50	.	.	PUNCT
dpc-1935	9	1	funding	funding	NOUN
dpc-1935	9	2	:	:	PUNCT
dpc-1935	9	3	none	none	NOUN
dpc-1935	9	4	.	.	PUNCT
dpc-1935	10	1	competing	compete	VERB
dpc-1935	10	2	interests	interest	NOUN
dpc-1935	10	3	:	:	PUNCT
dpc-1935	10	4	none	none	NOUN
dpc-1935	10	5	.	.	PUNCT
dpc-1935	11	1	authorship	authorship	NOUN
dpc-1935	11	2	:	:	PUNCT
dpc-1935	11	3	all	all	DET
dpc-1935	11	4	authors	author	NOUN
dpc-1935	11	5	have	have	AUX
dpc-1935	11	6	contributed	contribute	VERB
dpc-1935	11	7	significantly	significantly	ADV
dpc-1935	11	8	to	to	ADP
dpc-1935	11	9	this	this	DET
dpc-1935	11	10	publication	publication	NOUN
dpc-1935	11	11	.	.	PUNCT
dpc-1935	12	1	corresponding	correspond	VERB
dpc-1935	12	2	author	author	NOUN
dpc-1935	12	3	:	:	PUNCT
dpc-1935	12	4	funda	funda	PROPN
dpc-1935	12	5	tamer	tamer	NOUN
dpc-1935	12	6	,	,	PUNCT
dpc-1935	12	7	assoc	assoc	PROPN
dpc-1935	12	8	.	.	PUNCT
dpc-1935	12	9	prof	prof	PROPN
dpc-1935	12	10	.	.	PUNCT
dpc-1935	13	1	md	md	PROPN
dpc-1935	13	2	,	,	PUNCT
dpc-1935	13	3	gazi	gazi	PROPN
dpc-1935	13	4	university	university	PROPN
dpc-1935	13	5	school	school	NOUN
dpc-1935	13	6	of	of	ADP
dpc-1935	13	7	medicine	medicine	PROPN
dpc-1935	13	8	department	department	PROPN
dpc-1935	13	9	of	of	ADP
dpc-1935	13	10	dermatology	dermatology	NOUN
dpc-1935	13	11	,	,	PUNCT
dpc-1935	13	12	ankara	ankara	PROPN
dpc-1935	13	13	,	,	PUNCT
dpc-1935	13	14	turkey	turkey	PROPN
dpc-1935	13	15	.	.	PUNCT
dpc-1935	14	1	e	e	X
dpc-1935	14	2	-	-	NOUN
dpc-1935	14	3	mail	mail	NOUN
dpc-1935	14	4	:	:	PUNCT
dpc-1935	15	1	fundatmr@yahoo.com	fundatmr@yahoo.com	X
dpc-1935	15	2	introduction	introduction	NOUN
dpc-1935	15	3	:	:	PUNCT
dpc-1935	15	4	psoriasis	psoriasis	NOUN
dpc-1935	15	5	patients	patient	NOUN
dpc-1935	15	6	may	may	AUX
dpc-1935	15	7	be	be	AUX
dpc-1935	15	8	susceptible	susceptible	ADJ
dpc-1935	15	9	to	to	ADP
dpc-1935	15	10	malignancy	malignancy	NOUN
dpc-1935	15	11	due	due	ADP
dpc-1935	15	12	to	to	ADP
dpc-1935	15	13	chronic	chronic	ADJ
dpc-1935	15	14	inflammation	inflammation	NOUN
dpc-1935	15	15	.	.	PUNCT
dpc-1935	16	1	moreover	moreover	ADV
dpc-1935	16	2	,	,	PUNCT
dpc-1935	16	3	biological	biological	ADJ
dpc-1935	16	4	agents	agent	NOUN
dpc-1935	16	5	which	which	PRON
dpc-1935	16	6	are	be	AUX
dpc-1935	16	7	used	use	VERB
dpc-1935	16	8	in	in	ADP
dpc-1935	16	9	the	the	DET
dpc-1935	16	10	treatment	treatment	NOUN
dpc-1935	16	11	of	of	ADP
dpc-1935	16	12	psoriasis	psoriasis	NOUN
dpc-1935	16	13	might	might	AUX
dpc-1935	16	14	increase	increase	VERB
dpc-1935	16	15	the	the	DET
dpc-1935	16	16	risk	risk	NOUN
dpc-1935	16	17	of	of	ADP
dpc-1935	16	18	malignancy	malignancy	NOUN
dpc-1935	16	19	due	due	ADP
dpc-1935	16	20	to	to	ADP
dpc-1935	16	21	their	their	PRON
dpc-1935	16	22	immunosuppressive	immunosuppressive	ADJ
dpc-1935	16	23	effect	effect	NOUN
dpc-1935	16	24	.	.	PUNCT
dpc-1935	17	1	objectives	objective	NOUN
dpc-1935	17	2	:	:	PUNCT
dpc-1935	17	3	we	we	PRON
dpc-1935	17	4	evaluated	evaluate	VERB
dpc-1935	17	5	the	the	DET
dpc-1935	17	6	mammography	mammography	NOUN
dpc-1935	17	7	results	result	NOUN
dpc-1935	17	8	of	of	ADP
dpc-1935	17	9	female	female	ADJ
dpc-1935	17	10	patients	patient	NOUN
dpc-1935	17	11	with	with	ADP
dpc-1935	17	12	psoriasis	psoriasis	NOUN
dpc-1935	17	13	aged	age	VERB
dpc-1935	17	14	over	over	ADP
dpc-1935	17	15	40	40	NUM
dpc-1935	17	16	years	year	NOUN
dpc-1935	17	17	before	before	ADP
dpc-1935	17	18	the	the	DET
dpc-1935	17	19	initiation	initiation	NOUN
dpc-1935	17	20	of	of	ADP
dpc-1935	17	21	biological	biological	ADJ
dpc-1935	17	22	agent	agent	NOUN
dpc-1935	17	23	treatment	treatment	NOUN
dpc-1935	17	24	.	.	PUNCT
dpc-1935	18	1	we	we	PRON
dpc-1935	18	2	aimed	aim	VERB
dpc-1935	18	3	to	to	PART
dpc-1935	18	4	determine	determine	VERB
dpc-1935	18	5	whether	whether	SCONJ
dpc-1935	18	6	breast	breast	NOUN
dpc-1935	18	7	cancer	cancer	NOUN
dpc-1935	18	8	screening	screening	NOUN
dpc-1935	18	9	with	with	ADP
dpc-1935	18	10	mammography	mammography	NOUN
dpc-1935	18	11	should	should	AUX
dpc-1935	18	12	be	be	AUX
dpc-1935	18	13	a	a	DET
dpc-1935	18	14	prerequisite	prerequisite	NOUN
dpc-1935	18	15	before	before	ADP
dpc-1935	18	16	the	the	DET
dpc-1935	18	17	initiation	initiation	NOUN
dpc-1935	18	18	of	of	ADP
dpc-1935	18	19	biological	biological	ADJ
dpc-1935	18	20	agent	agent	NOUN
dpc-1935	18	21	treatment	treatment	NOUN
dpc-1935	18	22	for	for	ADP
dpc-1935	18	23	psoriasis	psoriasis	NOUN
dpc-1935	18	24	.	.	PUNCT
dpc-1935	19	1	methods	method	NOUN
dpc-1935	19	2	:	:	PUNCT
dpc-1935	19	3	between	between	ADP
dpc-1935	19	4	april	april	PROPN
dpc-1935	19	5	2019	2019	NUM
dpc-1935	19	6	and	and	CCONJ
dpc-1935	19	7	march	march	PROPN
dpc-1935	19	8	2021	2021	NUM
dpc-1935	19	9	,	,	PUNCT
dpc-1935	19	10	medical	medical	ADJ
dpc-1935	19	11	records	record	NOUN
dpc-1935	19	12	of	of	ADP
dpc-1935	19	13	female	female	ADJ
dpc-1935	19	14	psoriasis	psoriasis	NOUN
dpc-1935	19	15	patients	patient	NOUN
dpc-1935	19	16	aged	age	VERB
dpc-1935	19	17	over	over	ADP
dpc-1935	19	18	40	40	NUM
dpc-1935	19	19	years	year	NOUN
dpc-1935	19	20	were	be	AUX
dpc-1935	19	21	reviewed	review	VERB
dpc-1935	19	22	retrospectively	retrospectively	ADV
dpc-1935	19	23	.	.	PUNCT
dpc-1935	20	1	results	result	NOUN
dpc-1935	20	2	:	:	PUNCT
dpc-1935	20	3	this	this	DET
dpc-1935	20	4	study	study	NOUN
dpc-1935	20	5	included	include	VERB
dpc-1935	20	6	42	42	NUM
dpc-1935	20	7	female	female	ADJ
dpc-1935	20	8	psoriasis	psoriasis	NOUN
dpc-1935	20	9	patients	patient	NOUN
dpc-1935	20	10	(	(	PUNCT
dpc-1935	20	11	mean	mean	VERB
dpc-1935	20	12	age	age	NOUN
dpc-1935	20	13	:	:	PUNCT
dpc-1935	20	14	53.52	53.52	NUM
dpc-1935	20	15	±	±	NOUN
dpc-1935	20	16	7.09	7.09	NUM
dpc-1935	20	17	)	)	PUNCT
dpc-1935	20	18	.	.	PUNCT
dpc-1935	21	1	bi	bi	ADJ
dpc-1935	21	2	-	-	ADJ
dpc-1935	21	3	rads	rads	ADJ
dpc-1935	21	4	score	score	NOUN
dpc-1935	21	5	was	be	AUX
dpc-1935	21	6	2	2	NUM
dpc-1935	21	7	in	in	ADP
dpc-1935	21	8	18	18	NUM
dpc-1935	21	9	(	(	PUNCT
dpc-1935	21	10	42.9	42.9	NUM
dpc-1935	21	11	%	%	NOUN
dpc-1935	21	12	)	)	PUNCT
dpc-1935	21	13	patients	patient	NOUN
dpc-1935	21	14	,	,	PUNCT
dpc-1935	21	15	1	1	NUM
dpc-1935	21	16	in	in	ADP
dpc-1935	21	17	13	13	NUM
dpc-1935	21	18	(	(	PUNCT
dpc-1935	21	19	31	31	NUM
dpc-1935	21	20	%	%	NOUN
dpc-1935	21	21	)	)	PUNCT
dpc-1935	21	22	patients	patient	NOUN
dpc-1935	21	23	,	,	PUNCT
dpc-1935	21	24	3	3	NUM
dpc-1935	21	25	in	in	ADP
dpc-1935	21	26	9	9	NUM
dpc-1935	21	27	(	(	PUNCT
dpc-1935	21	28	21.4	21.4	NUM
dpc-1935	21	29	%	%	NOUN
dpc-1935	21	30	)	)	PUNCT
dpc-1935	21	31	patients	patient	NOUN
dpc-1935	21	32	and	and	CCONJ
dpc-1935	21	33	4a	4a	NOUN
dpc-1935	21	34	in	in	ADP
dpc-1935	21	35	1	1	NUM
dpc-1935	21	36	(	(	PUNCT
dpc-1935	21	37	2.4	2.4	NUM
dpc-1935	21	38	%	%	NOUN
dpc-1935	21	39	)	)	PUNCT
dpc-1935	21	40	patient	patient	NOUN
dpc-1935	21	41	.	.	PUNCT
dpc-1935	22	1	isodense	isodense	ADJ
dpc-1935	22	2	masses	masse	NOUN
dpc-1935	22	3	were	be	AUX
dpc-1935	22	4	detected	detect	VERB
dpc-1935	22	5	in	in	ADP
dpc-1935	22	6	10	10	NUM
dpc-1935	22	7	(	(	PUNCT
dpc-1935	22	8	23.8	23.8	NUM
dpc-1935	22	9	%	%	NOUN
dpc-1935	22	10	)	)	PUNCT
dpc-1935	22	11	patients	patient	NOUN
dpc-1935	22	12	,	,	PUNCT
dpc-1935	22	13	while	while	SCONJ
dpc-1935	22	14	6	6	NUM
dpc-1935	22	15	(	(	PUNCT
dpc-1935	22	16	14.3	14.3	NUM
dpc-1935	22	17	%	%	NOUN
dpc-1935	22	18	)	)	PUNCT
dpc-1935	22	19	patients	patient	NOUN
dpc-1935	22	20	had	have	VERB
dpc-1935	22	21	intramammary	intramammary	ADJ
dpc-1935	22	22	lymph	lymph	NOUN
dpc-1935	22	23	nodes	node	NOUN
dpc-1935	22	24	.	.	PUNCT
dpc-1935	23	1	mammography	mammography	NOUN
dpc-1935	23	2	revealed	reveal	VERB
dpc-1935	23	3	microcalcifications	microcalcification	NOUN
dpc-1935	23	4	in	in	ADP
dpc-1935	23	5	6	6	NUM
dpc-1935	23	6	(	(	PUNCT
dpc-1935	23	7	14.3	14.3	NUM
dpc-1935	23	8	%	%	NOUN
dpc-1935	23	9	)	)	PUNCT
dpc-1935	23	10	patients	patient	NOUN
dpc-1935	23	11	,	,	PUNCT
dpc-1935	23	12	macrocalcifications	macrocalcification	NOUN
dpc-1935	23	13	in	in	ADP
dpc-1935	23	14	1	1	NUM
dpc-1935	23	15	(	(	PUNCT
dpc-1935	23	16	2.4	2.4	NUM
dpc-1935	23	17	%	%	NOUN
dpc-1935	23	18	)	)	PUNCT
dpc-1935	23	19	patient	patient	NOUN
dpc-1935	23	20	and	and	CCONJ
dpc-1935	23	21	a	a	DET
dpc-1935	23	22	hamartoma	hamartoma	NOUN
dpc-1935	23	23	in	in	ADP
dpc-1935	23	24	1	1	NUM
dpc-1935	23	25	(	(	PUNCT
dpc-1935	23	26	2.4	2.4	NUM
dpc-1935	23	27	%	%	NOUN
dpc-1935	23	28	)	)	PUNCT
dpc-1935	23	29	patient	patient	NOUN
dpc-1935	23	30	.	.	PUNCT
dpc-1935	24	1	isodense	isodense	ADJ
dpc-1935	24	2	masses	masse	NOUN
dpc-1935	24	3	,	,	PUNCT
dpc-1935	24	4	calcifications	calcification	NOUN
dpc-1935	24	5	and	and	CCONJ
dpc-1935	24	6	intramammary	intramammary	ADJ
dpc-1935	24	7	lymph	lymph	NOUN
dpc-1935	24	8	nodes	node	NOUN
dpc-1935	24	9	were	be	AUX
dpc-1935	24	10	associated	associate	VERB
dpc-1935	24	11	with	with	ADP
dpc-1935	24	12	long	long	ADJ
dpc-1935	24	13	disease	disease	NOUN
dpc-1935	24	14	duration	duration	NOUN
dpc-1935	24	15	(	(	PUNCT
dpc-1935	24	16	>	>	X
dpc-1935	24	17	10	10	NUM
dpc-1935	24	18	years	year	NOUN
dpc-1935	24	19	)	)	PUNCT
dpc-1935	24	20	.	.	PUNCT
dpc-1935	25	1	intramammary	intramammary	ADJ
dpc-1935	25	2	lymph	lymph	NOUN
dpc-1935	25	3	nodes	node	NOUN
dpc-1935	25	4	were	be	AUX
dpc-1935	25	5	more	more	ADV
dpc-1935	25	6	common	common	ADJ
dpc-1935	25	7	in	in	ADP
dpc-1935	25	8	patients	patient	NOUN
dpc-1935	25	9	treated	treat	VERB
dpc-1935	25	10	with	with	ADP
dpc-1935	25	11	biological	biological	ADJ
dpc-1935	25	12	agents	agent	NOUN
dpc-1935	25	13	previously	previously	ADV
dpc-1935	25	14	compared	compare	VERB
dpc-1935	25	15	to	to	ADP
dpc-1935	25	16	biologic	biologic	ADJ
dpc-1935	25	17	-	-	PUNCT
dpc-1935	25	18	naive	naive	ADJ
dpc-1935	25	19	patients	patient	NOUN
dpc-1935	25	20	.	.	PUNCT
dpc-1935	26	1	conclusions	conclusion	NOUN
dpc-1935	26	2	:	:	PUNCT
dpc-1935	26	3	we	we	PRON
dpc-1935	26	4	suggest	suggest	VERB
dpc-1935	26	5	that	that	SCONJ
dpc-1935	26	6	female	female	ADJ
dpc-1935	26	7	patients	patient	NOUN
dpc-1935	26	8	over	over	ADP
dpc-1935	26	9	40	40	NUM
dpc-1935	26	10	years	year	NOUN
dpc-1935	26	11	,	,	PUNCT
dpc-1935	26	12	especially	especially	ADV
dpc-1935	26	13	those	those	PRON
dpc-1935	26	14	who	who	PRON
dpc-1935	26	15	had	have	VERB
dpc-1935	26	16	a	a	DET
dpc-1935	26	17	long	long	ADJ
dpc-1935	26	18	disease	disease	NOUN
dpc-1935	26	19	duration	duration	NOUN
dpc-1935	26	20	,	,	PUNCT
dpc-1935	26	21	family	family	NOUN
dpc-1935	26	22	history	history	NOUN
dpc-1935	26	23	of	of	ADP
dpc-1935	26	24	breast	breast	NOUN
dpc-1935	26	25	cancer	cancer	NOUN
dpc-1935	26	26	and	and	CCONJ
dpc-1935	26	27	previous	previous	ADJ
dpc-1935	26	28	history	history	NOUN
dpc-1935	26	29	of	of	ADP
dpc-1935	26	30	treatment	treatment	NOUN
dpc-1935	26	31	with	with	ADP
dpc-1935	26	32	biological	biological	ADJ
dpc-1935	26	33	agents	agent	NOUN
dpc-1935	26	34	should	should	AUX
dpc-1935	26	35	undergo	undergo	VERB
dpc-1935	26	36	mammography	mammography	NOUN
dpc-1935	26	37	before	before	ADP
dpc-1935	26	38	the	the	DET
dpc-1935	26	39	initiation	initiation	NOUN
dpc-1935	26	40	of	of	ADP
dpc-1935	26	41	biological	biological	ADJ
dpc-1935	26	42	agents	agent	NOUN
dpc-1935	26	43	for	for	ADP
dpc-1935	26	44	the	the	DET
dpc-1935	26	45	treatment	treatment	NOUN
dpc-1935	26	46	of	of	ADP
dpc-1935	26	47	psoriasis	psoriasis	NOUN
dpc-1935	26	48	.	.	PUNCT
dpc-1935	27	1	abstract	abstract	ADJ
dpc-1935	27	2	2	2	NUM
dpc-1935	27	3	original	original	ADJ
dpc-1935	27	4	article	article	NOUN
dpc-1935	27	5	|	|	ADV
dpc-1935	27	6	dermatol	dermatol	ADJ
dpc-1935	27	7	pract	pract	NOUN
dpc-1935	27	8	concept	concept	NOUN
dpc-1935	27	9	.	.	PUNCT
dpc-1935	28	1	2022;12(2):e2022081	2022;12(2):e2022081	NUM
dpc-1935	28	2	introduction	introduction	NOUN
dpc-1935	28	3	psoriasis	psoriasis	NOUN
dpc-1935	28	4	is	be	AUX
dpc-1935	28	5	a	a	DET
dpc-1935	28	6	chronic	chronic	ADJ
dpc-1935	28	7	inflammatory	inflammatory	ADJ
dpc-1935	28	8	skin	skin	NOUN
dpc-1935	28	9	disorder	disorder	NOUN
dpc-1935	28	10	accompanied	accompany	VERB
dpc-1935	28	11	by	by	ADP
dpc-1935	28	12	various	various	ADJ
dpc-1935	28	13	comorbidities	comorbiditie	NOUN
dpc-1935	28	14	such	such	ADJ
dpc-1935	28	15	as	as	ADP
dpc-1935	28	16	psoriatic	psoriatic	ADJ
dpc-1935	28	17	arthiritis	arthiritis	PROPN
dpc-1935	28	18	,	,	PUNCT
dpc-1935	28	19	metabolic	metabolic	NOUN
dpc-1935	28	20	syndrome	syndrome	NOUN
dpc-1935	28	21	and	and	CCONJ
dpc-1935	28	22	cardiovascular	cardiovascular	ADJ
dpc-1935	28	23	disease	disease	NOUN
dpc-1935	28	24	[	[	X
dpc-1935	28	25	1	1	NUM
dpc-1935	28	26	]	]	PUNCT
dpc-1935	28	27	.	.	PUNCT
dpc-1935	29	1	since	since	SCONJ
dpc-1935	29	2	chronic	chronic	ADJ
dpc-1935	29	3	inflammation	inflammation	NOUN
dpc-1935	29	4	has	have	AUX
dpc-1935	29	5	been	be	AUX
dpc-1935	29	6	implicated	implicate	VERB
dpc-1935	29	7	in	in	ADP
dpc-1935	29	8	the	the	DET
dpc-1935	29	9	etiopathogenesis	etiopathogenesis	NOUN
dpc-1935	29	10	of	of	ADP
dpc-1935	29	11	both	both	DET
dpc-1935	29	12	psoriasis	psoriasis	NOUN
dpc-1935	29	13	and	and	CCONJ
dpc-1935	29	14	malignancy	malignancy	NOUN
dpc-1935	29	15	,	,	PUNCT
dpc-1935	29	16	it	it	PRON
dpc-1935	29	17	has	have	AUX
dpc-1935	29	18	been	be	AUX
dpc-1935	29	19	suggested	suggest	VERB
dpc-1935	29	20	that	that	SCONJ
dpc-1935	29	21	psoriasis	psoriasis	NOUN
dpc-1935	29	22	might	might	AUX
dpc-1935	29	23	be	be	AUX
dpc-1935	29	24	associated	associate	VERB
dpc-1935	29	25	with	with	ADP
dpc-1935	29	26	increased	increase	VERB
dpc-1935	29	27	risk	risk	NOUN
dpc-1935	29	28	of	of	ADP
dpc-1935	29	29	malignancy	malignancy	NOUN
dpc-1935	29	30	.	.	PUNCT
dpc-1935	30	1	development	development	NOUN
dpc-1935	30	2	of	of	ADP
dpc-1935	30	3	cancer	cancer	NOUN
dpc-1935	30	4	was	be	AUX
dpc-1935	30	5	reported	report	VERB
dpc-1935	30	6	1.18	1.18	NUM
dpc-1935	30	7	times	time	NOUN
dpc-1935	30	8	more	more	ADV
dpc-1935	30	9	common	common	ADJ
dpc-1935	30	10	in	in	ADP
dpc-1935	30	11	patients	patient	NOUN
dpc-1935	30	12	with	with	ADP
dpc-1935	30	13	psoriasis	psoriasis	NOUN
dpc-1935	30	14	compared	compare	VERB
dpc-1935	30	15	to	to	ADP
dpc-1935	30	16	individuals	individual	NOUN
dpc-1935	30	17	without	without	ADP
dpc-1935	30	18	psoriasis	psoriasis	NOUN
dpc-1935	30	19	[	[	X
dpc-1935	30	20	2	2	NUM
dpc-1935	30	21	]	]	PUNCT
dpc-1935	30	22	.	.	PUNCT
dpc-1935	31	1	furthermore	furthermore	ADV
dpc-1935	31	2	,	,	PUNCT
dpc-1935	31	3	mortality	mortality	NOUN
dpc-1935	31	4	rates	rate	NOUN
dpc-1935	31	5	were	be	AUX
dpc-1935	31	6	elevated	elevate	VERB
dpc-1935	31	7	in	in	ADP
dpc-1935	31	8	accordance	accordance	NOUN
dpc-1935	31	9	with	with	ADP
dpc-1935	31	10	the	the	DET
dpc-1935	31	11	severity	severity	NOUN
dpc-1935	31	12	of	of	ADP
dpc-1935	31	13	psoriasis	psoriasis	NOUN
dpc-1935	31	14	.	.	PUNCT
dpc-1935	32	1	malignancies	malignancy	NOUN
dpc-1935	32	2	such	such	ADJ
dpc-1935	32	3	as	as	ADP
dpc-1935	32	4	squamous	squamous	ADJ
dpc-1935	32	5	cell	cell	NOUN
dpc-1935	32	6	carcinoma	carcinoma	NOUN
dpc-1935	32	7	,	,	PUNCT
dpc-1935	32	8	lymphoma	lymphoma	NOUN
dpc-1935	32	9	,	,	PUNCT
dpc-1935	32	10	colorectal	colorectal	ADJ
dpc-1935	32	11	,	,	PUNCT
dpc-1935	32	12	pancreatic	pancreatic	ADJ
dpc-1935	32	13	,	,	PUNCT
dpc-1935	32	14	kidney	kidney	NOUN
dpc-1935	32	15	,	,	PUNCT
dpc-1935	32	16	liver	liver	NOUN
dpc-1935	32	17	,	,	PUNCT
dpc-1935	32	18	esophageal	esophageal	ADJ
dpc-1935	32	19	and	and	CCONJ
dpc-1935	32	20	laryngeal	laryngeal	ADJ
dpc-1935	32	21	cancer	cancer	NOUN
dpc-1935	32	22	have	have	AUX
dpc-1935	32	23	been	be	AUX
dpc-1935	32	24	related	relate	VERB
dpc-1935	32	25	to	to	ADP
dpc-1935	32	26	psoriasis	psoriasis	NOUN
dpc-1935	32	27	[	[	X
dpc-1935	32	28	2	2	NUM
dpc-1935	32	29	]	]	PUNCT
dpc-1935	32	30	.	.	PUNCT
dpc-1935	33	1	high	high	ADJ
dpc-1935	33	2	prevalence	prevalence	NOUN
dpc-1935	33	3	of	of	ADP
dpc-1935	33	4	breast	breast	NOUN
dpc-1935	33	5	cancer	cancer	NOUN
dpc-1935	33	6	has	have	AUX
dpc-1935	33	7	also	also	ADV
dpc-1935	33	8	been	be	AUX
dpc-1935	33	9	reported	report	VERB
dpc-1935	33	10	in	in	ADP
dpc-1935	33	11	patients	patient	NOUN
dpc-1935	33	12	with	with	ADP
dpc-1935	33	13	psoriasis	psoriasis	NOUN
dpc-1935	33	14	[	[	X
dpc-1935	33	15	3	3	NUM
dpc-1935	33	16	]	]	PUNCT
dpc-1935	33	17	.	.	PUNCT
dpc-1935	34	1	however	however	ADV
dpc-1935	34	2	,	,	PUNCT
dpc-1935	34	3	relationship	relationship	NOUN
dpc-1935	34	4	between	between	ADP
dpc-1935	34	5	psoriasis	psoriasis	NOUN
dpc-1935	34	6	and	and	CCONJ
dpc-1935	34	7	the	the	DET
dpc-1935	34	8	risk	risk	NOUN
dpc-1935	34	9	for	for	ADP
dpc-1935	34	10	the	the	DET
dpc-1935	34	11	development	development	NOUN
dpc-1935	34	12	of	of	ADP
dpc-1935	34	13	malignancy	malignancy	NOUN
dpc-1935	34	14	remains	remain	VERB
dpc-1935	34	15	controversial	controversial	ADJ
dpc-1935	34	16	[	[	X
dpc-1935	34	17	4	4	NUM
dpc-1935	34	18	]	]	PUNCT
dpc-1935	34	19	.	.	PUNCT
dpc-1935	35	1	on	on	ADP
dpc-1935	35	2	the	the	DET
dpc-1935	35	3	other	other	ADJ
dpc-1935	35	4	hand	hand	NOUN
dpc-1935	35	5	,	,	PUNCT
dpc-1935	35	6	increased	increase	VERB
dpc-1935	35	7	use	use	NOUN
dpc-1935	35	8	of	of	ADP
dpc-1935	35	9	biological	biological	ADJ
dpc-1935	35	10	agents	agent	NOUN
dpc-1935	35	11	in	in	ADP
dpc-1935	35	12	the	the	DET
dpc-1935	35	13	treatment	treatment	NOUN
dpc-1935	35	14	of	of	ADP
dpc-1935	35	15	psoriasis	psoriasis	NOUN
dpc-1935	35	16	leads	lead	VERB
dpc-1935	35	17	to	to	ADP
dpc-1935	35	18	concerns	concern	NOUN
dpc-1935	35	19	about	about	ADP
dpc-1935	35	20	whether	whether	SCONJ
dpc-1935	35	21	biological	biological	ADJ
dpc-1935	35	22	agents	agent	NOUN
dpc-1935	35	23	increase	increase	VERB
dpc-1935	35	24	the	the	DET
dpc-1935	35	25	risk	risk	NOUN
dpc-1935	35	26	of	of	ADP
dpc-1935	35	27	malignancy	malignancy	NOUN
dpc-1935	35	28	or	or	CCONJ
dpc-1935	35	29	not	not	PART
dpc-1935	35	30	[	[	X
dpc-1935	35	31	5	5	NUM
dpc-1935	35	32	]	]	PUNCT
dpc-1935	35	33	.	.	PUNCT
dpc-1935	36	1	it	it	PRON
dpc-1935	36	2	has	have	AUX
dpc-1935	36	3	been	be	AUX
dpc-1935	36	4	suggested	suggest	VERB
dpc-1935	36	5	that	that	SCONJ
dpc-1935	36	6	tumor	tumor	NOUN
dpc-1935	36	7	necrosis	necrosis	NOUN
dpc-1935	36	8	factor	factor	NOUN
dpc-1935	36	9	-	-	PUNCT
dpc-1935	36	10	α	α	X
dpc-1935	36	11	(	(	PUNCT
dpc-1935	36	12	tnf	tnf	PROPN
dpc-1935	36	13	-	-	PUNCT
dpc-1935	36	14	α	α	NOUN
dpc-1935	36	15	)	)	PUNCT
dpc-1935	36	16	inhibitors	inhibitor	NOUN
dpc-1935	36	17	,	,	PUNCT
dpc-1935	36	18	anti	anti	ADJ
dpc-1935	36	19	-	-	ADJ
dpc-1935	36	20	interleukin	interleukin	ADJ
dpc-1935	36	21	(	(	PUNCT
dpc-1935	36	22	il)12	il)12	NOUN
dpc-1935	36	23	/	/	SYM
dpc-1935	36	24	il-23	il-23	NOUN
dpc-1935	36	25	and	and	CCONJ
dpc-1935	36	26	anti	anti	ADJ
dpc-1935	36	27	-	-	ADJ
dpc-1935	36	28	il-17a	il-17a	ADJ
dpc-1935	36	29	antibodies	antibodie	VERB
dpc-1935	36	30	might	might	AUX
dpc-1935	36	31	increase	increase	VERB
dpc-1935	36	32	the	the	DET
dpc-1935	36	33	risk	risk	NOUN
dpc-1935	36	34	of	of	ADP
dpc-1935	36	35	malignancies	malignancy	NOUN
dpc-1935	36	36	due	due	ADP
dpc-1935	36	37	to	to	ADP
dpc-1935	36	38	their	their	PRON
dpc-1935	36	39	immunosuppressive	immunosuppressive	ADJ
dpc-1935	36	40	effects	effect	NOUN
dpc-1935	36	41	[	[	X
dpc-1935	36	42	6	6	NUM
dpc-1935	36	43	]	]	PUNCT
dpc-1935	36	44	.	.	PUNCT
dpc-1935	37	1	for	for	ADP
dpc-1935	37	2	instance	instance	NOUN
dpc-1935	37	3	,	,	PUNCT
dpc-1935	37	4	use	use	NOUN
dpc-1935	37	5	of	of	ADP
dpc-1935	37	6	tnf	tnf	PROPN
dpc-1935	37	7	-	-	PUNCT
dpc-1935	37	8	α	α	NOUN
dpc-1935	37	9	inhibitors	inhibitor	NOUN
dpc-1935	37	10	such	such	ADJ
dpc-1935	37	11	as	as	ADP
dpc-1935	37	12	etanercept	etanercept	NOUN
dpc-1935	37	13	,	,	PUNCT
dpc-1935	37	14	adalimumab	adalimumab	NOUN
dpc-1935	37	15	and	and	CCONJ
dpc-1935	37	16	infliximab	infliximab	NOUN
dpc-1935	37	17	longer	long	ADV
dpc-1935	37	18	than	than	ADP
dpc-1935	37	19	12	12	NUM
dpc-1935	37	20	months	month	NOUN
dpc-1935	37	21	has	have	AUX
dpc-1935	37	22	been	be	AUX
dpc-1935	37	23	implicated	implicate	VERB
dpc-1935	37	24	in	in	ADP
dpc-1935	37	25	increased	increase	VERB
dpc-1935	37	26	risk	risk	NOUN
dpc-1935	37	27	for	for	ADP
dpc-1935	37	28	malignancy	malignancy	NOUN
dpc-1935	37	29	[	[	X
dpc-1935	37	30	5	5	NUM
dpc-1935	37	31	]	]	PUNCT
dpc-1935	37	32	.	.	PUNCT
dpc-1935	38	1	development	development	NOUN
dpc-1935	38	2	of	of	ADP
dpc-1935	38	3	breast	breast	NOUN
dpc-1935	38	4	cancer	cancer	NOUN
dpc-1935	38	5	was	be	AUX
dpc-1935	38	6	reported	report	VERB
dpc-1935	38	7	in	in	ADP
dpc-1935	38	8	a	a	DET
dpc-1935	38	9	patient	patient	NOUN
dpc-1935	38	10	following	follow	VERB
dpc-1935	38	11	systemic	systemic	ADJ
dpc-1935	38	12	psoriasis	psoriasis	NOUN
dpc-1935	38	13	treatment	treatment	NOUN
dpc-1935	38	14	with	with	ADP
dpc-1935	38	15	conventional	conventional	ADJ
dpc-1935	38	16	therapy	therapy	NOUN
dpc-1935	38	17	,	,	PUNCT
dpc-1935	38	18	adalimumab	adalimumab	NOUN
dpc-1935	38	19	and	and	CCONJ
dpc-1935	38	20	ustekinumab	ustekinumab	NOUN
dpc-1935	39	1	[	[	X
dpc-1935	39	2	6	6	NUM
dpc-1935	39	3	]	]	PUNCT
dpc-1935	39	4	.	.	PUNCT
dpc-1935	40	1	it	it	PRON
dpc-1935	40	2	has	have	AUX
dpc-1935	40	3	been	be	AUX
dpc-1935	40	4	suggested	suggest	VERB
dpc-1935	40	5	that	that	SCONJ
dpc-1935	40	6	breast	breast	NOUN
dpc-1935	40	7	cancer	cancer	NOUN
dpc-1935	40	8	was	be	AUX
dpc-1935	40	9	one	one	NUM
dpc-1935	40	10	of	of	ADP
dpc-1935	40	11	the	the	DET
dpc-1935	40	12	most	most	ADV
dpc-1935	40	13	commonly	commonly	ADV
dpc-1935	40	14	detected	detect	VERB
dpc-1935	40	15	malignancy	malignancy	NOUN
dpc-1935	40	16	in	in	ADP
dpc-1935	40	17	patients	patient	NOUN
dpc-1935	40	18	who	who	PRON
dpc-1935	40	19	received	receive	VERB
dpc-1935	40	20	ustekinumab	ustekinumab	NOUN
dpc-1935	41	1	[	[	X
dpc-1935	41	2	7	7	NUM
dpc-1935	41	3	]	]	PUNCT
dpc-1935	41	4	.	.	PUNCT
dpc-1935	42	1	biological	biological	ADJ
dpc-1935	42	2	agent	agent	NOUN
dpc-1935	42	3	treatment	treatment	NOUN
dpc-1935	42	4	is	be	AUX
dpc-1935	42	5	not	not	PART
dpc-1935	42	6	recommended	recommend	VERB
dpc-1935	42	7	in	in	ADP
dpc-1935	42	8	patients	patient	NOUN
dpc-1935	42	9	who	who	PRON
dpc-1935	42	10	had	have	VERB
dpc-1935	42	11	an	an	DET
dpc-1935	42	12	active	active	ADJ
dpc-1935	42	13	malignancy	malignancy	NOUN
dpc-1935	42	14	within	within	ADP
dpc-1935	42	15	the	the	DET
dpc-1935	42	16	last	last	ADJ
dpc-1935	42	17	five	five	NUM
dpc-1935	42	18	years	year	NOUN
dpc-1935	43	1	[	[	X
dpc-1935	43	2	8	8	NUM
dpc-1935	43	3	]	]	PUNCT
dpc-1935	43	4	.	.	PUNCT
dpc-1935	44	1	evaluation	evaluation	NOUN
dpc-1935	44	2	of	of	ADP
dpc-1935	44	3	patients	patient	NOUN
dpc-1935	44	4	with	with	ADP
dpc-1935	44	5	psoriasis	psoriasis	NOUN
dpc-1935	44	6	before	before	ADV
dpc-1935	44	7	and	and	CCONJ
dpc-1935	44	8	throughout	throughout	ADP
dpc-1935	44	9	the	the	DET
dpc-1935	44	10	biological	biological	ADJ
dpc-1935	44	11	agent	agent	NOUN
dpc-1935	44	12	treatment	treatment	NOUN
dpc-1935	44	13	according	accord	VERB
dpc-1935	44	14	to	to	ADP
dpc-1935	44	15	their	their	PRON
dpc-1935	44	16	medical	medical	ADJ
dpc-1935	44	17	history	history	NOUN
dpc-1935	44	18	of	of	ADP
dpc-1935	44	19	cancer	cancer	NOUN
dpc-1935	44	20	and	and	CCONJ
dpc-1935	44	21	risk	risk	NOUN
dpc-1935	44	22	for	for	ADP
dpc-1935	44	23	the	the	DET
dpc-1935	44	24	development	development	NOUN
dpc-1935	44	25	of	of	ADP
dpc-1935	44	26	cancer	cancer	NOUN
dpc-1935	44	27	is	be	AUX
dpc-1935	44	28	crucial	crucial	ADJ
dpc-1935	44	29	[	[	X
dpc-1935	44	30	9	9	NUM
dpc-1935	44	31	]	]	PUNCT
dpc-1935	44	32	.	.	PUNCT
dpc-1935	45	1	therefore	therefore	ADV
dpc-1935	45	2	,	,	PUNCT
dpc-1935	45	3	patients	patient	NOUN
dpc-1935	45	4	with	with	ADP
dpc-1935	45	5	psoriasis	psoriasis	NOUN
dpc-1935	45	6	receiving	receive	VERB
dpc-1935	45	7	biological	biological	ADJ
dpc-1935	45	8	agents	agent	NOUN
dpc-1935	45	9	should	should	AUX
dpc-1935	45	10	be	be	AUX
dpc-1935	45	11	encouraged	encourage	VERB
dpc-1935	45	12	to	to	PART
dpc-1935	45	13	participate	participate	VERB
dpc-1935	45	14	in	in	ADP
dpc-1935	45	15	national	national	ADJ
dpc-1935	45	16	cancer	cancer	NOUN
dpc-1935	45	17	screening	screen	VERB
dpc-1935	45	18	programmes	programme	NOUN
dpc-1935	45	19	[	[	X
dpc-1935	45	20	9,10	9,10	X
dpc-1935	45	21	]	]	PUNCT
dpc-1935	45	22	.	.	PUNCT
dpc-1935	46	1	however	however	ADV
dpc-1935	46	2	,	,	PUNCT
dpc-1935	46	3	it	it	PRON
dpc-1935	46	4	has	have	AUX
dpc-1935	46	5	been	be	AUX
dpc-1935	46	6	reported	report	VERB
dpc-1935	46	7	that	that	SCONJ
dpc-1935	46	8	patients	patient	NOUN
dpc-1935	46	9	with	with	ADP
dpc-1935	46	10	psoriasis	psoriasis	NOUN
dpc-1935	46	11	who	who	PRON
dpc-1935	46	12	were	be	AUX
dpc-1935	46	13	treated	treat	VERB
dpc-1935	46	14	with	with	ADP
dpc-1935	46	15	biological	biological	ADJ
dpc-1935	46	16	agents	agent	NOUN
dpc-1935	46	17	did	do	AUX
dpc-1935	46	18	not	not	PART
dpc-1935	46	19	undergo	undergo	VERB
dpc-1935	46	20	recommended	recommend	VERB
dpc-1935	46	21	tests	test	NOUN
dpc-1935	46	22	for	for	ADP
dpc-1935	46	23	breast	breast	NOUN
dpc-1935	46	24	cancer	cancer	NOUN
dpc-1935	46	25	screening	screen	VERB
dpc-1935	46	26	adequately	adequately	ADV
dpc-1935	46	27	despite	despite	SCONJ
dpc-1935	46	28	increased	increase	VERB
dpc-1935	46	29	risk	risk	NOUN
dpc-1935	46	30	for	for	ADP
dpc-1935	46	31	malignancy	malignancy	NOUN
dpc-1935	46	32	[	[	X
dpc-1935	46	33	11	11	NUM
dpc-1935	46	34	]	]	PUNCT
dpc-1935	46	35	.	.	PUNCT
dpc-1935	47	1	objectives	objective	NOUN
dpc-1935	47	2	within	within	ADP
dpc-1935	47	3	this	this	DET
dpc-1935	47	4	study	study	NOUN
dpc-1935	47	5	,	,	PUNCT
dpc-1935	47	6	we	we	PRON
dpc-1935	47	7	evaluated	evaluate	VERB
dpc-1935	47	8	the	the	DET
dpc-1935	47	9	mammography	mammography	NOUN
dpc-1935	47	10	results	result	NOUN
dpc-1935	47	11	of	of	ADP
dpc-1935	47	12	female	female	ADJ
dpc-1935	47	13	patients	patient	NOUN
dpc-1935	47	14	with	with	ADP
dpc-1935	47	15	psoriasis	psoriasis	NOUN
dpc-1935	47	16	aged	age	VERB
dpc-1935	47	17	over	over	ADP
dpc-1935	47	18	40	40	NUM
dpc-1935	47	19	years	year	NOUN
dpc-1935	47	20	before	before	ADP
dpc-1935	47	21	the	the	DET
dpc-1935	47	22	initiation	initiation	NOUN
dpc-1935	47	23	of	of	ADP
dpc-1935	47	24	biological	biological	ADJ
dpc-1935	47	25	agent	agent	NOUN
dpc-1935	47	26	treatment	treatment	NOUN
dpc-1935	47	27	in	in	ADP
dpc-1935	47	28	order	order	NOUN
dpc-1935	47	29	to	to	PART
dpc-1935	47	30	detect	detect	VERB
dpc-1935	47	31	premalignant	premalignant	ADJ
dpc-1935	47	32	and	and	CCONJ
dpc-1935	47	33	malignant	malignant	ADJ
dpc-1935	47	34	breast	breast	NOUN
dpc-1935	47	35	lesions	lesion	NOUN
dpc-1935	47	36	.	.	PUNCT
dpc-1935	48	1	we	we	PRON
dpc-1935	48	2	aimed	aim	VERB
dpc-1935	48	3	to	to	PART
dpc-1935	48	4	reveal	reveal	VERB
dpc-1935	48	5	whether	whether	SCONJ
dpc-1935	48	6	breast	breast	NOUN
dpc-1935	48	7	cancer	cancer	NOUN
dpc-1935	48	8	screening	screening	NOUN
dpc-1935	48	9	with	with	ADP
dpc-1935	48	10	mammography	mammography	NOUN
dpc-1935	48	11	should	should	AUX
dpc-1935	48	12	be	be	AUX
dpc-1935	48	13	a	a	DET
dpc-1935	48	14	prerequisite	prerequisite	NOUN
dpc-1935	48	15	prior	prior	ADV
dpc-1935	48	16	to	to	ADP
dpc-1935	48	17	biological	biological	ADJ
dpc-1935	48	18	agent	agent	NOUN
dpc-1935	48	19	treatment	treatment	NOUN
dpc-1935	48	20	for	for	ADP
dpc-1935	48	21	psoriasis	psoriasis	NOUN
dpc-1935	48	22	or	or	CCONJ
dpc-1935	48	23	not	not	PART
dpc-1935	48	24	.	.	PUNCT
dpc-1935	49	1	methods	method	NOUN
dpc-1935	49	2	between	between	ADP
dpc-1935	49	3	april	april	PROPN
dpc-1935	49	4	2019	2019	NUM
dpc-1935	49	5	and	and	CCONJ
dpc-1935	49	6	march	march	PROPN
dpc-1935	49	7	2021	2021	NUM
dpc-1935	49	8	,	,	PUNCT
dpc-1935	49	9	medical	medical	ADJ
dpc-1935	49	10	records	record	NOUN
dpc-1935	49	11	of	of	ADP
dpc-1935	49	12	the	the	DET
dpc-1935	49	13	female	female	ADJ
dpc-1935	49	14	psoriasis	psoriasis	NOUN
dpc-1935	49	15	patients	patient	NOUN
dpc-1935	49	16	aged	age	VERB
dpc-1935	49	17	over	over	ADP
dpc-1935	49	18	40	40	NUM
dpc-1935	49	19	years	year	NOUN
dpc-1935	49	20	who	who	PRON
dpc-1935	49	21	underwent	undergo	VERB
dpc-1935	49	22	mammography	mammography	NOUN
dpc-1935	49	23	before	before	ADP
dpc-1935	49	24	the	the	DET
dpc-1935	49	25	initiation	initiation	NOUN
dpc-1935	49	26	of	of	ADP
dpc-1935	49	27	biological	biological	ADJ
dpc-1935	49	28	agent	agent	NOUN
dpc-1935	49	29	treatment	treatment	NOUN
dpc-1935	49	30	were	be	AUX
dpc-1935	49	31	reviewed	review	VERB
dpc-1935	49	32	retrospectively	retrospectively	ADV
dpc-1935	49	33	.	.	PUNCT
dpc-1935	50	1	gazi	gazi	PROPN
dpc-1935	50	2	university	university	PROPN
dpc-1935	50	3	ethics	ethic	NOUN
dpc-1935	50	4	committee	committee	PROPN
dpc-1935	50	5	approval	approval	NOUN
dpc-1935	50	6	was	be	AUX
dpc-1935	50	7	obtained	obtain	VERB
dpc-1935	50	8	for	for	ADP
dpc-1935	50	9	this	this	DET
dpc-1935	50	10	study	study	NOUN
dpc-1935	50	11	(	(	PUNCT
dpc-1935	50	12	approval	approval	NOUN
dpc-1935	50	13	number	number	NOUN
dpc-1935	50	14	:	:	PUNCT
dpc-1935	50	15	2021	2021	NUM
dpc-1935	50	16	-	-	SYM
dpc-1935	50	17	412	412	NUM
dpc-1935	50	18	)	)	PUNCT
dpc-1935	50	19	.	.	PUNCT
dpc-1935	51	1	patients	patient	NOUN
dpc-1935	51	2	who	who	PRON
dpc-1935	51	3	had	have	VERB
dpc-1935	51	4	an	an	DET
dpc-1935	51	5	increased	increase	VERB
dpc-1935	51	6	risk	risk	NOUN
dpc-1935	51	7	for	for	ADP
dpc-1935	51	8	the	the	DET
dpc-1935	51	9	development	development	NOUN
dpc-1935	51	10	of	of	ADP
dpc-1935	51	11	breast	breast	NOUN
dpc-1935	51	12	cancer	cancer	NOUN
dpc-1935	51	13	such	such	ADJ
dpc-1935	51	14	as	as	ADP
dpc-1935	51	15	previous	previous	ADJ
dpc-1935	51	16	breast	breast	NOUN
dpc-1935	51	17	cancer	cancer	NOUN
dpc-1935	51	18	,	,	PUNCT
dpc-1935	51	19	radiation	radiation	NOUN
dpc-1935	51	20	exposure	exposure	NOUN
dpc-1935	51	21	to	to	ADP
dpc-1935	51	22	the	the	DET
dpc-1935	51	23	chest	chest	NOUN
dpc-1935	51	24	,	,	PUNCT
dpc-1935	51	25	high	high	ADJ
dpc-1935	51	26	hereditary	hereditary	ADJ
dpc-1935	51	27	risk	risk	NOUN
dpc-1935	51	28	for	for	ADP
dpc-1935	51	29	breast	breast	NOUN
dpc-1935	51	30	cancer	cancer	NOUN
dpc-1935	51	31	,	,	PUNCT
dpc-1935	51	32	patients	patient	NOUN
dpc-1935	51	33	with	with	ADP
dpc-1935	51	34	ovarian	ovarian	ADJ
dpc-1935	51	35	and	and	CCONJ
dpc-1935	51	36	endometrial	endometrial	ADJ
dpc-1935	51	37	malignancies	malignancy	NOUN
dpc-1935	51	38	and	and	CCONJ
dpc-1935	51	39	immunocompromised	immunocompromise	VERB
dpc-1935	51	40	patients	patient	NOUN
dpc-1935	51	41	were	be	AUX
dpc-1935	51	42	excluded	exclude	VERB
dpc-1935	51	43	from	from	ADP
dpc-1935	51	44	the	the	DET
dpc-1935	51	45	study	study	NOUN
dpc-1935	51	46	.	.	PUNCT
dpc-1935	52	1	mammography	mammography	NOUN
dpc-1935	52	2	was	be	AUX
dpc-1935	52	3	routinely	routinely	ADV
dpc-1935	52	4	performed	perform	VERB
dpc-1935	52	5	in	in	ADP
dpc-1935	52	6	female	female	ADJ
dpc-1935	52	7	psoriasis	psoriasis	NOUN
dpc-1935	52	8	patients	patient	NOUN
dpc-1935	52	9	over	over	ADP
dpc-1935	52	10	the	the	DET
dpc-1935	52	11	age	age	NOUN
dpc-1935	52	12	of	of	ADP
dpc-1935	52	13	40	40	NUM
dpc-1935	52	14	years	year	NOUN
dpc-1935	52	15	before	before	ADP
dpc-1935	52	16	treatment	treatment	NOUN
dpc-1935	52	17	with	with	ADP
dpc-1935	52	18	biological	biological	ADJ
dpc-1935	52	19	agents	agent	NOUN
dpc-1935	52	20	for	for	ADP
dpc-1935	52	21	screening	screen	VERB
dpc-1935	52	22	premalignant	premalignant	ADJ
dpc-1935	52	23	or	or	CCONJ
dpc-1935	52	24	malignant	malignant	ADJ
dpc-1935	52	25	lesions	lesion	NOUN
dpc-1935	52	26	of	of	ADP
dpc-1935	52	27	the	the	DET
dpc-1935	52	28	breast	breast	NOUN
dpc-1935	52	29	.	.	PUNCT
dpc-1935	53	1	breast	breast	NOUN
dpc-1935	53	2	imaging	imaging	NOUN
dpc-1935	53	3	-	-	PUNCT
dpc-1935	53	4	reporting	reporting	NOUN
dpc-1935	53	5	and	and	CCONJ
dpc-1935	53	6	data	datum	NOUN
dpc-1935	53	7	system	system	NOUN
dpc-1935	53	8	(	(	PUNCT
dpc-1935	53	9	bi	bi	NOUN
dpc-1935	53	10	-	-	NOUN
dpc-1935	53	11	rads	rad	NOUN
dpc-1935	53	12	)	)	PUNCT
dpc-1935	54	1	[	[	X
dpc-1935	54	2	12	12	NUM
dpc-1935	54	3	]	]	PUNCT
dpc-1935	54	4	,	,	PUNCT
dpc-1935	54	5	breast	breast	NOUN
dpc-1935	54	6	density	density	NOUN
dpc-1935	54	7	categories	category	NOUN
dpc-1935	54	8	,	,	PUNCT
dpc-1935	54	9	masses	masse	NOUN
dpc-1935	54	10	,	,	PUNCT
dpc-1935	54	11	lymph	lymph	NOUN
dpc-1935	54	12	nodes	node	NOUN
dpc-1935	54	13	,	,	PUNCT
dpc-1935	54	14	calcifications	calcification	NOUN
dpc-1935	54	15	and	and	CCONJ
dpc-1935	54	16	localization	localization	NOUN
dpc-1935	54	17	of	of	ADP
dpc-1935	54	18	the	the	DET
dpc-1935	54	19	lesions	lesion	NOUN
dpc-1935	54	20	were	be	AUX
dpc-1935	54	21	evaluated	evaluate	VERB
dpc-1935	54	22	.	.	PUNCT
dpc-1935	55	1	statistical	statistical	ADJ
dpc-1935	55	2	analysis	analysis	NOUN
dpc-1935	55	3	was	be	AUX
dpc-1935	55	4	performed	perform	VERB
dpc-1935	55	5	using	use	VERB
dpc-1935	55	6	spss	spss	PROPN
dpc-1935	55	7	version	version	PROPN
dpc-1935	55	8	20.0	20.0	NUM
dpc-1935	55	9	.	.	PUNCT
dpc-1935	56	1	data	datum	NOUN
dpc-1935	56	2	were	be	AUX
dpc-1935	56	3	represented	represent	VERB
dpc-1935	56	4	as	as	ADP
dpc-1935	56	5	mean	mean	NOUN
dpc-1935	56	6	±	±	NUM
dpc-1935	56	7	standard	standard	ADJ
dpc-1935	56	8	deviation	deviation	NOUN
dpc-1935	56	9	(	(	PUNCT
dpc-1935	56	10	sd	sd	NOUN
dpc-1935	56	11	)	)	PUNCT
dpc-1935	56	12	or	or	CCONJ
dpc-1935	56	13	median	median	NOUN
dpc-1935	56	14	for	for	ADP
dpc-1935	56	15	quantitative	quantitative	ADJ
dpc-1935	56	16	variables	variable	NOUN
dpc-1935	56	17	,	,	PUNCT
dpc-1935	56	18	counts	count	NOUN
dpc-1935	56	19	and	and	CCONJ
dpc-1935	56	20	percentage	percentage	NOUN
dpc-1935	56	21	for	for	ADP
dpc-1935	56	22	categorical	categorical	ADJ
dpc-1935	56	23	variables	variable	NOUN
dpc-1935	56	24	.	.	PUNCT
dpc-1935	57	1	differences	difference	NOUN
dpc-1935	57	2	between	between	ADP
dpc-1935	57	3	two	two	NUM
dpc-1935	57	4	groups	group	NOUN
dpc-1935	57	5	were	be	AUX
dpc-1935	57	6	evaluated	evaluate	VERB
dpc-1935	57	7	by	by	ADP
dpc-1935	57	8	chi	chi	ADJ
dpc-1935	57	9	-	-	PUNCT
dpc-1935	57	10	square	square	ADJ
dpc-1935	57	11	test	test	NOUN
dpc-1935	57	12	.	.	PUNCT
dpc-1935	58	1	p	p	X
dpc-1935	58	2	<	<	X
dpc-1935	58	3	0.05	0.05	NUM
dpc-1935	58	4	was	be	AUX
dpc-1935	58	5	considered	consider	VERB
dpc-1935	58	6	as	as	ADP
dpc-1935	58	7	statistically	statistically	ADV
dpc-1935	58	8	significant	significant	ADJ
dpc-1935	58	9	.	.	PUNCT
dpc-1935	59	1	results	result	VERB
dpc-1935	59	2	this	this	DET
dpc-1935	59	3	study	study	NOUN
dpc-1935	59	4	included	include	VERB
dpc-1935	59	5	42	42	NUM
dpc-1935	59	6	female	female	ADJ
dpc-1935	59	7	patients	patient	NOUN
dpc-1935	59	8	with	with	ADP
dpc-1935	59	9	a	a	DET
dpc-1935	59	10	mean	mean	ADJ
dpc-1935	59	11	age	age	NOUN
dpc-1935	59	12	of	of	ADP
dpc-1935	59	13	53.52	53.52	NUM
dpc-1935	59	14	±	±	NUM
dpc-1935	59	15	7.09	7.09	NUM
dpc-1935	59	16	(	(	PUNCT
dpc-1935	59	17	range	range	NOUN
dpc-1935	59	18	:	:	PUNCT
dpc-1935	59	19	41	41	NUM
dpc-1935	59	20	-	-	SYM
dpc-1935	59	21	65	65	NUM
dpc-1935	59	22	years	year	NOUN
dpc-1935	59	23	)	)	PUNCT
dpc-1935	59	24	.	.	PUNCT
dpc-1935	60	1	thity	thity	NOUN
dpc-1935	60	2	-	-	PUNCT
dpc-1935	60	3	two	two	NUM
dpc-1935	60	4	(	(	PUNCT
dpc-1935	60	5	76.2	76.2	NUM
dpc-1935	60	6	%	%	NOUN
dpc-1935	60	7	)	)	PUNCT
dpc-1935	61	1	patients	patient	NOUN
dpc-1935	61	2	had	have	VERB
dpc-1935	61	3	psoriasis	psoriasis	NOUN
dpc-1935	61	4	vulgaris	vulgaris	NOUN
dpc-1935	61	5	,	,	PUNCT
dpc-1935	61	6	5	5	NUM
dpc-1935	61	7	(	(	PUNCT
dpc-1935	61	8	11.9	11.9	NUM
dpc-1935	61	9	%	%	NOUN
dpc-1935	61	10	)	)	PUNCT
dpc-1935	61	11	patients	patient	NOUN
dpc-1935	61	12	had	have	VERB
dpc-1935	61	13	palmoplantar	palmoplantar	NOUN
dpc-1935	61	14	psoriasis	psoriasis	NOUN
dpc-1935	61	15	and	and	CCONJ
dpc-1935	61	16	5	5	NUM
dpc-1935	61	17	(	(	PUNCT
dpc-1935	61	18	11.9	11.9	NUM
dpc-1935	61	19	%	%	NOUN
dpc-1935	61	20	)	)	PUNCT
dpc-1935	62	1	patients	patient	NOUN
dpc-1935	62	2	had	have	AUX
dpc-1935	62	3	generalized	generalize	VERB
dpc-1935	62	4	pustular	pustular	ADJ
dpc-1935	62	5	psoriasis	psoriasis	NOUN
dpc-1935	62	6	(	(	PUNCT
dpc-1935	62	7	table	table	NOUN
dpc-1935	62	8	1	1	NUM
dpc-1935	62	9	)	)	PUNCT
dpc-1935	62	10	.	.	PUNCT
dpc-1935	63	1	the	the	DET
dpc-1935	63	2	mean	mean	ADJ
dpc-1935	63	3	disease	disease	NOUN
dpc-1935	63	4	duration	duration	NOUN
dpc-1935	63	5	was	be	AUX
dpc-1935	63	6	17.07	17.07	NUM
dpc-1935	63	7	±	±	NUM
dpc-1935	63	8	10.99	10.99	NUM
dpc-1935	63	9	years	year	NOUN
dpc-1935	63	10	(	(	PUNCT
dpc-1935	63	11	range	range	NOUN
dpc-1935	63	12	:	:	PUNCT
dpc-1935	63	13	1	1	NUM
dpc-1935	63	14	-	-	SYM
dpc-1935	63	15	47	47	NUM
dpc-1935	63	16	)	)	PUNCT
dpc-1935	63	17	.	.	PUNCT
dpc-1935	64	1	twenty	twenty	NUM
dpc-1935	64	2	-	-	PUNCT
dpc-1935	64	3	eight	eight	NUM
dpc-1935	64	4	(	(	PUNCT
dpc-1935	64	5	66.7	66.7	NUM
dpc-1935	64	6	%	%	NOUN
dpc-1935	64	7	)	)	PUNCT
dpc-1935	64	8	patients	patient	NOUN
dpc-1935	64	9	did	do	AUX
dpc-1935	64	10	not	not	PART
dpc-1935	64	11	complain	complain	VERB
dpc-1935	64	12	of	of	ADP
dpc-1935	64	13	joint	joint	ADJ
dpc-1935	64	14	pain	pain	NOUN
dpc-1935	64	15	,	,	PUNCT
dpc-1935	64	16	whereas	whereas	SCONJ
dpc-1935	64	17	14	14	NUM
dpc-1935	64	18	(	(	PUNCT
dpc-1935	64	19	33.3	33.3	NUM
dpc-1935	64	20	%	%	NOUN
dpc-1935	64	21	)	)	PUNCT
dpc-1935	64	22	patients	patient	NOUN
dpc-1935	64	23	had	have	VERB
dpc-1935	64	24	psoriatic	psoriatic	ADJ
dpc-1935	64	25	arthritis	arthritis	NOUN
dpc-1935	64	26	.	.	PUNCT
dpc-1935	65	1	past	past	ADP
dpc-1935	65	2	medical	medical	ADJ
dpc-1935	65	3	history	history	NOUN
dpc-1935	65	4	of	of	ADP
dpc-1935	65	5	16	16	NUM
dpc-1935	65	6	(	(	PUNCT
dpc-1935	65	7	38.1	38.1	NUM
dpc-1935	65	8	%	%	NOUN
dpc-1935	65	9	)	)	PUNCT
dpc-1935	66	1	patients	patient	NOUN
dpc-1935	66	2	was	be	AUX
dpc-1935	66	3	unremarkable	unremarkable	ADJ
dpc-1935	66	4	.	.	PUNCT
dpc-1935	67	1	ten	ten	NUM
dpc-1935	67	2	(	(	PUNCT
dpc-1935	67	3	23.8	23.8	NUM
dpc-1935	67	4	%	%	NOUN
dpc-1935	67	5	)	)	PUNCT
dpc-1935	68	1	patients	patient	NOUN
dpc-1935	68	2	had	have	VERB
dpc-1935	68	3	hypertension	hypertension	NOUN
dpc-1935	68	4	,	,	PUNCT
dpc-1935	68	5	7	7	NUM
dpc-1935	68	6	(	(	PUNCT
dpc-1935	68	7	16.7	16.7	NUM
dpc-1935	68	8	%	%	NOUN
dpc-1935	68	9	)	)	PUNCT
dpc-1935	69	1	patients	patient	NOUN
dpc-1935	69	2	had	have	VERB
dpc-1935	69	3	both	both	DET
dpc-1935	69	4	hypertension	hypertension	NOUN
dpc-1935	69	5	and	and	CCONJ
dpc-1935	69	6	type	type	NOUN
dpc-1935	69	7	2	2	NUM
dpc-1935	69	8	diabetes	diabete	NOUN
dpc-1935	69	9	,	,	PUNCT
dpc-1935	69	10	5	5	NUM
dpc-1935	69	11	(	(	PUNCT
dpc-1935	69	12	11.9	11.9	NUM
dpc-1935	69	13	%	%	NOUN
dpc-1935	69	14	)	)	PUNCT
dpc-1935	69	15	patients	patient	NOUN
dpc-1935	69	16	had	have	AUX
dpc-1935	69	17	type	type	NOUN
dpc-1935	69	18	2	2	NUM
dpc-1935	69	19	diabetes	diabete	NOUN
dpc-1935	69	20	,	,	PUNCT
dpc-1935	69	21	2	2	NUM
dpc-1935	69	22	(	(	PUNCT
dpc-1935	69	23	4.8	4.8	NUM
dpc-1935	69	24	%	%	NOUN
dpc-1935	69	25	)	)	PUNCT
dpc-1935	69	26	had	have	VERB
dpc-1935	69	27	hypothyroidism	hypothyroidism	NOUN
dpc-1935	69	28	,	,	PUNCT
dpc-1935	69	29	1	1	NUM
dpc-1935	69	30	(	(	PUNCT
dpc-1935	69	31	2.4	2.4	NUM
dpc-1935	69	32	%	%	NOUN
dpc-1935	69	33	)	)	PUNCT
dpc-1935	69	34	had	have	VERB
dpc-1935	69	35	coronary	coronary	ADJ
dpc-1935	69	36	artery	artery	NOUN
dpc-1935	69	37	disease	disease	NOUN
dpc-1935	69	38	and	and	CCONJ
dpc-1935	69	39	1	1	NUM
dpc-1935	69	40	(	(	PUNCT
dpc-1935	69	41	2.4	2.4	NUM
dpc-1935	69	42	%	%	NOUN
dpc-1935	69	43	)	)	PUNCT
dpc-1935	69	44	had	have	VERB
dpc-1935	69	45	granulomatous	granulomatous	ADJ
dpc-1935	69	46	mastitis	mastitis	NOUN
dpc-1935	69	47	.	.	PUNCT
dpc-1935	70	1	only	only	ADV
dpc-1935	70	2	1	1	NUM
dpc-1935	70	3	(	(	PUNCT
dpc-1935	70	4	2.4	2.4	NUM
dpc-1935	70	5	%	%	NOUN
dpc-1935	70	6	)	)	PUNCT
dpc-1935	70	7	patient	patient	NOUN
dpc-1935	70	8	had	have	VERB
dpc-1935	70	9	a	a	DET
dpc-1935	70	10	family	family	NOUN
dpc-1935	70	11	history	history	NOUN
dpc-1935	70	12	of	of	ADP
dpc-1935	70	13	breast	breast	NOUN
dpc-1935	70	14	cancer	cancer	NOUN
dpc-1935	70	15	.	.	PUNCT
dpc-1935	71	1	forty	forty	NUM
dpc-1935	71	2	-	-	PUNCT
dpc-1935	71	3	one	one	NUM
dpc-1935	71	4	(	(	PUNCT
dpc-1935	71	5	97.6	97.6	NUM
dpc-1935	71	6	%	%	NOUN
dpc-1935	71	7	)	)	PUNCT
dpc-1935	71	8	patients	patient	NOUN
dpc-1935	71	9	were	be	AUX
dpc-1935	71	10	treated	treat	VERB
dpc-1935	71	11	with	with	ADP
dpc-1935	71	12	conventional	conventional	ADJ
dpc-1935	71	13	systemic	systemic	ADJ
dpc-1935	71	14	treatments	treatment	NOUN
dpc-1935	71	15	such	such	ADJ
dpc-1935	71	16	as	as	ADP
dpc-1935	71	17	methotrexate	methotrexate	NOUN
dpc-1935	71	18	,	,	PUNCT
dpc-1935	71	19	cyclosporine	cyclosporine	NOUN
dpc-1935	71	20	and	and	CCONJ
dpc-1935	71	21	acitretin	acitretin	NOUN
dpc-1935	71	22	,	,	PUNCT
dpc-1935	71	23	7	7	NUM
dpc-1935	71	24	(	(	PUNCT
dpc-1935	71	25	16.6	16.6	NUM
dpc-1935	71	26	%	%	NOUN
dpc-1935	71	27	)	)	PUNCT
dpc-1935	71	28	patients	patient	NOUN
dpc-1935	71	29	were	be	AUX
dpc-1935	71	30	treated	treat	VERB
dpc-1935	71	31	with	with	ADP
dpc-1935	71	32	phototherapy	phototherapy	NOUN
dpc-1935	71	33	and	and	CCONJ
dpc-1935	71	34	19	19	NUM
dpc-1935	71	35	(	(	PUNCT
dpc-1935	71	36	45.2	45.2	NUM
dpc-1935	71	37	%	%	NOUN
dpc-1935	71	38	)	)	PUNCT
dpc-1935	71	39	patients	patient	NOUN
dpc-1935	71	40	were	be	AUX
dpc-1935	71	41	treated	treat	VERB
dpc-1935	71	42	with	with	ADP
dpc-1935	71	43	biological	biological	ADJ
dpc-1935	71	44	agents	agent	NOUN
dpc-1935	71	45	,	,	PUNCT
dpc-1935	71	46	previously	previously	ADV
dpc-1935	71	47	.	.	PUNCT
dpc-1935	72	1	twenty	twenty	NUM
dpc-1935	72	2	-	-	PUNCT
dpc-1935	72	3	three	three	NUM
dpc-1935	72	4	(	(	PUNCT
dpc-1935	72	5	54.8	54.8	NUM
dpc-1935	72	6	%	%	NOUN
dpc-1935	72	7	)	)	PUNCT
dpc-1935	72	8	patients	patient	NOUN
dpc-1935	72	9	original	original	ADJ
dpc-1935	72	10	article	article	NOUN
dpc-1935	72	11	|	|	ADV
dpc-1935	72	12	dermatol	dermatol	ADJ
dpc-1935	72	13	pract	pract	NOUN
dpc-1935	72	14	concept	concept	NOUN
dpc-1935	72	15	.	.	PUNCT
dpc-1935	73	1	2022;12(2):e2022081	2022;12(2):e2022081	NUM
dpc-1935	73	2	3	3	NUM
dpc-1935	73	3	isodense	isodense	NOUN
dpc-1935	73	4	breast	breast	NOUN
dpc-1935	73	5	masses	masse	NOUN
dpc-1935	73	6	ranged	range	VERB
dpc-1935	73	7	between	between	ADP
dpc-1935	73	8	5	5	NUM
dpc-1935	73	9	to	to	PART
dpc-1935	73	10	14	14	NUM
dpc-1935	73	11	mm	mm	NOUN
dpc-1935	73	12	.	.	PUNCT
dpc-1935	74	1	furthermore	furthermore	ADV
dpc-1935	74	2	,	,	PUNCT
dpc-1935	74	3	mammography	mammography	NOUN
dpc-1935	74	4	revealed	reveal	VERB
dpc-1935	74	5	microcalcifications	microcalcification	NOUN
dpc-1935	74	6	in	in	ADP
dpc-1935	74	7	6	6	NUM
dpc-1935	74	8	(	(	PUNCT
dpc-1935	74	9	14.3	14.3	NUM
dpc-1935	74	10	%	%	NOUN
dpc-1935	74	11	)	)	PUNCT
dpc-1935	74	12	patients	patient	NOUN
dpc-1935	74	13	,	,	PUNCT
dpc-1935	74	14	macrocalcifications	macrocalcification	NOUN
dpc-1935	74	15	in	in	ADP
dpc-1935	74	16	1	1	NUM
dpc-1935	74	17	(	(	PUNCT
dpc-1935	74	18	2.4	2.4	NUM
dpc-1935	74	19	%	%	NOUN
dpc-1935	74	20	)	)	PUNCT
dpc-1935	74	21	patient	patient	NOUN
dpc-1935	74	22	,	,	PUNCT
dpc-1935	74	23	both	both	CCONJ
dpc-1935	74	24	microcalcifications	microcalcification	NOUN
dpc-1935	74	25	and	and	CCONJ
dpc-1935	74	26	macrocalcifications	macrocalcification	NOUN
dpc-1935	74	27	in	in	ADP
dpc-1935	74	28	1	1	NUM
dpc-1935	74	29	(	(	PUNCT
dpc-1935	74	30	2.4	2.4	NUM
dpc-1935	74	31	%	%	NOUN
dpc-1935	74	32	)	)	PUNCT
dpc-1935	74	33	patient	patient	NOUN
dpc-1935	74	34	and	and	CCONJ
dpc-1935	74	35	a	a	DET
dpc-1935	74	36	hamartoma	hamartoma	NOUN
dpc-1935	74	37	in	in	ADP
dpc-1935	74	38	1	1	NUM
dpc-1935	74	39	(	(	PUNCT
dpc-1935	74	40	2.4	2.4	NUM
dpc-1935	74	41	%	%	NOUN
dpc-1935	74	42	)	)	PUNCT
dpc-1935	74	43	patient	patient	NOUN
dpc-1935	74	44	.	.	PUNCT
dpc-1935	75	1	intramammary	intramammary	ADJ
dpc-1935	75	2	lymph	lymph	NOUN
dpc-1935	75	3	nodes	node	NOUN
dpc-1935	75	4	were	be	AUX
dpc-1935	75	5	observed	observe	VERB
dpc-1935	75	6	in	in	ADP
dpc-1935	75	7	6	6	NUM
dpc-1935	75	8	(	(	PUNCT
dpc-1935	75	9	14.3	14.3	NUM
dpc-1935	75	10	%	%	NOUN
dpc-1935	75	11	)	)	PUNCT
dpc-1935	75	12	patients	patient	NOUN
dpc-1935	75	13	,	,	PUNCT
dpc-1935	75	14	whereas	whereas	SCONJ
dpc-1935	75	15	mamography	mamography	NOUN
dpc-1935	75	16	did	do	AUX
dpc-1935	75	17	not	not	PART
dpc-1935	75	18	reveal	reveal	VERB
dpc-1935	75	19	an	an	DET
dpc-1935	75	20	intramammary	intramammary	ADJ
dpc-1935	75	21	lymph	lymph	NOUN
dpc-1935	75	22	node	node	NOUN
dpc-1935	75	23	in	in	ADP
dpc-1935	75	24	36	36	NUM
dpc-1935	75	25	(	(	PUNCT
dpc-1935	75	26	85.7	85.7	NUM
dpc-1935	75	27	%	%	NOUN
dpc-1935	75	28	)	)	PUNCT
dpc-1935	75	29	patients	patient	NOUN
dpc-1935	75	30	.	.	PUNCT
dpc-1935	76	1	four	four	NUM
dpc-1935	76	2	(	(	PUNCT
dpc-1935	76	3	9.5	9.5	NUM
dpc-1935	76	4	%	%	NOUN
dpc-1935	76	5	)	)	PUNCT
dpc-1935	77	1	patients	patient	NOUN
dpc-1935	77	2	had	have	VERB
dpc-1935	77	3	1	1	NUM
dpc-1935	77	4	intramammary	intramammary	ADJ
dpc-1935	77	5	lymph	lymph	NOUN
dpc-1935	77	6	node	node	NOUN
dpc-1935	77	7	,	,	PUNCT
dpc-1935	77	8	1	1	NUM
dpc-1935	77	9	(	(	PUNCT
dpc-1935	77	10	2.4	2.4	NUM
dpc-1935	77	11	%	%	NOUN
dpc-1935	77	12	)	)	PUNCT
dpc-1935	77	13	patient	patient	NOUN
dpc-1935	77	14	had	have	VERB
dpc-1935	77	15	2	2	NUM
dpc-1935	77	16	and	and	CCONJ
dpc-1935	77	17	1	1	NUM
dpc-1935	77	18	(	(	PUNCT
dpc-1935	77	19	2.4	2.4	NUM
dpc-1935	77	20	%	%	NOUN
dpc-1935	77	21	)	)	PUNCT
dpc-1935	77	22	patient	patient	NOUN
dpc-1935	77	23	had	have	VERB
dpc-1935	77	24	multiple	multiple	ADJ
dpc-1935	77	25	intramammary	intramammary	ADJ
dpc-1935	77	26	lymph	lymph	NOUN
dpc-1935	77	27	nodes	node	NOUN
dpc-1935	77	28	,	,	PUNCT
dpc-1935	77	29	respectively	respectively	ADV
dpc-1935	77	30	.	.	PUNCT
dpc-1935	78	1	intramammary	intramammary	ADJ
dpc-1935	78	2	lymph	lymph	NOUN
dpc-1935	78	3	nodes	node	NOUN
dpc-1935	78	4	were	be	AUX
dpc-1935	78	5	localized	localize	VERB
dpc-1935	78	6	on	on	ADP
dpc-1935	78	7	the	the	DET
dpc-1935	78	8	left	left	ADJ
dpc-1935	78	9	breast	breast	NOUN
dpc-1935	78	10	in	in	ADP
dpc-1935	78	11	4	4	NUM
dpc-1935	78	12	(	(	PUNCT
dpc-1935	78	13	9.5	9.5	NUM
dpc-1935	78	14	%	%	NOUN
dpc-1935	78	15	)	)	PUNCT
dpc-1935	78	16	patients	patient	NOUN
dpc-1935	78	17	and	and	CCONJ
dpc-1935	78	18	on	on	ADP
dpc-1935	78	19	the	the	DET
dpc-1935	78	20	right	right	ADJ
dpc-1935	78	21	breast	breast	NOUN
dpc-1935	78	22	in	in	ADP
dpc-1935	78	23	1	1	NUM
dpc-1935	78	24	(	(	PUNCT
dpc-1935	78	25	2.4	2.4	NUM
dpc-1935	78	26	%	%	NOUN
dpc-1935	78	27	)	)	PUNCT
dpc-1935	78	28	patient	patient	NOUN
dpc-1935	78	29	.	.	PUNCT
dpc-1935	79	1	intramammary	intramammary	ADJ
dpc-1935	79	2	lymph	lymph	NOUN
dpc-1935	79	3	nodes	node	NOUN
dpc-1935	79	4	were	be	AUX
dpc-1935	79	5	detected	detect	VERB
dpc-1935	79	6	bilaterally	bilaterally	ADV
dpc-1935	79	7	in	in	ADP
dpc-1935	79	8	1	1	NUM
dpc-1935	79	9	(	(	PUNCT
dpc-1935	79	10	2.4	2.4	NUM
dpc-1935	79	11	%	%	NOUN
dpc-1935	79	12	)	)	PUNCT
dpc-1935	79	13	patient	patient	NOUN
dpc-1935	79	14	.	.	PUNCT
dpc-1935	80	1	moreover	moreover	ADV
dpc-1935	80	2	,	,	PUNCT
dpc-1935	80	3	in	in	ADP
dpc-1935	80	4	1	1	NUM
dpc-1935	80	5	(	(	PUNCT
dpc-1935	80	6	2.4	2.4	NUM
dpc-1935	80	7	%	%	NOUN
dpc-1935	80	8	)	)	PUNCT
dpc-1935	80	9	patient	patient	ADJ
dpc-1935	80	10	mammography	mammography	NOUN
dpc-1935	80	11	recommended	recommend	VERB
dpc-1935	80	12	further	further	ADJ
dpc-1935	80	13	evaluation	evaluation	NOUN
dpc-1935	80	14	of	of	ADP
dpc-1935	80	15	an	an	DET
dpc-1935	80	16	intramammary	intramammary	ADJ
dpc-1935	80	17	lymph	lymph	NOUN
dpc-1935	80	18	node	node	NOUN
dpc-1935	80	19	on	on	ADP
dpc-1935	80	20	the	the	DET
dpc-1935	80	21	right	right	ADJ
dpc-1935	80	22	breast	breast	NOUN
dpc-1935	80	23	,	,	PUNCT
dpc-1935	80	24	which	which	PRON
dpc-1935	80	25	was	be	AUX
dpc-1935	80	26	revealed	reveal	VERB
dpc-1935	80	27	to	to	PART
dpc-1935	80	28	be	be	AUX
dpc-1935	80	29	reactive	reactive	ADJ
dpc-1935	80	30	lymph	lymph	NOUN
dpc-1935	80	31	node	node	NOUN
dpc-1935	80	32	without	without	ADP
dpc-1935	80	33	an	an	DET
dpc-1935	80	34	atypical	atypical	ADJ
dpc-1935	80	35	cell	cell	NOUN
dpc-1935	80	36	.	.	PUNCT
dpc-1935	81	1	the	the	DET
dpc-1935	81	2	disease	disease	NOUN
dpc-1935	81	3	duration	duration	NOUN
dpc-1935	81	4	was	be	AUX
dpc-1935	81	5	less	less	ADJ
dpc-1935	81	6	than	than	ADP
dpc-1935	81	7	10	10	NUM
dpc-1935	81	8	years	year	NOUN
dpc-1935	81	9	in	in	ADP
dpc-1935	81	10	4	4	NUM
dpc-1935	81	11	(	(	PUNCT
dpc-1935	81	12	9.5	9.5	NUM
dpc-1935	81	13	%	%	NOUN
dpc-1935	81	14	)	)	PUNCT
dpc-1935	81	15	patients	patient	NOUN
dpc-1935	81	16	with	with	ADP
dpc-1935	81	17	an	an	DET
dpc-1935	81	18	isodense	isodense	ADJ
dpc-1935	81	19	mass	mass	NOUN
dpc-1935	81	20	of	of	ADP
dpc-1935	81	21	the	the	DET
dpc-1935	81	22	breast	breast	NOUN
dpc-1935	81	23	and	and	CCONJ
dpc-1935	81	24	more	more	ADJ
dpc-1935	81	25	than	than	ADP
dpc-1935	81	26	10	10	NUM
dpc-1935	81	27	years	year	NOUN
dpc-1935	81	28	in	in	ADP
dpc-1935	81	29	6	6	NUM
dpc-1935	81	30	(	(	PUNCT
dpc-1935	81	31	14.3	14.3	NUM
dpc-1935	81	32	%	%	NOUN
dpc-1935	81	33	)	)	PUNCT
dpc-1935	81	34	patients	patient	NOUN
dpc-1935	81	35	with	with	ADP
dpc-1935	81	36	an	an	DET
dpc-1935	81	37	isodense	isodense	NOUN
dpc-1935	81	38	mass	mass	NOUN
dpc-1935	81	39	(	(	PUNCT
dpc-1935	81	40	p	p	NOUN
dpc-1935	81	41	=	=	NOUN
dpc-1935	81	42	0.47	0.47	NUM
dpc-1935	81	43	)	)	PUNCT
dpc-1935	81	44	.	.	PUNCT
dpc-1935	82	1	the	the	DET
dpc-1935	82	2	disease	disease	NOUN
dpc-1935	82	3	duration	duration	NOUN
dpc-1935	82	4	was	be	AUX
dpc-1935	82	5	less	less	ADJ
dpc-1935	82	6	than	than	ADP
dpc-1935	82	7	10	10	NUM
dpc-1935	82	8	years	year	NOUN
dpc-1935	82	9	in	in	ADP
dpc-1935	82	10	1	1	NUM
dpc-1935	82	11	(	(	PUNCT
dpc-1935	82	12	2.4	2.4	NUM
dpc-1935	82	13	%	%	NOUN
dpc-1935	82	14	)	)	PUNCT
dpc-1935	82	15	patient	patient	NOUN
dpc-1935	82	16	with	with	ADP
dpc-1935	82	17	calcifications	calcification	NOUN
dpc-1935	82	18	of	of	ADP
dpc-1935	82	19	the	the	DET
dpc-1935	82	20	breast	breast	NOUN
dpc-1935	82	21	and	and	CCONJ
dpc-1935	82	22	more	more	ADJ
dpc-1935	82	23	than	than	ADP
dpc-1935	82	24	10	10	NUM
dpc-1935	82	25	years	year	NOUN
dpc-1935	82	26	in	in	ADP
dpc-1935	82	27	7	7	NUM
dpc-1935	82	28	(	(	PUNCT
dpc-1935	82	29	16.7	16.7	NUM
dpc-1935	82	30	%	%	NOUN
dpc-1935	82	31	)	)	PUNCT
dpc-1935	82	32	patients	patient	NOUN
dpc-1935	82	33	with	with	ADP
dpc-1935	82	34	calcifications	calcification	NOUN
dpc-1935	82	35	(	(	PUNCT
dpc-1935	82	36	p	p	X
dpc-1935	82	37	=	=	NOUN
dpc-1935	82	38	0.21	0.21	NUM
dpc-1935	82	39	)	)	PUNCT
dpc-1935	82	40	.	.	PUNCT
dpc-1935	83	1	the	the	DET
dpc-1935	83	2	disease	disease	NOUN
dpc-1935	83	3	duration	duration	NOUN
dpc-1935	83	4	was	be	AUX
dpc-1935	83	5	less	less	ADJ
dpc-1935	83	6	than	than	ADP
dpc-1935	83	7	10	10	NUM
dpc-1935	83	8	years	year	NOUN
dpc-1935	83	9	in	in	ADP
dpc-1935	83	10	1	1	NUM
dpc-1935	83	11	(	(	PUNCT
dpc-1935	83	12	2.4	2.4	NUM
dpc-1935	83	13	%	%	NOUN
dpc-1935	83	14	)	)	PUNCT
dpc-1935	83	15	patient	patient	NOUN
dpc-1935	83	16	with	with	ADP
dpc-1935	83	17	an	an	DET
dpc-1935	83	18	intramammary	intramammary	ADJ
dpc-1935	83	19	lymph	lymph	NOUN
dpc-1935	83	20	node	node	NOUN
dpc-1935	83	21	and	and	CCONJ
dpc-1935	83	22	more	more	ADJ
dpc-1935	83	23	than	than	ADP
dpc-1935	83	24	10	10	NUM
dpc-1935	83	25	years	year	NOUN
dpc-1935	83	26	in	in	ADP
dpc-1935	83	27	5	5	NUM
dpc-1935	83	28	(	(	PUNCT
dpc-1935	83	29	11.9	11.9	NUM
dpc-1935	83	30	%	%	NOUN
dpc-1935	83	31	)	)	PUNCT
dpc-1935	83	32	patients	patient	NOUN
dpc-1935	83	33	with	with	ADP
dpc-1935	83	34	intramammary	intramammary	ADJ
dpc-1935	83	35	lymph	lymph	NOUN
dpc-1935	83	36	nodes	node	NOUN
dpc-1935	83	37	(	(	PUNCT
dpc-1935	83	38	p	p	X
dpc-1935	83	39	=	=	NOUN
dpc-1935	83	40	0.41	0.41	NUM
dpc-1935	83	41	)	)	PUNCT
dpc-1935	83	42	.	.	PUNCT
dpc-1935	84	1	were	be	AUX
dpc-1935	84	2	biologicnaïve	biologicnaïve	PROPN
dpc-1935	84	3	.	.	PUNCT
dpc-1935	85	1	among	among	ADP
dpc-1935	85	2	the	the	DET
dpc-1935	85	3	patients	patient	NOUN
dpc-1935	85	4	who	who	PRON
dpc-1935	85	5	were	be	AUX
dpc-1935	85	6	treated	treat	VERB
dpc-1935	85	7	with	with	ADP
dpc-1935	85	8	biological	biological	ADJ
dpc-1935	85	9	agents	agent	NOUN
dpc-1935	85	10	previously	previously	ADV
dpc-1935	85	11	,	,	PUNCT
dpc-1935	85	12	13	13	NUM
dpc-1935	85	13	(	(	PUNCT
dpc-1935	85	14	31	31	NUM
dpc-1935	85	15	%	%	NOUN
dpc-1935	85	16	)	)	PUNCT
dpc-1935	85	17	patients	patient	NOUN
dpc-1935	85	18	received	receive	VERB
dpc-1935	85	19	anti	anti	ADJ
dpc-1935	85	20	-	-	ADJ
dpc-1935	85	21	tnf	tnf	ADJ
dpc-1935	85	22	-	-	PUNCT
dpc-1935	85	23	α	α	NOUN
dpc-1935	85	24	agents	agent	NOUN
dpc-1935	85	25	such	such	ADJ
dpc-1935	85	26	as	as	ADP
dpc-1935	85	27	infliximab	infliximab	NOUN
dpc-1935	85	28	,	,	PUNCT
dpc-1935	85	29	adalimumab	adalimumab	NOUN
dpc-1935	85	30	,	,	PUNCT
dpc-1935	85	31	etanercept	etanercept	NOUN
dpc-1935	85	32	and	and	CCONJ
dpc-1935	85	33	certolizumab	certolizumab	NOUN
dpc-1935	85	34	pegol	pegol	NOUN
dpc-1935	85	35	,	,	PUNCT
dpc-1935	85	36	5	5	NUM
dpc-1935	85	37	(	(	PUNCT
dpc-1935	85	38	11.9	11.9	NUM
dpc-1935	85	39	%	%	NOUN
dpc-1935	85	40	)	)	PUNCT
dpc-1935	85	41	patients	patient	NOUN
dpc-1935	85	42	received	receive	VERB
dpc-1935	85	43	both	both	DET
dpc-1935	85	44	anti	anti	ADJ
dpc-1935	85	45	-	-	ADJ
dpc-1935	85	46	tnf	tnf	ADJ
dpc-1935	85	47	-	-	PUNCT
dpc-1935	85	48	α	α	NOUN
dpc-1935	85	49	agents	agent	NOUN
dpc-1935	85	50	and	and	CCONJ
dpc-1935	85	51	ustekinumab	ustekinumab	NOUN
dpc-1935	85	52	,	,	PUNCT
dpc-1935	85	53	and	and	CCONJ
dpc-1935	85	54	1	1	NUM
dpc-1935	85	55	(	(	PUNCT
dpc-1935	85	56	2.4	2.4	NUM
dpc-1935	85	57	%	%	NOUN
dpc-1935	85	58	)	)	PUNCT
dpc-1935	85	59	patient	patient	NOUN
dpc-1935	85	60	received	receive	VERB
dpc-1935	85	61	ustekinumab	ustekinumab	NOUN
dpc-1935	85	62	.	.	PUNCT
dpc-1935	86	1	mammographic	mammographic	ADJ
dpc-1935	86	2	breast	breast	NOUN
dpc-1935	86	3	density	density	NOUN
dpc-1935	86	4	was	be	AUX
dpc-1935	86	5	type	type	NOUN
dpc-1935	86	6	b	b	NOUN
dpc-1935	86	7	in	in	ADP
dpc-1935	86	8	24	24	NUM
dpc-1935	86	9	(	(	PUNCT
dpc-1935	86	10	57.1	57.1	NUM
dpc-1935	86	11	%	%	NOUN
dpc-1935	86	12	)	)	PUNCT
dpc-1935	86	13	patients	patient	NOUN
dpc-1935	86	14	,	,	PUNCT
dpc-1935	86	15	type	type	NOUN
dpc-1935	86	16	c	c	NOUN
dpc-1935	86	17	in	in	ADP
dpc-1935	86	18	13	13	NUM
dpc-1935	86	19	(	(	PUNCT
dpc-1935	86	20	31	31	NUM
dpc-1935	86	21	%	%	NOUN
dpc-1935	86	22	)	)	PUNCT
dpc-1935	86	23	patients	patient	NOUN
dpc-1935	86	24	,	,	PUNCT
dpc-1935	86	25	type	type	VERB
dpc-1935	86	26	a	a	DET
dpc-1935	86	27	in	in	ADP
dpc-1935	86	28	4	4	NUM
dpc-1935	86	29	(	(	PUNCT
dpc-1935	86	30	9.5	9.5	NUM
dpc-1935	86	31	%	%	NOUN
dpc-1935	86	32	)	)	PUNCT
dpc-1935	86	33	patients	patient	NOUN
dpc-1935	86	34	and	and	CCONJ
dpc-1935	86	35	type	type	NOUN
dpc-1935	86	36	d	d	NOUN
dpc-1935	86	37	in	in	ADP
dpc-1935	86	38	1	1	NUM
dpc-1935	86	39	(	(	PUNCT
dpc-1935	86	40	2.4	2.4	NUM
dpc-1935	86	41	%	%	NOUN
dpc-1935	86	42	)	)	PUNCT
dpc-1935	86	43	patient	patient	NOUN
dpc-1935	86	44	.	.	PUNCT
dpc-1935	87	1	bi	bi	ADJ
dpc-1935	87	2	-	-	ADJ
dpc-1935	87	3	rads	rads	ADJ
dpc-1935	87	4	score	score	NOUN
dpc-1935	87	5	was	be	AUX
dpc-1935	87	6	2	2	NUM
dpc-1935	87	7	in	in	ADP
dpc-1935	87	8	18	18	NUM
dpc-1935	87	9	(	(	PUNCT
dpc-1935	87	10	42.9	42.9	NUM
dpc-1935	87	11	%	%	NOUN
dpc-1935	87	12	)	)	PUNCT
dpc-1935	87	13	patients	patient	NOUN
dpc-1935	87	14	,	,	PUNCT
dpc-1935	87	15	1	1	NUM
dpc-1935	87	16	in	in	ADP
dpc-1935	87	17	13	13	NUM
dpc-1935	87	18	(	(	PUNCT
dpc-1935	87	19	31	31	NUM
dpc-1935	87	20	%	%	NOUN
dpc-1935	87	21	)	)	PUNCT
dpc-1935	87	22	patients	patient	NOUN
dpc-1935	87	23	,	,	PUNCT
dpc-1935	87	24	3	3	NUM
dpc-1935	87	25	in	in	ADP
dpc-1935	87	26	9	9	NUM
dpc-1935	87	27	(	(	PUNCT
dpc-1935	87	28	21.4	21.4	NUM
dpc-1935	87	29	%	%	NOUN
dpc-1935	87	30	)	)	PUNCT
dpc-1935	87	31	patients	patient	NOUN
dpc-1935	87	32	and	and	CCONJ
dpc-1935	87	33	bi	bi	NOUN
dpc-1935	87	34	-	-	ADJ
dpc-1935	87	35	rads	rad	NOUN
dpc-1935	87	36	score	score	NOUN
dpc-1935	87	37	was	be	AUX
dpc-1935	87	38	4a	4a	NUM
dpc-1935	87	39	in	in	ADP
dpc-1935	87	40	1	1	NUM
dpc-1935	87	41	(	(	PUNCT
dpc-1935	87	42	2.4	2.4	NUM
dpc-1935	87	43	%	%	NOUN
dpc-1935	87	44	)	)	PUNCT
dpc-1935	87	45	patient	patient	NOUN
dpc-1935	87	46	.	.	PUNCT
dpc-1935	88	1	no	no	DET
dpc-1935	88	2	statistically	statistically	ADV
dpc-1935	88	3	significant	significant	ADJ
dpc-1935	88	4	association	association	NOUN
dpc-1935	88	5	was	be	AUX
dpc-1935	88	6	observed	observe	VERB
dpc-1935	88	7	between	between	ADP
dpc-1935	88	8	bi	bi	ADJ
dpc-1935	88	9	-	-	ADJ
dpc-1935	88	10	rads	rads	ADJ
dpc-1935	88	11	score	score	NOUN
dpc-1935	88	12	and	and	CCONJ
dpc-1935	88	13	disease	disease	NOUN
dpc-1935	88	14	duration	duration	NOUN
dpc-1935	88	15	or	or	CCONJ
dpc-1935	88	16	previous	previous	ADJ
dpc-1935	88	17	biological	biological	ADJ
dpc-1935	88	18	agent	agent	NOUN
dpc-1935	88	19	treatment	treatment	NOUN
dpc-1935	88	20	(	(	PUNCT
dpc-1935	88	21	p	p	NOUN
dpc-1935	88	22	=	=	NOUN
dpc-1935	88	23	0.51	0.51	NUM
dpc-1935	88	24	and	and	CCONJ
dpc-1935	88	25	p	p	NOUN
dpc-1935	88	26	=	=	PROPN
dpc-1935	88	27	0.65	0.65	NUM
dpc-1935	88	28	,	,	PUNCT
dpc-1935	88	29	respectively	respectively	ADV
dpc-1935	88	30	)	)	PUNCT
dpc-1935	88	31	.	.	PUNCT
dpc-1935	89	1	the	the	DET
dpc-1935	89	2	patient	patient	NOUN
dpc-1935	89	3	with	with	ADP
dpc-1935	89	4	bi	bi	ADJ
dpc-1935	89	5	-	-	ADJ
dpc-1935	89	6	rads	rads	ADJ
dpc-1935	89	7	4a	4a	NOUN
dpc-1935	89	8	had	have	VERB
dpc-1935	89	9	microcalcifications	microcalcification	NOUN
dpc-1935	89	10	with	with	ADP
dpc-1935	89	11	loose	loose	ADJ
dpc-1935	89	12	clusters	cluster	NOUN
dpc-1935	89	13	in	in	ADP
dpc-1935	89	14	some	some	DET
dpc-1935	89	15	areas	area	NOUN
dpc-1935	89	16	,	,	PUNCT
dpc-1935	89	17	and	and	CCONJ
dpc-1935	89	18	mild	mild	ADJ
dpc-1935	89	19	pleomorphism	pleomorphism	NOUN
dpc-1935	89	20	in	in	ADP
dpc-1935	89	21	the	the	DET
dpc-1935	89	22	upper	upper	ADJ
dpc-1935	89	23	outer	outer	ADJ
dpc-1935	89	24	quadrant	quadrant	NOUN
dpc-1935	89	25	of	of	ADP
dpc-1935	89	26	the	the	DET
dpc-1935	89	27	left	left	ADJ
dpc-1935	89	28	breast	breast	NOUN
dpc-1935	89	29	which	which	PRON
dpc-1935	89	30	was	be	AUX
dpc-1935	89	31	revealed	reveal	VERB
dpc-1935	89	32	to	to	PART
dpc-1935	89	33	be	be	AUX
dpc-1935	89	34	nodular	nodular	ADJ
dpc-1935	89	35	adenosis	adenosis	NOUN
dpc-1935	89	36	with	with	ADP
dpc-1935	89	37	columnar	columnar	ADJ
dpc-1935	89	38	cell	cell	NOUN
dpc-1935	89	39	change	change	NOUN
dpc-1935	89	40	.	.	PUNCT
dpc-1935	90	1	isodense	isodense	ADJ
dpc-1935	90	2	masses	masse	NOUN
dpc-1935	90	3	of	of	ADP
dpc-1935	90	4	the	the	DET
dpc-1935	90	5	breast	breast	NOUN
dpc-1935	90	6	were	be	AUX
dpc-1935	90	7	observed	observe	VERB
dpc-1935	90	8	in	in	ADP
dpc-1935	90	9	10	10	NUM
dpc-1935	90	10	(	(	PUNCT
dpc-1935	90	11	23.8	23.8	NUM
dpc-1935	90	12	%	%	NOUN
dpc-1935	90	13	)	)	PUNCT
dpc-1935	90	14	patients	patient	NOUN
dpc-1935	90	15	whereas	whereas	SCONJ
dpc-1935	90	16	mammography	mammography	NOUN
dpc-1935	90	17	of	of	ADP
dpc-1935	90	18	32	32	NUM
dpc-1935	90	19	(	(	PUNCT
dpc-1935	90	20	76.2	76.2	NUM
dpc-1935	90	21	%	%	NOUN
dpc-1935	90	22	)	)	PUNCT
dpc-1935	90	23	patients	patient	NOUN
dpc-1935	90	24	did	do	AUX
dpc-1935	90	25	not	not	PART
dpc-1935	90	26	reveal	reveal	VERB
dpc-1935	90	27	a	a	DET
dpc-1935	90	28	breast	breast	NOUN
dpc-1935	90	29	mass	mass	NOUN
dpc-1935	90	30	.	.	PUNCT
dpc-1935	91	1	isodense	isodense	ADJ
dpc-1935	91	2	masses	masse	NOUN
dpc-1935	91	3	were	be	AUX
dpc-1935	91	4	localized	localize	VERB
dpc-1935	91	5	on	on	ADP
dpc-1935	91	6	the	the	DET
dpc-1935	91	7	left	left	ADJ
dpc-1935	91	8	breast	breast	NOUN
dpc-1935	91	9	in	in	ADP
dpc-1935	91	10	5	5	NUM
dpc-1935	91	11	(	(	PUNCT
dpc-1935	91	12	11.9	11.9	NUM
dpc-1935	91	13	%	%	NOUN
dpc-1935	91	14	)	)	PUNCT
dpc-1935	91	15	patients	patient	NOUN
dpc-1935	91	16	and	and	CCONJ
dpc-1935	91	17	on	on	ADP
dpc-1935	91	18	the	the	DET
dpc-1935	91	19	right	right	ADJ
dpc-1935	91	20	breast	breast	NOUN
dpc-1935	91	21	in	in	ADP
dpc-1935	91	22	2	2	NUM
dpc-1935	91	23	(	(	PUNCT
dpc-1935	91	24	4.8	4.8	NUM
dpc-1935	91	25	%	%	NOUN
dpc-1935	91	26	)	)	PUNCT
dpc-1935	91	27	patients	patient	NOUN
dpc-1935	91	28	.	.	PUNCT
dpc-1935	92	1	moreover	moreover	ADV
dpc-1935	92	2	,	,	PUNCT
dpc-1935	92	3	in	in	ADP
dpc-1935	92	4	3	3	NUM
dpc-1935	92	5	(	(	PUNCT
dpc-1935	92	6	7.1	7.1	NUM
dpc-1935	92	7	%	%	NOUN
dpc-1935	92	8	)	)	PUNCT
dpc-1935	92	9	patients	patient	NOUN
dpc-1935	92	10	,	,	PUNCT
dpc-1935	92	11	isodense	isodense	ADJ
dpc-1935	92	12	masses	masse	NOUN
dpc-1935	92	13	were	be	AUX
dpc-1935	92	14	localized	localize	VERB
dpc-1935	92	15	on	on	ADP
dpc-1935	92	16	the	the	DET
dpc-1935	92	17	breasts	breast	NOUN
dpc-1935	92	18	bilaterally	bilaterally	ADV
dpc-1935	92	19	.	.	PUNCT
dpc-1935	93	1	seven	seven	NUM
dpc-1935	93	2	(	(	PUNCT
dpc-1935	93	3	16.7	16.7	NUM
dpc-1935	93	4	%	%	NOUN
dpc-1935	93	5	)	)	PUNCT
dpc-1935	93	6	patients	patient	NOUN
dpc-1935	93	7	had	have	VERB
dpc-1935	93	8	1	1	NUM
dpc-1935	93	9	isodense	isodense	NOUN
dpc-1935	93	10	mass	mass	NOUN
dpc-1935	93	11	,	,	PUNCT
dpc-1935	93	12	3	3	NUM
dpc-1935	93	13	(	(	PUNCT
dpc-1935	93	14	7.1	7.1	NUM
dpc-1935	93	15	%	%	NOUN
dpc-1935	93	16	)	)	PUNCT
dpc-1935	93	17	patients	patient	NOUN
dpc-1935	93	18	had	have	VERB
dpc-1935	93	19	multiple	multiple	ADJ
dpc-1935	93	20	isodense	isodense	ADJ
dpc-1935	93	21	masses	masse	NOUN
dpc-1935	93	22	.	.	PUNCT
dpc-1935	94	1	largest	large	ADJ
dpc-1935	94	2	size	size	NOUN
dpc-1935	94	3	of	of	ADP
dpc-1935	94	4	the	the	DET
dpc-1935	94	5	table	table	NOUN
dpc-1935	94	6	1	1	NUM
dpc-1935	94	7	.	.	PUNCT
dpc-1935	95	1	characteristics	characteristic	NOUN
dpc-1935	95	2	and	and	CCONJ
dpc-1935	95	3	mammography	mammography	NOUN
dpc-1935	95	4	results	result	NOUN
dpc-1935	95	5	of	of	ADP
dpc-1935	95	6	female	female	ADJ
dpc-1935	95	7	psoriasis	psoriasis	NOUN
dpc-1935	95	8	patients	patient	NOUN
dpc-1935	95	9	who	who	PRON
dpc-1935	95	10	underwent	undergo	VERB
dpc-1935	95	11	mammography	mammography	NOUN
dpc-1935	95	12	before	before	ADP
dpc-1935	95	13	the	the	DET
dpc-1935	95	14	initiation	initiation	NOUN
dpc-1935	95	15	of	of	ADP
dpc-1935	95	16	biological	biological	ADJ
dpc-1935	95	17	agent	agent	NOUN
dpc-1935	95	18	treatment	treatment	NOUN
dpc-1935	95	19	patients	patient	NOUN
dpc-1935	95	20	with	with	ADP
dpc-1935	95	21	psoriasis	psoriasis	NOUN
dpc-1935	95	22	(	(	PUNCT
dpc-1935	95	23	n	n	NOUN
dpc-1935	95	24	=	=	SYM
dpc-1935	95	25	42	42	NUM
dpc-1935	95	26	)	)	PUNCT
dpc-1935	95	27	mean	mean	VERB
dpc-1935	95	28	age	age	NOUN
dpc-1935	95	29	(	(	PUNCT
dpc-1935	95	30	years	year	NOUN
dpc-1935	95	31	,	,	PUNCT
dpc-1935	95	32	±	±	NUM
dpc-1935	95	33	sd	sd	NOUN
dpc-1935	95	34	)	)	PUNCT
dpc-1935	95	35	53.52	53.52	NUM
dpc-1935	95	36	±	±	NUM
dpc-1935	95	37	7.09	7.09	NUM
dpc-1935	95	38	(	(	PUNCT
dpc-1935	95	39	range	range	NOUN
dpc-1935	95	40	:	:	PUNCT
dpc-1935	95	41	41	41	NUM
dpc-1935	95	42	-	-	SYM
dpc-1935	95	43	65	65	NUM
dpc-1935	95	44	)	)	PUNCT
dpc-1935	95	45	mean	mean	NOUN
dpc-1935	95	46	disease	disease	NOUN
dpc-1935	95	47	duration	duration	NOUN
dpc-1935	95	48	(	(	PUNCT
dpc-1935	95	49	years	year	NOUN
dpc-1935	95	50	,	,	PUNCT
dpc-1935	95	51	±	±	NUM
dpc-1935	95	52	sd	sd	NOUN
dpc-1935	95	53	)	)	PUNCT
dpc-1935	95	54	17.07±10.99	17.07±10.99	NOUN
dpc-1935	95	55	(	(	PUNCT
dpc-1935	95	56	range:1	range:1	NOUN
dpc-1935	95	57	-	-	PUNCT
dpc-1935	95	58	47	47	NUM
dpc-1935	95	59	)	)	PUNCT
dpc-1935	95	60	psoriatic	psoriatic	ADJ
dpc-1935	95	61	arthritis	arthritis	NOUN
dpc-1935	95	62	patients	patient	NOUN
dpc-1935	95	63	with	with	ADP
dpc-1935	95	64	arthritis	arthritis	NOUN
dpc-1935	95	65	14	14	NUM
dpc-1935	95	66	(	(	PUNCT
dpc-1935	95	67	33.3	33.3	NUM
dpc-1935	95	68	)	)	PUNCT
dpc-1935	95	69	patients	patient	NOUN
dpc-1935	95	70	without	without	ADP
dpc-1935	95	71	joint	joint	ADJ
dpc-1935	95	72	pain	pain	NOUN
dpc-1935	95	73	28	28	NUM
dpc-1935	95	74	(	(	PUNCT
dpc-1935	95	75	66.7	66.7	NUM
dpc-1935	95	76	)	)	PUNCT
dpc-1935	95	77	comorbidities	comorbiditie	NOUN
dpc-1935	95	78	,	,	PUNCT
dpc-1935	95	79	n	n	CCONJ
dpc-1935	95	80	(	(	PUNCT
dpc-1935	95	81	%	%	INTJ
dpc-1935	95	82	)	)	PUNCT
dpc-1935	95	83	patients	patient	NOUN
dpc-1935	95	84	with	with	ADP
dpc-1935	95	85	comorbidities	comorbiditie	NOUN
dpc-1935	95	86	26	26	NUM
dpc-1935	95	87	(	(	PUNCT
dpc-1935	95	88	61.9	61.9	NUM
dpc-1935	95	89	)	)	PUNCT
dpc-1935	95	90	patients	patient	NOUN
dpc-1935	95	91	without	without	ADP
dpc-1935	95	92	comorbidities	comorbiditie	NOUN
dpc-1935	95	93	16	16	NUM
dpc-1935	95	94	(	(	PUNCT
dpc-1935	95	95	38.1	38.1	NUM
dpc-1935	95	96	)	)	PUNCT
dpc-1935	95	97	psoriasis	psoriasis	NOUN
dpc-1935	95	98	type	type	NOUN
dpc-1935	95	99	,	,	PUNCT
dpc-1935	95	100	n	n	CCONJ
dpc-1935	95	101	(	(	PUNCT
dpc-1935	95	102	%	%	INTJ
dpc-1935	95	103	)	)	PUNCT
dpc-1935	95	104	pv	pv	ADP
dpc-1935	95	105	32	32	NUM
dpc-1935	95	106	(	(	PUNCT
dpc-1935	95	107	76.2	76.2	NUM
dpc-1935	95	108	)	)	PUNCT
dpc-1935	95	109	ppp	ppp	NOUN
dpc-1935	95	110	5	5	NUM
dpc-1935	95	111	(	(	PUNCT
dpc-1935	95	112	11.9	11.9	NUM
dpc-1935	95	113	)	)	PUNCT
dpc-1935	95	114	gpp	gpp	NOUN
dpc-1935	95	115	5	5	NUM
dpc-1935	95	116	(	(	PUNCT
dpc-1935	95	117	11.9	11.9	NUM
dpc-1935	95	118	)	)	PUNCT
dpc-1935	95	119	previous	previous	ADJ
dpc-1935	95	120	treatment	treatment	NOUN
dpc-1935	95	121	,	,	PUNCT
dpc-1935	95	122	n	n	CCONJ
dpc-1935	95	123	(	(	PUNCT
dpc-1935	95	124	%	%	INTJ
dpc-1935	95	125	)	)	PUNCT
dpc-1935	95	126	conventional	conventional	ADJ
dpc-1935	95	127	treatment	treatment	NOUN
dpc-1935	95	128	41	41	NUM
dpc-1935	95	129	(	(	PUNCT
dpc-1935	95	130	97.6	97.6	NUM
dpc-1935	95	131	)	)	PUNCT
dpc-1935	95	132	phototherapy	phototherapy	NOUN
dpc-1935	95	133	7	7	NUM
dpc-1935	95	134	(	(	PUNCT
dpc-1935	95	135	16.6	16.6	NUM
dpc-1935	95	136	)	)	PUNCT
dpc-1935	95	137	biological	biological	ADJ
dpc-1935	95	138	treatment	treatment	NOUN
dpc-1935	95	139	19	19	NUM
dpc-1935	95	140	(	(	PUNCT
dpc-1935	95	141	45.2	45.2	NUM
dpc-1935	95	142	)	)	PUNCT
dpc-1935	95	143	breast	breast	NOUN
dpc-1935	95	144	density	density	NOUN
dpc-1935	95	145	type	type	NOUN
dpc-1935	95	146	,	,	PUNCT
dpc-1935	95	147	n	n	CCONJ
dpc-1935	95	148	(	(	PUNCT
dpc-1935	95	149	%	%	INTJ
dpc-1935	95	150	)	)	PUNCT
dpc-1935	95	151	a	a	DET
dpc-1935	95	152	4	4	NUM
dpc-1935	95	153	(	(	PUNCT
dpc-1935	95	154	9.5	9.5	NUM
dpc-1935	95	155	)	)	PUNCT
dpc-1935	95	156	b	b	NOUN
dpc-1935	95	157	24	24	NUM
dpc-1935	95	158	(	(	PUNCT
dpc-1935	95	159	57.1	57.1	NUM
dpc-1935	95	160	)	)	PUNCT
dpc-1935	95	161	c	c	NOUN
dpc-1935	95	162	13	13	NUM
dpc-1935	95	163	(	(	PUNCT
dpc-1935	95	164	31	31	NUM
dpc-1935	95	165	)	)	PUNCT
dpc-1935	95	166	d	d	NOUN
dpc-1935	95	167	1	1	NUM
dpc-1935	95	168	(	(	PUNCT
dpc-1935	95	169	2.4	2.4	NUM
dpc-1935	95	170	)	)	PUNCT
dpc-1935	95	171	bi	bi	ADJ
dpc-1935	95	172	-	-	PUNCT
dpc-1935	95	173	rads	rads	ADJ
dpc-1935	95	174	score	score	NOUN
dpc-1935	95	175	,	,	PUNCT
dpc-1935	95	176	n	n	PROPN
dpc-1935	95	177	(	(	PUNCT
dpc-1935	95	178	%	%	INTJ
dpc-1935	95	179	)	)	PUNCT
dpc-1935	95	180	1	1	NUM
dpc-1935	95	181	13	13	NUM
dpc-1935	95	182	(	(	PUNCT
dpc-1935	95	183	31	31	NUM
dpc-1935	95	184	)	)	PUNCT
dpc-1935	95	185	2	2	NUM
dpc-1935	95	186	18	18	NUM
dpc-1935	95	187	(	(	PUNCT
dpc-1935	95	188	42.9	42.9	NUM
dpc-1935	95	189	)	)	PUNCT
dpc-1935	95	190	3	3	NUM
dpc-1935	95	191	9	9	NUM
dpc-1935	95	192	(	(	PUNCT
dpc-1935	95	193	21.4	21.4	NUM
dpc-1935	95	194	)	)	PUNCT
dpc-1935	95	195	4a	4a	NOUN
dpc-1935	95	196	1	1	NUM
dpc-1935	95	197	(	(	PUNCT
dpc-1935	95	198	2.4	2.4	NUM
dpc-1935	95	199	)	)	PUNCT
dpc-1935	95	200	isodense	isodense	NOUN
dpc-1935	95	201	mass	mass	PROPN
dpc-1935	95	202	,	,	PUNCT
dpc-1935	95	203	n	n	PROPN
dpc-1935	95	204	(	(	PUNCT
dpc-1935	95	205	%	%	INTJ
dpc-1935	95	206	)	)	PUNCT
dpc-1935	95	207	patients	patient	NOUN
dpc-1935	95	208	with	with	ADP
dpc-1935	95	209	i	i	PRON
dpc-1935	95	210	m	m	VERB
dpc-1935	95	211	10	10	NUM
dpc-1935	95	212	(	(	PUNCT
dpc-1935	95	213	23.8	23.8	NUM
dpc-1935	95	214	)	)	PUNCT
dpc-1935	95	215	patients	patient	NOUN
dpc-1935	95	216	without	without	ADP
dpc-1935	95	217	i	i	PRON
dpc-1935	95	218	m	m	VERB
dpc-1935	95	219	32	32	NUM
dpc-1935	95	220	(	(	PUNCT
dpc-1935	95	221	76.2	76.2	NUM
dpc-1935	95	222	)	)	PUNCT
dpc-1935	95	223	localization	localization	NOUN
dpc-1935	95	224	of	of	ADP
dpc-1935	95	225	i	i	PRON
dpc-1935	95	226	m	m	PROPN
dpc-1935	95	227	,	,	PUNCT
dpc-1935	95	228	n	n	PROPN
dpc-1935	95	229	(	(	PUNCT
dpc-1935	95	230	%	%	INTJ
dpc-1935	95	231	)	)	PUNCT
dpc-1935	95	232	left	leave	VERB
dpc-1935	95	233	breast	breast	NOUN
dpc-1935	95	234	5	5	NUM
dpc-1935	95	235	(	(	PUNCT
dpc-1935	95	236	11.9	11.9	NUM
dpc-1935	95	237	)	)	PUNCT
dpc-1935	95	238	right	right	ADJ
dpc-1935	95	239	breast	breast	NOUN
dpc-1935	95	240	2	2	NUM
dpc-1935	95	241	(	(	PUNCT
dpc-1935	95	242	4.8	4.8	NUM
dpc-1935	95	243	)	)	PUNCT
dpc-1935	95	244	bilateral	bilateral	ADJ
dpc-1935	95	245	3	3	NUM
dpc-1935	95	246	(	(	PUNCT
dpc-1935	95	247	7.1	7.1	NUM
dpc-1935	95	248	%	%	NOUN
dpc-1935	95	249	)	)	PUNCT
dpc-1935	95	250	intramammary	intramammary	ADJ
dpc-1935	95	251	lymph	lymph	NOUN
dpc-1935	95	252	node	node	ADJ
dpc-1935	95	253	patients	patient	NOUN
dpc-1935	95	254	with	with	ADP
dpc-1935	95	255	iln	iln	PROPN
dpc-1935	95	256	6	6	NUM
dpc-1935	95	257	(	(	PUNCT
dpc-1935	95	258	14.3	14.3	NUM
dpc-1935	95	259	)	)	PUNCT
dpc-1935	95	260	patients	patient	NOUN
dpc-1935	95	261	without	without	ADP
dpc-1935	95	262	iln	iln	PROPN
dpc-1935	95	263	36	36	NUM
dpc-1935	95	264	(	(	PUNCT
dpc-1935	95	265	85.7	85.7	NUM
dpc-1935	95	266	)	)	PUNCT
dpc-1935	95	267	localization	localization	NOUN
dpc-1935	95	268	of	of	ADP
dpc-1935	95	269	iln	iln	NOUN
dpc-1935	95	270	,	,	PUNCT
dpc-1935	95	271	n	n	PROPN
dpc-1935	95	272	(	(	PUNCT
dpc-1935	95	273	%	%	INTJ
dpc-1935	95	274	)	)	PUNCT
dpc-1935	95	275	left	leave	VERB
dpc-1935	95	276	breast	breast	NOUN
dpc-1935	95	277	4	4	NUM
dpc-1935	95	278	(	(	PUNCT
dpc-1935	95	279	9.5	9.5	NUM
dpc-1935	95	280	)	)	PUNCT
dpc-1935	95	281	right	right	ADJ
dpc-1935	95	282	breast	breast	NOUN
dpc-1935	95	283	1	1	NUM
dpc-1935	95	284	(	(	PUNCT
dpc-1935	95	285	2.4	2.4	NUM
dpc-1935	95	286	)	)	PUNCT
dpc-1935	95	287	bilateral	bilateral	ADJ
dpc-1935	95	288	1	1	NUM
dpc-1935	95	289	(	(	PUNCT
dpc-1935	95	290	2.4	2.4	NUM
dpc-1935	95	291	)	)	PUNCT
dpc-1935	95	292	other	other	ADJ
dpc-1935	95	293	lesions	lesion	NOUN
dpc-1935	95	294	,	,	PUNCT
dpc-1935	95	295	n	n	PROPN
dpc-1935	95	296	(	(	PUNCT
dpc-1935	95	297	%	%	INTJ
dpc-1935	95	298	)	)	PUNCT
dpc-1935	95	299	microcalcifications	microcalcification	NOUN
dpc-1935	95	300	6	6	NUM
dpc-1935	95	301	(	(	PUNCT
dpc-1935	95	302	14.3	14.3	NUM
dpc-1935	95	303	)	)	PUNCT
dpc-1935	95	304	macrocalcifications	macrocalcification	NOUN
dpc-1935	95	305	1	1	NUM
dpc-1935	95	306	(	(	PUNCT
dpc-1935	95	307	2.4	2.4	NUM
dpc-1935	95	308	)	)	PUNCT
dpc-1935	95	309	both	both	DET
dpc-1935	95	310	micro	micro	NOUN
dpc-1935	95	311	and	and	CCONJ
dpc-1935	95	312	macrocalcifications	macrocalcification	NOUN
dpc-1935	95	313	1	1	NUM
dpc-1935	95	314	(	(	PUNCT
dpc-1935	95	315	2.4	2.4	NUM
dpc-1935	95	316	)	)	PUNCT
dpc-1935	95	317	hamartoma	hamartoma	NOUN
dpc-1935	95	318	1	1	NUM
dpc-1935	95	319	(	(	PUNCT
dpc-1935	95	320	2.4	2.4	NUM
dpc-1935	95	321	)	)	PUNCT
dpc-1935	95	322	bi	bi	NOUN
dpc-1935	95	323	-	-	NOUN
dpc-1935	95	324	rads	rad	NOUN
dpc-1935	95	325	=	=	SYM
dpc-1935	95	326	breast	breast	NOUN
dpc-1935	95	327	imaging	imaging	NOUN
dpc-1935	95	328	-	-	PUNCT
dpc-1935	95	329	reporting	reporting	NOUN
dpc-1935	95	330	and	and	CCONJ
dpc-1935	95	331	data	datum	NOUN
dpc-1935	95	332	system	system	NOUN
dpc-1935	95	333	;	;	PUNCT
dpc-1935	95	334	gpp	gpp	NOUN
dpc-1935	95	335	=	=	SYM
dpc-1935	95	336	generalized	generalize	VERB
dpc-1935	95	337	pustular	pustular	ADJ
dpc-1935	95	338	psoriasis	psoriasis	NOUN
dpc-1935	95	339	;	;	PUNCT
dpc-1935	95	340	iln	iln	PROPN
dpc-1935	95	341	=	=	PUNCT
dpc-1935	95	342	intramammary	intramammary	ADJ
dpc-1935	95	343	lymph	lymph	NOUN
dpc-1935	95	344	node	node	NOUN
dpc-1935	95	345	;	;	PUNCT
dpc-1935	96	1	i	i	PRON
dpc-1935	96	2	m	m	NOUN
dpc-1935	96	3	=	=	VERB
dpc-1935	96	4	isodense	isodense	NOUN
dpc-1935	96	5	mass	mass	NOUN
dpc-1935	96	6	;	;	PUNCT
dpc-1935	96	7	ppp	ppp	NOUN
dpc-1935	96	8	=	=	NOUN
dpc-1935	96	9	palmoplantar	palmoplantar	NOUN
dpc-1935	96	10	psoriasis	psoriasis	NOUN
dpc-1935	96	11	;	;	PUNCT
dpc-1935	96	12	pv	pv	NOUN
dpc-1935	96	13	=	=	VERB
dpc-1935	96	14	psoriasis	psoriasis	NOUN
dpc-1935	96	15	vulgaris	vulgaris	NOUN
dpc-1935	96	16	;	;	PUNCT
dpc-1935	96	17	sd	sd	NOUN
dpc-1935	96	18	=	=	SYM
dpc-1935	96	19	standard	standard	ADJ
dpc-1935	96	20	deviation	deviation	NOUN
dpc-1935	96	21	.	.	PUNCT
dpc-1935	97	1	4	4	NUM
dpc-1935	97	2	original	original	ADJ
dpc-1935	97	3	article	article	NOUN
dpc-1935	97	4	|	|	ADV
dpc-1935	97	5	dermatol	dermatol	ADJ
dpc-1935	97	6	pract	pract	NOUN
dpc-1935	97	7	concept	concept	NOUN
dpc-1935	97	8	.	.	PUNCT
dpc-1935	98	1	2022;12(2):e2022081	2022;12(2):e2022081	NUM
dpc-1935	98	2	it	it	PRON
dpc-1935	98	3	may	may	AUX
dpc-1935	98	4	also	also	ADV
dpc-1935	98	5	be	be	AUX
dpc-1935	98	6	stopped	stop	VERB
dpc-1935	98	7	in	in	ADP
dpc-1935	98	8	accordance	accordance	NOUN
dpc-1935	98	9	with	with	ADP
dpc-1935	98	10	the	the	DET
dpc-1935	98	11	agreement	agreement	NOUN
dpc-1935	98	12	of	of	ADP
dpc-1935	98	13	both	both	CCONJ
dpc-1935	98	14	the	the	DET
dpc-1935	98	15	physician	physician	NOUN
dpc-1935	98	16	and	and	CCONJ
dpc-1935	98	17	the	the	DET
dpc-1935	98	18	patient	patient	NOUN
dpc-1935	98	19	[	[	X
dpc-1935	98	20	15	15	NUM
dpc-1935	98	21	]	]	PUNCT
dpc-1935	98	22	.	.	PUNCT
dpc-1935	99	1	however	however	ADV
dpc-1935	99	2	,	,	PUNCT
dpc-1935	99	3	us	us	PROPN
dpc-1935	99	4	preventive	preventive	ADJ
dpc-1935	99	5	services	service	NOUN
dpc-1935	99	6	task	task	NOUN
dpc-1935	99	7	force	force	NOUN
dpc-1935	99	8	recommends	recommend	VERB
dpc-1935	99	9	biennial	biennial	ADJ
dpc-1935	99	10	mammography	mammography	NOUN
dpc-1935	99	11	screening	screen	VERB
dpc-1935	99	12	between	between	ADP
dpc-1935	99	13	the	the	DET
dpc-1935	99	14	ages	age	NOUN
dpc-1935	99	15	of	of	ADP
dpc-1935	99	16	50	50	NUM
dpc-1935	99	17	to	to	PART
dpc-1935	99	18	74	74	NUM
dpc-1935	99	19	years	year	NOUN
dpc-1935	99	20	[	[	X
dpc-1935	99	21	16,17	16,17	NUM
dpc-1935	99	22	]	]	PUNCT
dpc-1935	99	23	.	.	PUNCT
dpc-1935	100	1	moreover	moreover	ADV
dpc-1935	100	2	,	,	PUNCT
dpc-1935	100	3	national	national	ADJ
dpc-1935	100	4	comprehensive	comprehensive	ADJ
dpc-1935	100	5	cancer	cancer	NOUN
dpc-1935	100	6	network	network	NOUN
dpc-1935	100	7	recommends	recommend	VERB
dpc-1935	100	8	to	to	PART
dpc-1935	100	9	start	start	VERB
dpc-1935	100	10	mammography	mammography	NOUN
dpc-1935	100	11	at	at	ADP
dpc-1935	100	12	the	the	DET
dpc-1935	100	13	age	age	NOUN
dpc-1935	100	14	of	of	ADP
dpc-1935	100	15	40	40	NUM
dpc-1935	100	16	years	year	NOUN
dpc-1935	100	17	and	and	CCONJ
dpc-1935	100	18	to	to	PART
dpc-1935	100	19	repeat	repeat	VERB
dpc-1935	100	20	it	it	PRON
dpc-1935	100	21	every	every	DET
dpc-1935	100	22	year	year	NOUN
dpc-1935	100	23	[	[	X
dpc-1935	100	24	15	15	NUM
dpc-1935	100	25	]	]	PUNCT
dpc-1935	100	26	.	.	PUNCT
dpc-1935	101	1	breast	breast	NOUN
dpc-1935	101	2	cancer	cancer	NOUN
dpc-1935	101	3	has	have	AUX
dpc-1935	101	4	been	be	AUX
dpc-1935	101	5	associated	associate	VERB
dpc-1935	101	6	with	with	ADP
dpc-1935	101	7	psoriasis	psoriasis	NOUN
dpc-1935	101	8	[	[	X
dpc-1935	101	9	18	18	NUM
dpc-1935	101	10	]	]	PUNCT
dpc-1935	101	11	.	.	PUNCT
dpc-1935	102	1	it	it	PRON
dpc-1935	102	2	has	have	AUX
dpc-1935	102	3	been	be	AUX
dpc-1935	102	4	suggested	suggest	VERB
dpc-1935	102	5	that	that	SCONJ
dpc-1935	102	6	the	the	DET
dpc-1935	102	7	risk	risk	NOUN
dpc-1935	102	8	of	of	ADP
dpc-1935	102	9	cancer	cancer	NOUN
dpc-1935	102	10	might	might	AUX
dpc-1935	102	11	increase	increase	VERB
dpc-1935	102	12	in	in	ADP
dpc-1935	102	13	patients	patient	NOUN
dpc-1935	102	14	with	with	ADP
dpc-1935	102	15	psoriasis	psoriasis	NOUN
dpc-1935	102	16	due	due	ADJ
dpc-1935	102	17	to	to	ADP
dpc-1935	102	18	chronic	chronic	ADJ
dpc-1935	102	19	inflammation	inflammation	NOUN
dpc-1935	102	20	[	[	X
dpc-1935	102	21	19	19	NUM
dpc-1935	102	22	]	]	PUNCT
dpc-1935	102	23	.	.	PUNCT
dpc-1935	103	1	elevated	elevated	ADJ
dpc-1935	103	2	incidence	incidence	NOUN
dpc-1935	103	3	of	of	ADP
dpc-1935	103	4	psoriasis	psoriasis	NOUN
dpc-1935	103	5	has	have	AUX
dpc-1935	103	6	also	also	ADV
dpc-1935	103	7	been	be	AUX
dpc-1935	103	8	reported	report	VERB
dpc-1935	103	9	among	among	ADP
dpc-1935	103	10	patients	patient	NOUN
dpc-1935	103	11	with	with	ADP
dpc-1935	103	12	breast	breast	NOUN
dpc-1935	103	13	cancer	cancer	NOUN
dpc-1935	103	14	[	[	X
dpc-1935	103	15	20	20	NUM
dpc-1935	103	16	]	]	PUNCT
dpc-1935	103	17	.	.	PUNCT
dpc-1935	104	1	in	in	ADP
dpc-1935	104	2	addition	addition	NOUN
dpc-1935	104	3	,	,	PUNCT
dpc-1935	104	4	there	there	PRON
dpc-1935	104	5	are	be	VERB
dpc-1935	104	6	concerns	concern	NOUN
dpc-1935	104	7	that	that	SCONJ
dpc-1935	104	8	biological	biological	ADJ
dpc-1935	104	9	agents	agent	NOUN
dpc-1935	104	10	may	may	AUX
dpc-1935	104	11	be	be	AUX
dpc-1935	104	12	associated	associate	VERB
dpc-1935	104	13	with	with	ADP
dpc-1935	104	14	cancer	cancer	NOUN
dpc-1935	104	15	development	development	NOUN
dpc-1935	104	16	based	base	VERB
dpc-1935	104	17	on	on	ADP
dpc-1935	104	18	their	their	PRON
dpc-1935	104	19	effect	effect	NOUN
dpc-1935	104	20	on	on	ADP
dpc-1935	104	21	immune	immune	ADJ
dpc-1935	104	22	system	system	NOUN
dpc-1935	104	23	[	[	X
dpc-1935	104	24	21	21	NUM
dpc-1935	104	25	]	]	PUNCT
dpc-1935	104	26	.	.	PUNCT
dpc-1935	105	1	since	since	SCONJ
dpc-1935	105	2	biological	biological	ADJ
dpc-1935	105	3	treatment	treatment	NOUN
dpc-1935	105	4	has	have	AUX
dpc-1935	105	5	been	be	AUX
dpc-1935	105	6	associated	associate	VERB
dpc-1935	105	7	with	with	ADP
dpc-1935	105	8	malignancy	malignancy	NOUN
dpc-1935	105	9	,	,	PUNCT
dpc-1935	105	10	it	it	PRON
dpc-1935	105	11	is	be	AUX
dpc-1935	105	12	mandatory	mandatory	ADJ
dpc-1935	105	13	to	to	PART
dpc-1935	105	14	exclude	exclude	VERB
dpc-1935	105	15	malignancies	malignancy	NOUN
dpc-1935	105	16	before	before	ADP
dpc-1935	105	17	the	the	DET
dpc-1935	105	18	initiation	initiation	NOUN
dpc-1935	105	19	of	of	ADP
dpc-1935	105	20	biological	biological	ADJ
dpc-1935	105	21	agents	agent	NOUN
dpc-1935	105	22	and	and	CCONJ
dpc-1935	105	23	to	to	PART
dpc-1935	105	24	monitor	monitor	VERB
dpc-1935	105	25	patients	patient	NOUN
dpc-1935	105	26	for	for	ADP
dpc-1935	105	27	cancer	cancer	NOUN
dpc-1935	105	28	development	development	NOUN
dpc-1935	105	29	during	during	ADP
dpc-1935	105	30	treatment	treatment	NOUN
dpc-1935	105	31	[	[	X
dpc-1935	105	32	22	22	NUM
dpc-1935	105	33	]	]	PUNCT
dpc-1935	105	34	.	.	PUNCT
dpc-1935	106	1	within	within	ADP
dpc-1935	106	2	this	this	DET
dpc-1935	106	3	study	study	NOUN
dpc-1935	106	4	,	,	PUNCT
dpc-1935	106	5	mammography	mammography	NOUN
dpc-1935	106	6	results	result	NOUN
dpc-1935	106	7	of	of	ADP
dpc-1935	106	8	patients	patient	NOUN
dpc-1935	106	9	with	with	ADP
dpc-1935	106	10	psoriasis	psoriasis	NOUN
dpc-1935	106	11	over	over	ADP
dpc-1935	106	12	the	the	DET
dpc-1935	106	13	age	age	NOUN
dpc-1935	106	14	of	of	ADP
dpc-1935	106	15	40	40	NUM
dpc-1935	106	16	years	year	NOUN
dpc-1935	106	17	were	be	AUX
dpc-1935	106	18	evaluated	evaluate	VERB
dpc-1935	106	19	before	before	ADP
dpc-1935	106	20	the	the	DET
dpc-1935	106	21	initiation	initiation	NOUN
dpc-1935	106	22	of	of	ADP
dpc-1935	106	23	biological	biological	ADJ
dpc-1935	106	24	agent	agent	NOUN
dpc-1935	106	25	treatment	treatment	NOUN
dpc-1935	106	26	.	.	PUNCT
dpc-1935	107	1	most	most	ADJ
dpc-1935	107	2	of	of	ADP
dpc-1935	107	3	the	the	DET
dpc-1935	107	4	patients	patient	NOUN
dpc-1935	107	5	(	(	PUNCT
dpc-1935	107	6	42.9	42.9	NUM
dpc-1935	107	7	%	%	NOUN
dpc-1935	107	8	)	)	PUNCT
dpc-1935	107	9	had	have	VERB
dpc-1935	107	10	bi	bi	ADJ
dpc-1935	107	11	-	-	ADJ
dpc-1935	107	12	rads	rad	NOUN
dpc-1935	107	13	score	score	NOUN
dpc-1935	107	14	2	2	NUM
dpc-1935	107	15	,	,	PUNCT
dpc-1935	107	16	which	which	PRON
dpc-1935	107	17	indicated	indicate	VERB
dpc-1935	107	18	benign	benign	ADJ
dpc-1935	107	19	findings	finding	NOUN
dpc-1935	107	20	[	[	X
dpc-1935	107	21	12	12	NUM
dpc-1935	107	22	]	]	PUNCT
dpc-1935	107	23	.	.	PUNCT
dpc-1935	108	1	however	however	ADV
dpc-1935	108	2	,	,	PUNCT
dpc-1935	108	3	bi	bi	ADJ
dpc-1935	108	4	-	-	ADJ
dpc-1935	108	5	rads	rad	NOUN
dpc-1935	108	6	score	score	NOUN
dpc-1935	108	7	3	3	NUM
dpc-1935	108	8	,	,	PUNCT
dpc-1935	108	9	which	which	PRON
dpc-1935	108	10	indicated	indicate	VERB
dpc-1935	108	11	probably	probably	ADV
dpc-1935	108	12	benign	benign	ADJ
dpc-1935	108	13	lesions	lesion	NOUN
dpc-1935	108	14	requiring	require	VERB
dpc-1935	108	15	close	close	ADJ
dpc-1935	108	16	follow	follow	NOUN
dpc-1935	108	17	-	-	PUNCT
dpc-1935	108	18	up	up	NOUN
dpc-1935	108	19	was	be	AUX
dpc-1935	108	20	detected	detect	VERB
dpc-1935	108	21	in	in	ADP
dpc-1935	108	22	21.4	21.4	NUM
dpc-1935	108	23	%	%	NOUN
dpc-1935	108	24	of	of	ADP
dpc-1935	108	25	the	the	DET
dpc-1935	108	26	patients	patient	NOUN
dpc-1935	108	27	[	[	X
dpc-1935	108	28	12	12	NUM
dpc-1935	108	29	]	]	PUNCT
dpc-1935	108	30	.	.	PUNCT
dpc-1935	109	1	furthermore	furthermore	ADV
dpc-1935	109	2	,	,	PUNCT
dpc-1935	109	3	1	1	NUM
dpc-1935	109	4	patient	patient	NOUN
dpc-1935	109	5	had	have	VERB
dpc-1935	109	6	bi	bi	ADJ
dpc-1935	109	7	-	-	ADJ
dpc-1935	109	8	rads	rads	ADJ
dpc-1935	109	9	score	score	NOUN
dpc-1935	109	10	4a	4a	NOUN
dpc-1935	109	11	,	,	PUNCT
dpc-1935	109	12	which	which	PRON
dpc-1935	109	13	indicated	indicate	VERB
dpc-1935	109	14	2	2	NUM
dpc-1935	109	15	%	%	NOUN
dpc-1935	109	16	to	to	PART
dpc-1935	109	17	10	10	NUM
dpc-1935	109	18	%	%	NOUN
dpc-1935	109	19	of	of	ADP
dpc-1935	109	20	risk	risk	NOUN
dpc-1935	109	21	of	of	ADP
dpc-1935	109	22	malignancy	malignancy	NOUN
dpc-1935	109	23	[	[	X
dpc-1935	109	24	12	12	NUM
dpc-1935	109	25	]	]	PUNCT
dpc-1935	109	26	.	.	PUNCT
dpc-1935	110	1	isodense	isodense	ADJ
dpc-1935	110	2	masses	masse	NOUN
dpc-1935	110	3	were	be	AUX
dpc-1935	110	4	detected	detect	VERB
dpc-1935	110	5	in	in	ADP
dpc-1935	110	6	23.8	23.8	NUM
dpc-1935	110	7	%	%	NOUN
dpc-1935	110	8	,	,	PUNCT
dpc-1935	110	9	microcalcifications	microcalcification	NOUN
dpc-1935	110	10	or	or	CCONJ
dpc-1935	110	11	macrocalcifications	macrocalcification	NOUN
dpc-1935	110	12	in	in	ADP
dpc-1935	110	13	19.1	19.1	NUM
dpc-1935	110	14	%	%	NOUN
dpc-1935	110	15	and	and	CCONJ
dpc-1935	110	16	intramammary	intramammary	ADJ
dpc-1935	110	17	lymph	lymph	NOUN
dpc-1935	110	18	nodes	node	NOUN
dpc-1935	110	19	in	in	ADP
dpc-1935	110	20	14.3	14.3	NUM
dpc-1935	110	21	%	%	NOUN
dpc-1935	110	22	patients	patient	NOUN
dpc-1935	110	23	.	.	PUNCT
dpc-1935	111	1	isodense	isodense	ADJ
dpc-1935	111	2	masses	masse	NOUN
dpc-1935	111	3	,	,	PUNCT
dpc-1935	111	4	calcifications	calcification	NOUN
dpc-1935	111	5	and	and	CCONJ
dpc-1935	111	6	intramammary	intramammary	ADJ
dpc-1935	111	7	lymph	lymph	NOUN
dpc-1935	111	8	nodes	node	NOUN
dpc-1935	111	9	were	be	AUX
dpc-1935	111	10	more	more	ADV
dpc-1935	111	11	common	common	ADJ
dpc-1935	111	12	in	in	ADP
dpc-1935	111	13	patients	patient	NOUN
dpc-1935	111	14	with	with	ADP
dpc-1935	111	15	history	history	NOUN
dpc-1935	111	16	of	of	ADP
dpc-1935	111	17	psoriasis	psoriasis	NOUN
dpc-1935	111	18	longer	long	ADV
dpc-1935	111	19	than	than	ADP
dpc-1935	111	20	10	10	NUM
dpc-1935	111	21	years	year	NOUN
dpc-1935	111	22	.	.	PUNCT
dpc-1935	112	1	however	however	ADV
dpc-1935	112	2	,	,	PUNCT
dpc-1935	112	3	no	no	DET
dpc-1935	112	4	statistically	statistically	ADV
dpc-1935	112	5	significant	significant	ADJ
dpc-1935	112	6	difference	difference	NOUN
dpc-1935	112	7	was	be	AUX
dpc-1935	112	8	observed	observe	VERB
dpc-1935	112	9	between	between	ADP
dpc-1935	112	10	disease	disease	NOUN
dpc-1935	112	11	duration	duration	NOUN
dpc-1935	112	12	and	and	CCONJ
dpc-1935	112	13	the	the	DET
dpc-1935	112	14	frequency	frequency	NOUN
dpc-1935	112	15	of	of	ADP
dpc-1935	112	16	isodense	isodense	NOUN
dpc-1935	112	17	masses	masse	NOUN
dpc-1935	112	18	,	,	PUNCT
dpc-1935	112	19	calcifications	calcification	NOUN
dpc-1935	112	20	or	or	CCONJ
dpc-1935	112	21	intramammary	intramammary	ADJ
dpc-1935	112	22	lymph	lymph	NOUN
dpc-1935	112	23	nodes	node	NOUN
dpc-1935	112	24	(	(	PUNCT
dpc-1935	112	25	p	p	X
dpc-1935	112	26	=	=	NOUN
dpc-1935	112	27	0.47	0.47	NUM
dpc-1935	112	28	,	,	PUNCT
dpc-1935	112	29	p	p	X
dpc-1935	112	30	=	=	NOUN
dpc-1935	112	31	0.21	0.21	NUM
dpc-1935	112	32	,	,	PUNCT
dpc-1935	112	33	p	p	X
dpc-1935	112	34	=	=	PROPN
dpc-1935	112	35	0.41	0.41	NUM
dpc-1935	112	36	,	,	PUNCT
dpc-1935	112	37	respectively	respectively	ADV
dpc-1935	112	38	)	)	PUNCT
dpc-1935	112	39	.	.	PUNCT
dpc-1935	113	1	on	on	ADP
dpc-1935	113	2	the	the	DET
dpc-1935	113	3	other	other	ADJ
dpc-1935	113	4	hand	hand	NOUN
dpc-1935	113	5	,	,	PUNCT
dpc-1935	113	6	intramammary	intramammary	ADJ
dpc-1935	113	7	lymph	lymph	NOUN
dpc-1935	113	8	nodes	node	NOUN
dpc-1935	113	9	were	be	AUX
dpc-1935	113	10	more	more	ADV
dpc-1935	113	11	common	common	ADJ
dpc-1935	113	12	in	in	ADP
dpc-1935	113	13	patients	patient	NOUN
dpc-1935	113	14	who	who	PRON
dpc-1935	113	15	were	be	AUX
dpc-1935	113	16	previously	previously	ADV
dpc-1935	113	17	treated	treat	VERB
dpc-1935	113	18	with	with	ADP
dpc-1935	113	19	biological	biological	ADJ
dpc-1935	113	20	agents	agent	NOUN
dpc-1935	113	21	compared	compare	VERB
dpc-1935	113	22	to	to	ADP
dpc-1935	113	23	biologicnaïve	biologicnaïve	ADJ
dpc-1935	113	24	patients	patient	NOUN
dpc-1935	113	25	(	(	PUNCT
dpc-1935	113	26	p	p	X
dpc-1935	113	27	=	=	NOUN
dpc-1935	113	28	0.04	0.04	NUM
dpc-1935	113	29	)	)	PUNCT
dpc-1935	113	30	.	.	PUNCT
dpc-1935	114	1	in	in	ADP
dpc-1935	114	2	addition	addition	NOUN
dpc-1935	114	3	,	,	PUNCT
dpc-1935	114	4	a	a	DET
dpc-1935	114	5	patient	patient	NOUN
dpc-1935	114	6	with	with	ADP
dpc-1935	114	7	family	family	NOUN
dpc-1935	114	8	history	history	NOUN
dpc-1935	114	9	of	of	ADP
dpc-1935	114	10	both	both	DET
dpc-1935	114	11	psoriasis	psoriasis	NOUN
dpc-1935	114	12	and	and	CCONJ
dpc-1935	114	13	breast	breast	NOUN
dpc-1935	114	14	cancer	cancer	NOUN
dpc-1935	114	15	who	who	PRON
dpc-1935	114	16	had	have	AUX
dpc-1935	114	17	already	already	ADV
dpc-1935	114	18	been	be	AUX
dpc-1935	114	19	diagnosed	diagnose	VERB
dpc-1935	114	20	with	with	ADP
dpc-1935	114	21	breast	breast	NOUN
dpc-1935	114	22	cancer	cancer	NOUN
dpc-1935	114	23	while	while	SCONJ
dpc-1935	114	24	receiving	receive	VERB
dpc-1935	114	25	adalimumab	adalimumab	NOUN
dpc-1935	114	26	was	be	AUX
dpc-1935	114	27	detected	detect	VERB
dpc-1935	114	28	.	.	PUNCT
dpc-1935	115	1	therefore	therefore	ADV
dpc-1935	115	2	,	,	PUNCT
dpc-1935	115	3	we	we	PRON
dpc-1935	115	4	suggest	suggest	VERB
dpc-1935	115	5	that	that	SCONJ
dpc-1935	115	6	female	female	ADJ
dpc-1935	115	7	patients	patient	NOUN
dpc-1935	115	8	over	over	ADP
dpc-1935	115	9	40	40	NUM
dpc-1935	115	10	years	year	NOUN
dpc-1935	115	11	,	,	PUNCT
dpc-1935	115	12	especially	especially	ADV
dpc-1935	115	13	those	those	PRON
dpc-1935	115	14	who	who	PRON
dpc-1935	115	15	had	have	VERB
dpc-1935	115	16	a	a	DET
dpc-1935	115	17	long	long	ADJ
dpc-1935	115	18	disease	disease	NOUN
dpc-1935	115	19	duration	duration	NOUN
dpc-1935	115	20	,	,	PUNCT
dpc-1935	115	21	family	family	NOUN
dpc-1935	115	22	history	history	NOUN
dpc-1935	115	23	of	of	ADP
dpc-1935	115	24	breast	breast	NOUN
dpc-1935	115	25	cancer	cancer	NOUN
dpc-1935	115	26	and	and	CCONJ
dpc-1935	115	27	previous	previous	ADJ
dpc-1935	115	28	history	history	NOUN
dpc-1935	115	29	of	of	ADP
dpc-1935	115	30	treatment	treatment	NOUN
dpc-1935	115	31	with	with	ADP
dpc-1935	115	32	biological	biological	ADJ
dpc-1935	115	33	agents	agent	NOUN
dpc-1935	115	34	,	,	PUNCT
dpc-1935	115	35	should	should	AUX
dpc-1935	115	36	undergo	undergo	VERB
dpc-1935	115	37	mammography	mammography	NOUN
dpc-1935	115	38	screening	screen	VERB
dpc-1935	115	39	before	before	ADP
dpc-1935	115	40	the	the	DET
dpc-1935	115	41	initiation	initiation	NOUN
dpc-1935	115	42	of	of	ADP
dpc-1935	115	43	biological	biological	ADJ
dpc-1935	115	44	agents	agent	NOUN
dpc-1935	115	45	for	for	ADP
dpc-1935	115	46	the	the	DET
dpc-1935	115	47	treatment	treatment	NOUN
dpc-1935	115	48	of	of	ADP
dpc-1935	115	49	psoriasis	psoriasis	NOUN
dpc-1935	115	50	.	.	PUNCT
dpc-1935	116	1	the	the	DET
dpc-1935	116	2	limitations	limitation	NOUN
dpc-1935	116	3	of	of	ADP
dpc-1935	116	4	this	this	DET
dpc-1935	116	5	study	study	NOUN
dpc-1935	116	6	were	be	AUX
dpc-1935	116	7	small	small	ADJ
dpc-1935	116	8	sample	sample	NOUN
dpc-1935	116	9	size	size	NOUN
dpc-1935	116	10	and	and	CCONJ
dpc-1935	116	11	lack	lack	NOUN
dpc-1935	116	12	of	of	ADP
dpc-1935	116	13	a	a	DET
dpc-1935	116	14	control	control	NOUN
dpc-1935	116	15	group	group	NOUN
dpc-1935	116	16	.	.	PUNCT
dpc-1935	117	1	british	british	PROPN
dpc-1935	117	2	association	association	PROPN
dpc-1935	117	3	of	of	ADP
dpc-1935	117	4	dermatologists	dermatologists	PROPN
dpc-1935	117	5	recommends	recommend	VERB
dpc-1935	117	6	the	the	DET
dpc-1935	117	7	evaluation	evaluation	NOUN
dpc-1935	117	8	of	of	ADP
dpc-1935	117	9	psoriasis	psoriasis	NOUN
dpc-1935	117	10	patients	patient	NOUN
dpc-1935	117	11	before	before	ADP
dpc-1935	117	12	the	the	DET
dpc-1935	117	13	treatment	treatment	NOUN
dpc-1935	117	14	with	with	ADP
dpc-1935	117	15	biological	biological	ADJ
dpc-1935	117	16	agents	agent	NOUN
dpc-1935	117	17	according	accord	VERB
dpc-1935	117	18	to	to	ADP
dpc-1935	117	19	existing	exist	VERB
dpc-1935	117	20	cancer	cancer	NOUN
dpc-1935	117	21	or	or	CCONJ
dpc-1935	117	22	future	future	ADJ
dpc-1935	117	23	malignancy	malignancy	NOUN
dpc-1935	117	24	risk	risk	NOUN
dpc-1935	117	25	and	and	CCONJ
dpc-1935	117	26	thus	thus	ADV
dpc-1935	117	27	it	it	PRON
dpc-1935	117	28	directs	direct	VERB
dpc-1935	117	29	patients	patient	NOUN
dpc-1935	117	30	to	to	PART
dpc-1935	117	31	attend	attend	VERB
dpc-1935	117	32	the	the	DET
dpc-1935	117	33	national	national	ADJ
dpc-1935	117	34	five	five	NUM
dpc-1935	117	35	(	(	PUNCT
dpc-1935	117	36	11.9	11.9	NUM
dpc-1935	117	37	%	%	NOUN
dpc-1935	117	38	)	)	PUNCT
dpc-1935	117	39	patients	patient	NOUN
dpc-1935	117	40	with	with	ADP
dpc-1935	117	41	an	an	DET
dpc-1935	117	42	isodense	isodense	ADJ
dpc-1935	117	43	mass	mass	NOUN
dpc-1935	117	44	of	of	ADP
dpc-1935	117	45	the	the	DET
dpc-1935	117	46	breast	breast	NOUN
dpc-1935	117	47	were	be	AUX
dpc-1935	117	48	treated	treat	VERB
dpc-1935	117	49	with	with	ADP
dpc-1935	117	50	biological	biological	ADJ
dpc-1935	117	51	agents	agent	NOUN
dpc-1935	117	52	,	,	PUNCT
dpc-1935	117	53	previously	previously	ADV
dpc-1935	117	54	and	and	CCONJ
dpc-1935	117	55	5	5	NUM
dpc-1935	117	56	(	(	PUNCT
dpc-1935	117	57	11.9	11.9	NUM
dpc-1935	117	58	%	%	NOUN
dpc-1935	117	59	)	)	PUNCT
dpc-1935	117	60	patients	patient	NOUN
dpc-1935	117	61	with	with	ADP
dpc-1935	117	62	an	an	DET
dpc-1935	117	63	isodense	isodense	NOUN
dpc-1935	117	64	mass	mass	NOUN
dpc-1935	117	65	were	be	AUX
dpc-1935	117	66	biologic	biologic	ADJ
dpc-1935	117	67	naïve	naïve	ADJ
dpc-1935	117	68	(	(	PUNCT
dpc-1935	117	69	p	p	X
dpc-1935	117	70	=	=	NOUN
dpc-1935	117	71	0.72	0.72	NUM
dpc-1935	117	72	)	)	PUNCT
dpc-1935	117	73	.	.	PUNCT
dpc-1935	118	1	three	three	NUM
dpc-1935	118	2	(	(	PUNCT
dpc-1935	118	3	7.1	7.1	NUM
dpc-1935	118	4	%	%	NOUN
dpc-1935	118	5	)	)	PUNCT
dpc-1935	118	6	patients	patient	NOUN
dpc-1935	118	7	with	with	ADP
dpc-1935	118	8	calcifications	calcification	NOUN
dpc-1935	118	9	were	be	AUX
dpc-1935	118	10	treated	treat	VERB
dpc-1935	118	11	with	with	ADP
dpc-1935	118	12	biological	biological	ADJ
dpc-1935	118	13	agents	agent	NOUN
dpc-1935	118	14	previously	previously	ADV
dpc-1935	118	15	,	,	PUNCT
dpc-1935	118	16	however	however	ADV
dpc-1935	118	17	,	,	PUNCT
dpc-1935	118	18	5	5	NUM
dpc-1935	118	19	(	(	PUNCT
dpc-1935	118	20	11.9	11.9	NUM
dpc-1935	118	21	%	%	NOUN
dpc-1935	118	22	)	)	PUNCT
dpc-1935	118	23	patients	patient	NOUN
dpc-1935	118	24	with	with	ADP
dpc-1935	118	25	calcifications	calcification	NOUN
dpc-1935	118	26	were	be	AUX
dpc-1935	118	27	biologicnaïve	biologicnaïve	VERB
dpc-1935	118	28	(	(	PUNCT
dpc-1935	118	29	p	p	X
dpc-1935	118	30	=	=	NOUN
dpc-1935	118	31	0.62	0.62	NUM
dpc-1935	118	32	)	)	PUNCT
dpc-1935	118	33	.	.	PUNCT
dpc-1935	119	1	five	five	NUM
dpc-1935	119	2	(	(	PUNCT
dpc-1935	119	3	11.9	11.9	NUM
dpc-1935	119	4	%	%	NOUN
dpc-1935	119	5	)	)	PUNCT
dpc-1935	119	6	patients	patient	NOUN
dpc-1935	119	7	with	with	ADP
dpc-1935	119	8	an	an	DET
dpc-1935	119	9	intramammary	intramammary	ADJ
dpc-1935	119	10	lymph	lymph	NOUN
dpc-1935	119	11	node	node	NOUN
dpc-1935	119	12	were	be	AUX
dpc-1935	119	13	treated	treat	VERB
dpc-1935	119	14	with	with	ADP
dpc-1935	119	15	biological	biological	ADJ
dpc-1935	119	16	agents	agent	NOUN
dpc-1935	119	17	previously	previously	ADV
dpc-1935	119	18	and	and	CCONJ
dpc-1935	119	19	1	1	NUM
dpc-1935	119	20	(	(	PUNCT
dpc-1935	119	21	2.4	2.4	NUM
dpc-1935	119	22	%	%	NOUN
dpc-1935	119	23	)	)	PUNCT
dpc-1935	119	24	patient	patient	NOUN
dpc-1935	119	25	with	with	ADP
dpc-1935	119	26	an	an	DET
dpc-1935	119	27	intramammary	intramammary	ADJ
dpc-1935	119	28	lymph	lymph	NOUN
dpc-1935	119	29	node	node	NOUN
dpc-1935	119	30	was	be	AUX
dpc-1935	119	31	biologicnaïve	biologicnaïve	VERB
dpc-1935	119	32	(	(	PUNCT
dpc-1935	119	33	p	p	X
dpc-1935	119	34	=	=	NOUN
dpc-1935	119	35	0.04	0.04	NUM
dpc-1935	119	36	)	)	PUNCT
dpc-1935	119	37	.	.	PUNCT
dpc-1935	120	1	in	in	ADP
dpc-1935	120	2	addition	addition	NOUN
dpc-1935	120	3	,	,	PUNCT
dpc-1935	120	4	a	a	DET
dpc-1935	120	5	58	58	NUM
dpc-1935	120	6	-	-	PUNCT
dpc-1935	120	7	year	year	NOUN
dpc-1935	120	8	-	-	PUNCT
dpc-1935	120	9	old	old	ADJ
dpc-1935	120	10	female	female	ADJ
dpc-1935	120	11	patient	patient	NOUN
dpc-1935	120	12	with	with	ADP
dpc-1935	120	13	a	a	DET
dpc-1935	120	14	30	30	NUM
dpc-1935	120	15	-	-	PUNCT
dpc-1935	120	16	year	year	NOUN
dpc-1935	120	17	history	history	NOUN
dpc-1935	120	18	of	of	ADP
dpc-1935	120	19	psoriasis	psoriasis	NOUN
dpc-1935	120	20	vulgaris	vulgaris	NOUN
dpc-1935	120	21	and	and	CCONJ
dpc-1935	120	22	psoriatic	psoriatic	ADJ
dpc-1935	120	23	arthritis	arthritis	NOUN
dpc-1935	120	24	who	who	PRON
dpc-1935	120	25	had	have	AUX
dpc-1935	120	26	already	already	ADV
dpc-1935	120	27	been	be	AUX
dpc-1935	120	28	diagnosed	diagnose	VERB
dpc-1935	120	29	with	with	ADP
dpc-1935	120	30	breast	breast	NOUN
dpc-1935	120	31	cancer	cancer	NOUN
dpc-1935	120	32	was	be	AUX
dpc-1935	120	33	determined	determine	VERB
dpc-1935	120	34	.	.	PUNCT
dpc-1935	121	1	family	family	NOUN
dpc-1935	121	2	history	history	NOUN
dpc-1935	121	3	of	of	ADP
dpc-1935	121	4	the	the	DET
dpc-1935	121	5	patient	patient	NOUN
dpc-1935	121	6	was	be	AUX
dpc-1935	121	7	remarkable	remarkable	ADJ
dpc-1935	121	8	for	for	ADP
dpc-1935	121	9	both	both	PRON
dpc-1935	121	10	psoriasis	psoriasis	NOUN
dpc-1935	121	11	and	and	CCONJ
dpc-1935	121	12	breast	breast	NOUN
dpc-1935	121	13	cancer	cancer	NOUN
dpc-1935	121	14	.	.	PUNCT
dpc-1935	122	1	the	the	DET
dpc-1935	122	2	patient	patient	NOUN
dpc-1935	122	3	was	be	AUX
dpc-1935	122	4	treated	treat	VERB
dpc-1935	122	5	with	with	ADP
dpc-1935	122	6	methotrexate	methotrexate	NOUN
dpc-1935	122	7	,	,	PUNCT
dpc-1935	122	8	cyclosporine	cyclosporine	NOUN
dpc-1935	122	9	,	,	PUNCT
dpc-1935	122	10	acitretin	acitretin	NOUN
dpc-1935	122	11	,	,	PUNCT
dpc-1935	122	12	puva	puva	PROPN
dpc-1935	122	13	and	and	CCONJ
dpc-1935	122	14	adalimumab	adalimumab	PROPN
dpc-1935	122	15	,	,	PUNCT
dpc-1935	122	16	previously	previously	ADV
dpc-1935	122	17	.	.	PUNCT
dpc-1935	123	1	after	after	ADP
dpc-1935	123	2	10	10	NUM
dpc-1935	123	3	months	month	NOUN
dpc-1935	123	4	of	of	ADP
dpc-1935	123	5	adalimumab	adalimumab	NOUN
dpc-1935	123	6	treatment	treatment	NOUN
dpc-1935	123	7	,	,	PUNCT
dpc-1935	123	8	the	the	DET
dpc-1935	123	9	patient	patient	NOUN
dpc-1935	123	10	was	be	AUX
dpc-1935	123	11	diagnosed	diagnose	VERB
dpc-1935	123	12	with	with	ADP
dpc-1935	123	13	grade	grade	NOUN
dpc-1935	123	14	1	1	NUM
dpc-1935	123	15	invasive	invasive	ADJ
dpc-1935	123	16	ductal	ductal	ADJ
dpc-1935	123	17	carcinoma	carcinoma	NOUN
dpc-1935	123	18	,	,	PUNCT
dpc-1935	123	19	therefore	therefore	ADV
dpc-1935	123	20	adalimumab	adalimumab	NOUN
dpc-1935	123	21	treatment	treatment	NOUN
dpc-1935	123	22	was	be	AUX
dpc-1935	123	23	stopped	stop	VERB
dpc-1935	123	24	.	.	PUNCT
dpc-1935	124	1	conclusions	conclusion	NOUN
dpc-1935	124	2	breast	breast	NOUN
dpc-1935	124	3	cancer	cancer	NOUN
dpc-1935	124	4	is	be	AUX
dpc-1935	124	5	the	the	DET
dpc-1935	124	6	most	most	ADV
dpc-1935	124	7	frequently	frequently	ADV
dpc-1935	124	8	detected	detect	VERB
dpc-1935	124	9	malignancy	malignancy	NOUN
dpc-1935	124	10	and	and	CCONJ
dpc-1935	124	11	the	the	DET
dpc-1935	124	12	second	second	ADJ
dpc-1935	124	13	most	most	ADV
dpc-1935	124	14	frequent	frequent	ADJ
dpc-1935	124	15	reason	reason	NOUN
dpc-1935	124	16	of	of	ADP
dpc-1935	124	17	malignancy	malignancy	NOUN
dpc-1935	124	18	related	relate	VERB
dpc-1935	124	19	mortality	mortality	NOUN
dpc-1935	124	20	in	in	ADP
dpc-1935	124	21	women	woman	NOUN
dpc-1935	124	22	globally	globally	ADV
dpc-1935	124	23	.	.	PUNCT
dpc-1935	125	1	breast	breast	NOUN
dpc-1935	125	2	cancer	cancer	NOUN
dpc-1935	125	3	is	be	AUX
dpc-1935	125	4	an	an	DET
dpc-1935	125	5	insidious	insidious	ADJ
dpc-1935	125	6	disease	disease	NOUN
dpc-1935	125	7	and	and	CCONJ
dpc-1935	125	8	it	it	PRON
dpc-1935	125	9	is	be	AUX
dpc-1935	125	10	usually	usually	ADV
dpc-1935	125	11	detected	detect	VERB
dpc-1935	125	12	by	by	ADP
dpc-1935	125	13	routine	routine	ADJ
dpc-1935	125	14	screening	screening	NOUN
dpc-1935	125	15	procedures	procedure	NOUN
dpc-1935	125	16	[	[	X
dpc-1935	125	17	13	13	NUM
dpc-1935	125	18	]	]	PUNCT
dpc-1935	125	19	.	.	PUNCT
dpc-1935	126	1	however	however	ADV
dpc-1935	126	2	,	,	PUNCT
dpc-1935	126	3	recommendations	recommendation	NOUN
dpc-1935	126	4	of	of	ADP
dpc-1935	126	5	major	major	ADJ
dpc-1935	126	6	guidelines	guideline	NOUN
dpc-1935	126	7	for	for	ADP
dpc-1935	126	8	breast	breast	NOUN
dpc-1935	126	9	cancer	cancer	NOUN
dpc-1935	126	10	screening	screening	NOUN
dpc-1935	126	11	in	in	ADP
dpc-1935	126	12	the	the	DET
dpc-1935	126	13	united	united	PROPN
dpc-1935	126	14	states	states	PROPN
dpc-1935	126	15	differ	differ	VERB
dpc-1935	126	16	about	about	ADP
dpc-1935	126	17	the	the	DET
dpc-1935	126	18	initiation	initiation	NOUN
dpc-1935	126	19	age	age	NOUN
dpc-1935	126	20	of	of	ADP
dpc-1935	126	21	breast	breast	NOUN
dpc-1935	126	22	cancer	cancer	NOUN
dpc-1935	126	23	screening	screening	NOUN
dpc-1935	126	24	with	with	ADP
dpc-1935	126	25	mammography	mammography	NOUN
dpc-1935	126	26	,	,	PUNCT
dpc-1935	126	27	screening	screen	VERB
dpc-1935	126	28	intervals	interval	NOUN
dpc-1935	126	29	and	and	CCONJ
dpc-1935	126	30	when	when	SCONJ
dpc-1935	126	31	to	to	PART
dpc-1935	126	32	discontinue	discontinue	VERB
dpc-1935	126	33	mammography	mammography	NOUN
dpc-1935	126	34	[	[	X
dpc-1935	126	35	14	14	NUM
dpc-1935	126	36	-	-	SYM
dpc-1935	126	37	17	17	NUM
dpc-1935	126	38	]	]	PUNCT
dpc-1935	126	39	.	.	PUNCT
dpc-1935	127	1	according	accord	VERB
dpc-1935	127	2	to	to	ADP
dpc-1935	127	3	the	the	DET
dpc-1935	127	4	american	american	ADJ
dpc-1935	127	5	cancer	cancer	NOUN
dpc-1935	127	6	society	society	NOUN
dpc-1935	127	7	,	,	PUNCT
dpc-1935	127	8	individuals	individual	NOUN
dpc-1935	127	9	without	without	ADP
dpc-1935	127	10	medical	medical	ADJ
dpc-1935	127	11	history	history	NOUN
dpc-1935	127	12	of	of	ADP
dpc-1935	127	13	breast	breast	NOUN
dpc-1935	127	14	cancer	cancer	NOUN
dpc-1935	127	15	,	,	PUNCT
dpc-1935	127	16	brca1	brca1	PROPN
dpc-1935	127	17	/	/	SYM
dpc-1935	127	18	brca2	brca2	PROPN
dpc-1935	127	19	gene	gene	NOUN
dpc-1935	127	20	mutation	mutation	NOUN
dpc-1935	127	21	and	and	CCONJ
dpc-1935	127	22	former	former	ADJ
dpc-1935	127	23	radiation	radiation	NOUN
dpc-1935	127	24	treatment	treatment	NOUN
dpc-1935	127	25	to	to	ADP
dpc-1935	127	26	the	the	DET
dpc-1935	127	27	chest	chest	NOUN
dpc-1935	127	28	at	at	ADP
dpc-1935	127	29	the	the	DET
dpc-1935	127	30	age	age	NOUN
dpc-1935	127	31	of	of	ADP
dpc-1935	127	32	10	10	NUM
dpc-1935	127	33	to	to	PART
dpc-1935	127	34	30	30	NUM
dpc-1935	127	35	years	year	NOUN
dpc-1935	127	36	are	be	AUX
dpc-1935	127	37	at	at	ADP
dpc-1935	127	38	average	average	ADJ
dpc-1935	127	39	risk	risk	NOUN
dpc-1935	127	40	for	for	ADP
dpc-1935	127	41	breast	breast	NOUN
dpc-1935	127	42	cancer	cancer	NOUN
dpc-1935	127	43	.	.	PUNCT
dpc-1935	128	1	the	the	DET
dpc-1935	128	2	american	american	PROPN
dpc-1935	128	3	cancer	cancer	NOUN
dpc-1935	128	4	society	society	NOUN
dpc-1935	128	5	recommends	recommend	VERB
dpc-1935	128	6	to	to	PART
dpc-1935	128	7	start	start	VERB
dpc-1935	128	8	breast	breast	NOUN
dpc-1935	128	9	cancer	cancer	NOUN
dpc-1935	128	10	screening	screening	NOUN
dpc-1935	128	11	with	with	ADP
dpc-1935	128	12	mammography	mammography	NOUN
dpc-1935	128	13	for	for	ADP
dpc-1935	128	14	women	woman	NOUN
dpc-1935	128	15	with	with	ADP
dpc-1935	128	16	average	average	ADJ
dpc-1935	128	17	breast	breast	NOUN
dpc-1935	128	18	cancer	cancer	NOUN
dpc-1935	128	19	risk	risk	NOUN
dpc-1935	128	20	at	at	ADP
dpc-1935	128	21	45	45	NUM
dpc-1935	128	22	years	year	NOUN
dpc-1935	128	23	of	of	ADP
dpc-1935	128	24	age	age	NOUN
dpc-1935	128	25	[	[	X
dpc-1935	128	26	14	14	NUM
dpc-1935	128	27	]	]	PUNCT
dpc-1935	128	28	.	.	PUNCT
dpc-1935	129	1	however	however	ADV
dpc-1935	129	2	,	,	PUNCT
dpc-1935	129	3	women	woman	NOUN
dpc-1935	129	4	aged	age	VERB
dpc-1935	129	5	40	40	NUM
dpc-1935	129	6	to	to	PART
dpc-1935	129	7	44	44	NUM
dpc-1935	129	8	years	year	NOUN
dpc-1935	129	9	may	may	AUX
dpc-1935	129	10	also	also	ADV
dpc-1935	129	11	undergo	undergo	VERB
dpc-1935	129	12	mammography	mammography	NOUN
dpc-1935	129	13	if	if	SCONJ
dpc-1935	129	14	they	they	PRON
dpc-1935	129	15	request	request	VERB
dpc-1935	129	16	it	it	PRON
dpc-1935	129	17	.	.	PUNCT
dpc-1935	130	1	the	the	DET
dpc-1935	130	2	american	american	PROPN
dpc-1935	130	3	cancer	cancer	NOUN
dpc-1935	130	4	society	society	NOUN
dpc-1935	130	5	recommends	recommend	VERB
dpc-1935	130	6	to	to	PART
dpc-1935	130	7	repeat	repeat	VERB
dpc-1935	130	8	mammography	mammography	NOUN
dpc-1935	130	9	between	between	ADP
dpc-1935	130	10	the	the	DET
dpc-1935	130	11	ages	age	NOUN
dpc-1935	130	12	of	of	ADP
dpc-1935	130	13	45	45	NUM
dpc-1935	130	14	to	to	PART
dpc-1935	130	15	54	54	NUM
dpc-1935	130	16	years	year	NOUN
dpc-1935	130	17	annually	annually	ADV
dpc-1935	130	18	and	and	CCONJ
dpc-1935	130	19	over	over	ADP
dpc-1935	130	20	the	the	DET
dpc-1935	130	21	age	age	NOUN
dpc-1935	130	22	of	of	ADP
dpc-1935	130	23	55	55	NUM
dpc-1935	130	24	years	year	NOUN
dpc-1935	130	25	biennially	biennially	ADV
dpc-1935	130	26	.	.	PUNCT
dpc-1935	131	1	however	however	ADV
dpc-1935	131	2	,	,	PUNCT
dpc-1935	131	3	women	woman	NOUN
dpc-1935	131	4	aged	age	VERB
dpc-1935	131	5	55	55	NUM
dpc-1935	131	6	years	year	NOUN
dpc-1935	131	7	and	and	CCONJ
dpc-1935	131	8	over	over	ADV
dpc-1935	131	9	may	may	AUX
dpc-1935	131	10	undergo	undergo	VERB
dpc-1935	131	11	mammography	mammography	NOUN
dpc-1935	131	12	annually	annually	ADV
dpc-1935	131	13	if	if	SCONJ
dpc-1935	131	14	they	they	PRON
dpc-1935	131	15	request	request	VERB
dpc-1935	131	16	.	.	PUNCT
dpc-1935	132	1	breast	breast	NOUN
dpc-1935	132	2	cancer	cancer	NOUN
dpc-1935	132	3	screening	screening	NOUN
dpc-1935	132	4	should	should	AUX
dpc-1935	132	5	also	also	ADV
dpc-1935	132	6	proceed	proceed	VERB
dpc-1935	132	7	in	in	ADP
dpc-1935	132	8	healthy	healthy	ADJ
dpc-1935	132	9	individuals	individual	NOUN
dpc-1935	132	10	with	with	ADP
dpc-1935	132	11	life	life	NOUN
dpc-1935	132	12	expectancy	expectancy	NOUN
dpc-1935	132	13	longer	long	ADV
dpc-1935	132	14	than	than	ADP
dpc-1935	132	15	10	10	NUM
dpc-1935	132	16	years	year	NOUN
dpc-1935	132	17	[	[	X
dpc-1935	132	18	14	14	NUM
dpc-1935	132	19	]	]	PUNCT
dpc-1935	132	20	.	.	PUNCT
dpc-1935	133	1	nevertheless	nevertheless	ADV
dpc-1935	133	2	,	,	PUNCT
dpc-1935	133	3	the	the	DET
dpc-1935	133	4	american	american	PROPN
dpc-1935	133	5	college	college	PROPN
dpc-1935	133	6	of	of	ADP
dpc-1935	133	7	obstetricians	obstetrician	NOUN
dpc-1935	133	8	and	and	CCONJ
dpc-1935	133	9	gynecologists	gynecologist	NOUN
dpc-1935	133	10	recommends	recommend	VERB
dpc-1935	133	11	to	to	PART
dpc-1935	133	12	start	start	VERB
dpc-1935	133	13	mammography	mammography	NOUN
dpc-1935	133	14	at	at	ADP
dpc-1935	133	15	the	the	DET
dpc-1935	133	16	age	age	NOUN
dpc-1935	133	17	of	of	ADP
dpc-1935	133	18	40	40	NUM
dpc-1935	133	19	years	year	NOUN
dpc-1935	133	20	,	,	PUNCT
dpc-1935	133	21	however	however	ADV
dpc-1935	133	22	,	,	PUNCT
dpc-1935	133	23	screening	screen	VERB
dpc-1935	133	24	may	may	AUX
dpc-1935	133	25	be	be	AUX
dpc-1935	133	26	initiated	initiate	VERB
dpc-1935	133	27	between	between	ADP
dpc-1935	133	28	the	the	DET
dpc-1935	133	29	ages	age	NOUN
dpc-1935	133	30	of	of	ADP
dpc-1935	133	31	40	40	NUM
dpc-1935	133	32	to	to	PART
dpc-1935	133	33	49	49	NUM
dpc-1935	133	34	years	year	NOUN
dpc-1935	133	35	based	base	VERB
dpc-1935	133	36	on	on	ADP
dpc-1935	133	37	shared	shared	ADJ
dpc-1935	133	38	decision	decision	NOUN
dpc-1935	133	39	of	of	ADP
dpc-1935	133	40	the	the	DET
dpc-1935	133	41	physician	physician	NOUN
dpc-1935	133	42	and	and	CCONJ
dpc-1935	133	43	the	the	DET
dpc-1935	133	44	patient	patient	NOUN
dpc-1935	133	45	.	.	PUNCT
dpc-1935	134	1	individuals	individual	NOUN
dpc-1935	134	2	should	should	AUX
dpc-1935	134	3	repeat	repeat	VERB
dpc-1935	134	4	mammography	mammography	NOUN
dpc-1935	134	5	every	every	DET
dpc-1935	134	6	year	year	NOUN
dpc-1935	134	7	or	or	CCONJ
dpc-1935	134	8	biennially	biennially	NOUN
dpc-1935	134	9	.	.	PUNCT
dpc-1935	135	1	mammography	mammography	NOUN
dpc-1935	135	2	is	be	AUX
dpc-1935	135	3	not	not	PART
dpc-1935	135	4	required	require	VERB
dpc-1935	135	5	in	in	ADP
dpc-1935	135	6	women	woman	NOUN
dpc-1935	135	7	older	old	ADJ
dpc-1935	135	8	than	than	ADP
dpc-1935	135	9	75	75	NUM
dpc-1935	135	10	years	year	NOUN
dpc-1935	135	11	,	,	PUNCT
dpc-1935	135	12	however	however	ADV
dpc-1935	135	13	,	,	PUNCT
dpc-1935	135	14	original	original	ADJ
dpc-1935	135	15	article	article	NOUN
dpc-1935	135	16	|	|	ADV
dpc-1935	135	17	dermatol	dermatol	ADJ
dpc-1935	135	18	pract	pract	NOUN
dpc-1935	135	19	concept	concept	NOUN
dpc-1935	135	20	.	.	PUNCT
dpc-1935	136	1	2022;12(2):e2022081	2022;12(2):e2022081	NUM
dpc-1935	136	2	5	5	NUM
dpc-1935	136	3	dermatol	dermatol	NOUN
dpc-1935	136	4	.	.	PUNCT
dpc-1935	137	1	2019;155(12):1390	2019;155(12):1390	NUM
dpc-1935	137	2	-	-	SYM
dpc-1935	137	3	1403	1403	NUM
dpc-1935	137	4	.	.	PUNCT
dpc-1935	138	1	doi	doi	NOUN
dpc-1935	138	2	:	:	PUNCT
dpc-1935	138	3	10.1001	10.1001	NUM
dpc-1935	138	4	/	/	SYM
dpc-1935	138	5	jamadermatol.2019.3056	jamadermatol.2019.3056	PROPN
dpc-1935	138	6	.	.	PUNCT
dpc-1935	139	1	pmid	pmid	NOUN
dpc-1935	139	2	:	:	PUNCT
dpc-1935	139	3	31617868;.pmcid	31617868;.pmcid	NUM
dpc-1935	139	4	:	:	PUNCT
dpc-1935	139	5	pmc6802036	pmc6802036	NOUN
dpc-1935	139	6	.	.	PUNCT
dpc-1935	140	1	3	3	X
dpc-1935	140	2	.	.	X
dpc-1935	140	3	kimball	kimball	PROPN
dpc-1935	140	4	ab	ab	PROPN
dpc-1935	140	5	,	,	PUNCT
dpc-1935	140	6	sundaram	sundaram	PROPN
dpc-1935	140	7	m	m	PROPN
dpc-1935	140	8	,	,	PUNCT
dpc-1935	140	9	cloutier	cloutier	PROPN
dpc-1935	140	10	m	m	PROPN
dpc-1935	140	11	,	,	PUNCT
dpc-1935	140	12	et	et	PROPN
dpc-1935	140	13	al	al	PROPN
dpc-1935	140	14	.	.	PROPN
dpc-1935	140	15	increased	increase	VERB
dpc-1935	140	16	prevalence	prevalence	NOUN
dpc-1935	140	17	of	of	ADP
dpc-1935	140	18	cancer	cancer	NOUN
dpc-1935	140	19	in	in	ADP
dpc-1935	140	20	adult	adult	NOUN
dpc-1935	140	21	patients	patient	NOUN
dpc-1935	140	22	with	with	ADP
dpc-1935	140	23	psoriasis	psoriasis	NOUN
dpc-1935	140	24	in	in	ADP
dpc-1935	140	25	the	the	DET
dpc-1935	140	26	united	united	PROPN
dpc-1935	140	27	states	states	PROPN
dpc-1935	140	28	:	:	PUNCT
dpc-1935	140	29	a	a	DET
dpc-1935	140	30	claims	claim	NOUN
dpc-1935	140	31	based	base	VERB
dpc-1935	140	32	analysis	analysis	NOUN
dpc-1935	140	33	.	.	PUNCT
dpc-1935	141	1	j	j	PROPN
dpc-1935	141	2	drugs	drug	NOUN
dpc-1935	141	3	dermatol	dermatol	NOUN
dpc-1935	141	4	.	.	PUNCT
dpc-1935	142	1	2018;17(2):180	2018;17(2):180	NOUN
dpc-1935	142	2	-	-	SYM
dpc-1935	142	3	186	186	NUM
dpc-1935	142	4	.	.	PUNCT
dpc-1935	143	1	pmid	pmid	NOUN
dpc-1935	143	2	:	:	PUNCT
dpc-1935	143	3	29462226	29462226	NUM
dpc-1935	143	4	.	.	PUNCT
dpc-1935	144	1	4	4	X
dpc-1935	144	2	.	.	X
dpc-1935	144	3	pouplard	pouplard	PROPN
dpc-1935	144	4	c	c	PROPN
dpc-1935	144	5	,	,	PUNCT
dpc-1935	144	6	brenaut	brenaut	PROPN
dpc-1935	144	7	e	e	NOUN
dpc-1935	144	8	,	,	PUNCT
dpc-1935	144	9	horreau	horreau	PROPN
dpc-1935	144	10	c	c	NOUN
dpc-1935	144	11	,	,	PUNCT
dpc-1935	144	12	et	et	PROPN
dpc-1935	144	13	al	al	PROPN
dpc-1935	144	14	.	.	PROPN
dpc-1935	144	15	risk	risk	NOUN
dpc-1935	144	16	of	of	ADP
dpc-1935	144	17	cancer	cancer	NOUN
dpc-1935	144	18	in	in	ADP
dpc-1935	144	19	psoriasis	psoriasis	NOUN
dpc-1935	144	20	:	:	PUNCT
dpc-1935	144	21	a	a	DET
dpc-1935	144	22	systematic	systematic	ADJ
dpc-1935	144	23	review	review	NOUN
dpc-1935	144	24	and	and	CCONJ
dpc-1935	144	25	meta	meta	ADJ
dpc-1935	144	26	-	-	PUNCT
dpc-1935	144	27	analysis	analysis	NOUN
dpc-1935	144	28	of	of	ADP
dpc-1935	144	29	epidemiological	epidemiological	ADJ
dpc-1935	144	30	studies	study	NOUN
dpc-1935	144	31	.	.	PUNCT
dpc-1935	145	1	j	j	PROPN
dpc-1935	145	2	eur	eur	PROPN
dpc-1935	145	3	acad	acad	PROPN
dpc-1935	145	4	dermatol	dermatol	NOUN
dpc-1935	145	5	venereol	venereol	NOUN
dpc-1935	145	6	.	.	PUNCT
dpc-1935	146	1	2013;27(suppl	2013;27(suppl	ADJ
dpc-1935	146	2	3):36	3):36	NUM
dpc-1935	146	3	-	-	SYM
dpc-1935	146	4	46	46	NUM
dpc-1935	146	5	.	.	PUNCT
dpc-1935	147	1	doi	doi	NOUN
dpc-1935	147	2	:	:	PUNCT
dpc-1935	147	3	10.1111	10.1111	NUM
dpc-1935	147	4	/	/	SYM
dpc-1935	147	5	jdv.12165	jdv.12165	ADJ
dpc-1935	147	6	.	.	PUNCT
dpc-1935	148	1	pmid	pmid	NOUN
dpc-1935	148	2	:	:	PUNCT
dpc-1935	148	3	23845151	23845151	NUM
dpc-1935	148	4	.	.	PUNCT
dpc-1935	149	1	5	5	X
dpc-1935	149	2	.	.	X
dpc-1935	149	3	fiorentino	fiorentino	PROPN
dpc-1935	149	4	d	d	PROPN
dpc-1935	149	5	,	,	PUNCT
dpc-1935	149	6	ho	ho	PROPN
dpc-1935	149	7	v	v	NOUN
dpc-1935	149	8	,	,	PUNCT
dpc-1935	149	9	lebwohl	lebwohl	VERB
dpc-1935	149	10	mg	mg	PROPN
dpc-1935	149	11	,	,	PUNCT
dpc-1935	149	12	et	et	PROPN
dpc-1935	149	13	al	al	PROPN
dpc-1935	149	14	.	.	PROPN
dpc-1935	150	1	risk	risk	NOUN
dpc-1935	150	2	of	of	ADP
dpc-1935	150	3	malignancy	malignancy	NOUN
dpc-1935	150	4	with	with	ADP
dpc-1935	150	5	systemic	systemic	ADJ
dpc-1935	150	6	psoriasis	psoriasis	NOUN
dpc-1935	150	7	treatment	treatment	NOUN
dpc-1935	150	8	in	in	ADP
dpc-1935	150	9	the	the	DET
dpc-1935	150	10	psoriasis	psoriasis	NOUN
dpc-1935	150	11	longitudinal	longitudinal	ADJ
dpc-1935	150	12	assessment	assessment	NOUN
dpc-1935	150	13	registry	registry	NOUN
dpc-1935	150	14	.	.	PUNCT
dpc-1935	151	1	j	j	PROPN
dpc-1935	151	2	am	be	AUX
dpc-1935	151	3	acad	acad	ADJ
dpc-1935	151	4	dermatol	dermatol	NOUN
dpc-1935	151	5	.	.	PUNCT
dpc-1935	152	1	2017;77(5):845	2017;77(5):845	PROPN
dpc-1935	152	2	-	-	PUNCT
dpc-1935	152	3	854	854	PROPN
dpc-1935	152	4	.	.	PUNCT
dpc-1935	152	5	doi	doi	NOUN
dpc-1935	152	6	:	:	PUNCT
dpc-1935	152	7	10.1016	10.1016	NUM
dpc-1935	152	8	/	/	SYM
dpc-1935	152	9	j.jaad.2017.07.013	j.jaad.2017.07.013	PROPN
dpc-1935	152	10	.	.	PUNCT
dpc-1935	153	1	pmid	pmid	NOUN
dpc-1935	153	2	:	:	PUNCT
dpc-1935	153	3	28893407	28893407	NUM
dpc-1935	153	4	.	.	PUNCT
dpc-1935	154	1	6	6	X
dpc-1935	154	2	.	.	X
dpc-1935	154	3	morizane	morizane	PROPN
dpc-1935	154	4	s	s	PROPN
dpc-1935	154	5	,	,	PUNCT
dpc-1935	154	6	sugimoto	sugimoto	PROPN
dpc-1935	154	7	s	s	PROPN
dpc-1935	154	8	,	,	PUNCT
dpc-1935	154	9	motoki	motoki	PROPN
dpc-1935	154	10	t	t	PROPN
dpc-1935	154	11	,	,	PUNCT
dpc-1935	154	12	katayama	katayama	PROPN
dpc-1935	154	13	n	n	CCONJ
dpc-1935	154	14	,	,	PUNCT
dpc-1935	154	15	omori	omori	PROPN
dpc-1935	154	16	m	m	PROPN
dpc-1935	154	17	,	,	PUNCT
dpc-1935	154	18	iwatsuki	iwatsuki	PROPN
dpc-1935	154	19	k.	k.	PROPN
dpc-1935	155	1	a	a	DET
dpc-1935	155	2	case	case	NOUN
dpc-1935	155	3	of	of	ADP
dpc-1935	155	4	psoriasis	psoriasis	NOUN
dpc-1935	155	5	complicated	complicate	VERB
dpc-1935	155	6	by	by	ADP
dpc-1935	155	7	breast	breast	NOUN
dpc-1935	155	8	cancer	cancer	NOUN
dpc-1935	155	9	after	after	ADP
dpc-1935	155	10	systemic	systemic	ADJ
dpc-1935	155	11	treatments	treatment	NOUN
dpc-1935	155	12	including	include	VERB
dpc-1935	155	13	biologics	biologic	NOUN
dpc-1935	155	14	.	.	PUNCT
dpc-1935	156	1	acta	acta	PROPN
dpc-1935	156	2	med	med	PROPN
dpc-1935	156	3	okayama	okayama	PROPN
dpc-1935	156	4	.	.	PUNCT
dpc-1935	157	1	2018;72(2):185	2018;72(2):185	NUM
dpc-1935	157	2	-	-	PUNCT
dpc-1935	157	3	187	187	NUM
dpc-1935	157	4	.	.	PUNCT
dpc-1935	158	1	doi	doi	NOUN
dpc-1935	158	2	:	:	PUNCT
dpc-1935	158	3	10.18926	10.18926	NUM
dpc-1935	158	4	/	/	SYM
dpc-1935	158	5	amo/55860	amo/55860	NOUN
dpc-1935	158	6	.	.	PUNCT
dpc-1935	159	1	pmid	pmid	NOUN
dpc-1935	159	2	:	:	PUNCT
dpc-1935	159	3	29674768	29674768	NUM
dpc-1935	159	4	.	.	PUNCT
dpc-1935	160	1	s	s	PART
dpc-1935	160	2	7	7	NUM
dpc-1935	160	3	.	.	PUNCT
dpc-1935	160	4	subhadarshani	subhadarshani	PROPN
dpc-1935	160	5	s	s	PROPN
dpc-1935	160	6	,	,	PUNCT
dpc-1935	160	7	yusuf	yusuf	PROPN
dpc-1935	160	8	n	n	CCONJ
dpc-1935	160	9	,	,	PUNCT
dpc-1935	160	10	elmets	elmet	VERB
dpc-1935	160	11	ca	ca	NOUN
dpc-1935	160	12	.	.	PUNCT
dpc-1935	161	1	il-23	il-23	NOUN
dpc-1935	161	2	and	and	CCONJ
dpc-1935	161	3	the	the	DET
dpc-1935	161	4	tumor	tumor	NOUN
dpc-1935	161	5	microenvironment	microenvironment	NOUN
dpc-1935	161	6	.	.	PUNCT
dpc-1935	162	1	adv	adv	PROPN
dpc-1935	162	2	exp	exp	NUM
dpc-1935	162	3	med	med	ADJ
dpc-1935	162	4	biol	biol	NOUN
dpc-1935	162	5	.	.	PUNCT
dpc-1935	163	1	2021;1290:89	2021;1290:89	NUM
dpc-1935	163	2	-	-	SYM
dpc-1935	163	3	98	98	NUM
dpc-1935	163	4	.	.	PUNCT
dpc-1935	164	1	doi	doi	NOUN
dpc-1935	164	2	:	:	PUNCT
dpc-1935	164	3	10.1007/978	10.1007/978	NUM
dpc-1935	164	4	-	-	SYM
dpc-1935	164	5	3	3	NUM
dpc-1935	164	6	-	-	PUNCT
dpc-1935	164	7	030	030	NUM
dpc-1935	164	8	-	-	PUNCT
dpc-1935	164	9	55617	55617	NUM
dpc-1935	164	10	-	-	SYM
dpc-1935	164	11	4_6	4_6	NUM
dpc-1935	164	12	.	.	PUNCT
dpc-1935	165	1	pmid	pmid	NOUN
dpc-1935	165	2	:	:	PUNCT
dpc-1935	165	3	33559857	33559857	NUM
dpc-1935	165	4	.	.	PUNCT
dpc-1935	166	1	8	8	X
dpc-1935	166	2	.	.	X
dpc-1935	167	1	poelman	poelman	PROPN
dpc-1935	167	2	sm	sm	PROPN
dpc-1935	167	3	,	,	PUNCT
dpc-1935	167	4	keeling	keeling	PROPN
dpc-1935	167	5	cp	cp	PROPN
dpc-1935	167	6	,	,	PUNCT
dpc-1935	167	7	metelitsa	metelitsa	NOUN
dpc-1935	167	8	ai	ai	VERB
dpc-1935	167	9	.	.	PUNCT
dpc-1935	168	1	practical	practical	ADJ
dpc-1935	168	2	guidelines	guideline	NOUN
dpc-1935	168	3	for	for	ADP
dpc-1935	168	4	managing	manage	VERB
dpc-1935	168	5	patients	patient	NOUN
dpc-1935	168	6	with	with	ADP
dpc-1935	168	7	psoriasis	psoriasis	NOUN
dpc-1935	168	8	on	on	ADP
dpc-1935	168	9	biologics	biologic	NOUN
dpc-1935	168	10	:	:	PUNCT
dpc-1935	168	11	an	an	DET
dpc-1935	168	12	update	update	NOUN
dpc-1935	168	13	.	.	PUNCT
dpc-1935	169	1	j	j	PROPN
dpc-1935	169	2	cutan	cutan	PROPN
dpc-1935	169	3	med	med	ADJ
dpc-1935	169	4	surg	surg	NOUN
dpc-1935	169	5	.	.	PUNCT
dpc-1935	170	1	2019;23(suppl	2019;23(suppl	PROPN
dpc-1935	170	2	1):3	1):3	NUM
dpc-1935	170	3	-	-	SYM
dpc-1935	170	4	12	12	NUM
dpc-1935	170	5	.	.	PUNCT
dpc-1935	171	1	doi	doi	NOUN
dpc-1935	171	2	:	:	PUNCT
dpc-1935	171	3	10.1177/1203475418811347	10.1177/1203475418811347	NUM
dpc-1935	171	4	.	.	PUNCT
dpc-1935	172	1	pmid	pmid	NOUN
dpc-1935	172	2	:	:	PUNCT
dpc-1935	172	3	30789012	30789012	NUM
dpc-1935	172	4	.	.	PUNCT
dpc-1935	173	1	9	9	X
dpc-1935	173	2	.	.	X
dpc-1935	173	3	smith	smith	PROPN
dpc-1935	173	4	ch	ch	PROPN
dpc-1935	173	5	,	,	PUNCT
dpc-1935	173	6	yiu	yiu	PROPN
dpc-1935	173	7	zzn	zzn	NOUN
dpc-1935	173	8	,	,	PUNCT
dpc-1935	173	9	bale	bale	NOUN
dpc-1935	173	10	t	t	PROPN
dpc-1935	173	11	,	,	PUNCT
dpc-1935	173	12	et	et	PROPN
dpc-1935	173	13	al	al	PROPN
dpc-1935	173	14	.	.	PROPN
dpc-1935	174	1	british	british	PROPN
dpc-1935	174	2	association	association	PROPN
dpc-1935	174	3	of	of	ADP
dpc-1935	174	4	dermatologists	dermatologists	PROPN
dpc-1935	174	5	guidelines	guideline	NOUN
dpc-1935	174	6	for	for	ADP
dpc-1935	174	7	biologic	biologic	NOUN
dpc-1935	174	8	therapy	therapy	NOUN
dpc-1935	174	9	for	for	ADP
dpc-1935	174	10	psoriasis	psoriasis	NOUN
dpc-1935	174	11	2020	2020	NUM
dpc-1935	174	12	:	:	PUNCT
dpc-1935	174	13	a	a	DET
dpc-1935	174	14	rapid	rapid	ADJ
dpc-1935	174	15	update	update	NOUN
dpc-1935	174	16	.	.	PUNCT
dpc-1935	175	1	br	br	PROPN
dpc-1935	175	2	j	j	PROPN
dpc-1935	175	3	dermatol	dermatol	NOUN
dpc-1935	175	4	.	.	PUNCT
dpc-1935	176	1	2020;183(4):628	2020;183(4):628	NUM
dpc-1935	176	2	-	-	PUNCT
dpc-1935	176	3	637	637	NUM
dpc-1935	176	4	.	.	PUNCT
dpc-1935	177	1	doi	doi	NOUN
dpc-1935	177	2	:	:	PUNCT
dpc-1935	177	3	10.1111	10.1111	NUM
dpc-1935	177	4	/	/	SYM
dpc-1935	177	5	bjd.19039	bjd.19039	PROPN
dpc-1935	177	6	.	.	PUNCT
dpc-1935	178	1	pmid	pmid	NOUN
dpc-1935	178	2	:	:	PUNCT
dpc-1935	178	3	32189327	32189327	NUM
dpc-1935	178	4	.	.	PUNCT
dpc-1935	179	1	10	10	NUM
dpc-1935	179	2	.	.	PUNCT
dpc-1935	180	1	menter	menter	PROPN
dpc-1935	180	2	a	a	PRON
dpc-1935	180	3	,	,	PUNCT
dpc-1935	180	4	strober	strober	ADV
dpc-1935	180	5	be	be	AUX
dpc-1935	180	6	,	,	PUNCT
dpc-1935	180	7	kaplan	kaplan	PROPN
dpc-1935	180	8	dh	dh	PROPN
dpc-1935	180	9	,	,	PUNCT
dpc-1935	180	10	et	et	PROPN
dpc-1935	180	11	al	al	PROPN
dpc-1935	180	12	.	.	PUNCT
dpc-1935	181	1	joint	joint	ADJ
dpc-1935	181	2	aad	aad	ADJ
dpc-1935	181	3	-	-	PUNCT
dpc-1935	181	4	npf	npf	NOUN
dpc-1935	181	5	guidelines	guideline	NOUN
dpc-1935	181	6	of	of	ADP
dpc-1935	181	7	care	care	NOUN
dpc-1935	181	8	for	for	ADP
dpc-1935	181	9	the	the	DET
dpc-1935	181	10	management	management	NOUN
dpc-1935	181	11	and	and	CCONJ
dpc-1935	181	12	treatment	treatment	NOUN
dpc-1935	181	13	of	of	ADP
dpc-1935	181	14	psoriasis	psoriasis	NOUN
dpc-1935	181	15	with	with	ADP
dpc-1935	181	16	biologics	biologic	NOUN
dpc-1935	181	17	.	.	PUNCT
dpc-1935	182	1	j	j	PROPN
dpc-1935	182	2	am	be	AUX
dpc-1935	182	3	acad	acad	ADJ
dpc-1935	182	4	dermatol	dermatol	NOUN
dpc-1935	182	5	.	.	PUNCT
dpc-1935	183	1	2019;80(4):1029	2019;80(4):1029	PROPN
dpc-1935	183	2	-	-	PUNCT
dpc-1935	183	3	1072	1072	NUM
dpc-1935	183	4	.	.	PUNCT
dpc-1935	184	1	doi	doi	NOUN
dpc-1935	184	2	:	:	PUNCT
dpc-1935	184	3	10.1016	10.1016	NUM
dpc-1935	184	4	/	/	SYM
dpc-1935	184	5	j.jaad.2018.11.057	j.jaad.2018.11.057	NOUN
dpc-1935	184	6	.	.	PUNCT
dpc-1935	185	1	pmid	pmid	NOUN
dpc-1935	185	2	:	:	PUNCT
dpc-1935	185	3	30772098	30772098	NUM
dpc-1935	185	4	.	.	PUNCT
dpc-1935	186	1	11	11	NUM
dpc-1935	186	2	.	.	PUNCT
dpc-1935	187	1	barbieri	barbieri	PROPN
dpc-1935	187	2	js	js	PROPN
dpc-1935	187	3	,	,	PUNCT
dpc-1935	187	4	wang	wang	PROPN
dpc-1935	187	5	s	s	PROPN
dpc-1935	187	6	,	,	PUNCT
dpc-1935	187	7	ogdie	ogdie	PROPN
dpc-1935	187	8	ar	ar	PROPN
dpc-1935	187	9	,	,	PUNCT
dpc-1935	187	10	shin	shin	PROPN
dpc-1935	187	11	db	db	PROPN
dpc-1935	187	12	,	,	PUNCT
dpc-1935	187	13	takeshita	takeshita	PROPN
dpc-1935	187	14	j.	j.	PROPN
dpc-1935	187	15	age	age	PROPN
dpc-1935	187	16	-	-	PUNCT
dpc-1935	187	17	appropriate	appropriate	ADJ
dpc-1935	187	18	cancer	cancer	NOUN
dpc-1935	187	19	screening	screening	NOUN
dpc-1935	187	20	:	:	PUNCT
dpc-1935	187	21	a	a	DET
dpc-1935	187	22	cohort	cohort	NOUN
dpc-1935	187	23	study	study	NOUN
dpc-1935	187	24	of	of	ADP
dpc-1935	187	25	adults	adult	NOUN
dpc-1935	187	26	with	with	ADP
dpc-1935	187	27	psoriasis	psoriasis	NOUN
dpc-1935	187	28	prescribed	prescribe	VERB
dpc-1935	187	29	biologics	biologic	NOUN
dpc-1935	187	30	,	,	PUNCT
dpc-1935	187	31	adults	adult	NOUN
dpc-1935	187	32	in	in	ADP
dpc-1935	187	33	the	the	DET
dpc-1935	187	34	general	general	ADJ
dpc-1935	187	35	population	population	NOUN
dpc-1935	187	36	,	,	PUNCT
dpc-1935	187	37	and	and	CCONJ
dpc-1935	187	38	adults	adult	NOUN
dpc-1935	187	39	with	with	ADP
dpc-1935	187	40	hypertension	hypertension	NOUN
dpc-1935	187	41	.	.	PUNCT
dpc-1935	188	1	j	j	PROPN
dpc-1935	188	2	am	be	AUX
dpc-1935	188	3	acad	acad	ADJ
dpc-1935	188	4	dermatol	dermatol	NOUN
dpc-1935	188	5	.	.	PUNCT
dpc-1935	189	1	2021;84(6):16021609	2021;84(6):16021609	NUM
dpc-1935	189	2	.	.	PUNCT
dpc-1935	190	1	doi	doi	NOUN
dpc-1935	190	2	:	:	PUNCT
dpc-1935	190	3	10.1016	10.1016	NUM
dpc-1935	190	4	/	/	SYM
dpc-1935	190	5	j.jaad.2020.10.045	j.jaad.2020.10.045	PROPN
dpc-1935	190	6	.	.	PUNCT
dpc-1935	191	1	pmid	pmid	NOUN
dpc-1935	191	2	:	:	PUNCT
dpc-1935	191	3	33470207	33470207	NUM
dpc-1935	191	4	.	.	PUNCT
dpc-1935	192	1	12	12	NUM
dpc-1935	192	2	.	.	PUNCT
dpc-1935	193	1	magny	magny	PROPN
dpc-1935	193	2	sj	sj	PROPN
dpc-1935	193	3	,	,	PUNCT
dpc-1935	193	4	shikhman	shikhman	NOUN
dpc-1935	193	5	r	r	NOUN
dpc-1935	193	6	,	,	PUNCT
dpc-1935	193	7	keppke	keppke	PROPN
dpc-1935	193	8	al	al	PROPN
dpc-1935	193	9	.	.	PUNCT
dpc-1935	193	10	breast	breast	NOUN
dpc-1935	193	11	imaging	imaging	NOUN
dpc-1935	193	12	reporting	reporting	NOUN
dpc-1935	193	13	and	and	CCONJ
dpc-1935	193	14	data	datum	NOUN
dpc-1935	193	15	system	system	NOUN
dpc-1935	193	16	.	.	PUNCT
dpc-1935	194	1	2021	2021	NUM
dpc-1935	194	2	aug	aug	PROPN
dpc-1935	194	3	31	31	NUM
dpc-1935	194	4	.	.	PUNCT
dpc-1935	195	1	in	in	ADP
dpc-1935	195	2	:	:	PUNCT
dpc-1935	195	3	statpearls	statpearl	NOUN
dpc-1935	196	1	[	[	X
dpc-1935	196	2	internet	internet	NOUN
dpc-1935	196	3	]	]	PUNCT
dpc-1935	196	4	.	.	PUNCT
dpc-1935	197	1	treasure	treasure	NOUN
dpc-1935	197	2	island	island	NOUN
dpc-1935	197	3	(	(	PUNCT
dpc-1935	197	4	fl	fl	PROPN
dpc-1935	197	5	):	):	PUNCT
dpc-1935	197	6	statpearls	statpearls	PROPN
dpc-1935	197	7	publishing	publishing	NOUN
dpc-1935	197	8	;	;	PUNCT
dpc-1935	197	9	2022	2022	NUM
dpc-1935	197	10	.	.	PUNCT
dpc-1935	198	1	pmid	pmid	NOUN
dpc-1935	198	2	:	:	PUNCT
dpc-1935	198	3	29083600	29083600	NUM
dpc-1935	198	4	.	.	PUNCT
dpc-1935	199	1	13	13	NUM
dpc-1935	199	2	.	.	PUNCT
dpc-1935	199	3	alkabban	alkabban	PROPN
dpc-1935	199	4	fm	fm	PROPN
dpc-1935	199	5	,	,	PUNCT
dpc-1935	199	6	ferguson	ferguson	PROPN
dpc-1935	199	7	t.	t.	PROPN
dpc-1935	199	8	breast	breast	NOUN
dpc-1935	199	9	cancer	cancer	NOUN
dpc-1935	199	10	.	.	PUNCT
dpc-1935	200	1	2021	2021	NUM
dpc-1935	200	2	aug	aug	PROPN
dpc-1935	200	3	7	7	NUM
dpc-1935	200	4	.	.	PUNCT
dpc-1935	201	1	in	in	ADP
dpc-1935	201	2	:	:	PUNCT
dpc-1935	201	3	statpearls	statpearl	NOUN
dpc-1935	202	1	[	[	X
dpc-1935	202	2	internet	internet	NOUN
dpc-1935	202	3	]	]	PUNCT
dpc-1935	202	4	.	.	PUNCT
dpc-1935	203	1	treasure	treasure	NOUN
dpc-1935	203	2	island	island	NOUN
dpc-1935	203	3	(	(	PUNCT
dpc-1935	203	4	fl	fl	PROPN
dpc-1935	203	5	):	):	PUNCT
dpc-1935	203	6	statpearls	statpearls	PROPN
dpc-1935	203	7	publishing	publishing	NOUN
dpc-1935	203	8	;	;	PUNCT
dpc-1935	203	9	2022	2022	NUM
dpc-1935	203	10	.	.	PUNCT
dpc-1935	204	1	pmid	pmid	NOUN
dpc-1935	204	2	:	:	PUNCT
dpc-1935	204	3	29493913	29493913	NUM
dpc-1935	204	4	.	.	PUNCT
dpc-1935	205	1	14	14	NUM
dpc-1935	205	2	.	.	PUNCT
dpc-1935	206	1	oeffinger	oeffinger	PROPN
dpc-1935	206	2	kc	kc	PROPN
dpc-1935	206	3	,	,	PUNCT
dpc-1935	206	4	fontham	fontham	PROPN
dpc-1935	206	5	et	et	PROPN
dpc-1935	206	6	,	,	PUNCT
dpc-1935	206	7	etzioni	etzioni	PROPN
dpc-1935	206	8	r	r	PROPN
dpc-1935	206	9	,	,	PUNCT
dpc-1935	206	10	et	et	PROPN
dpc-1935	206	11	al	al	PROPN
dpc-1935	206	12	.	.	PUNCT
dpc-1935	206	13	breast	breast	NOUN
dpc-1935	206	14	cancer	cancer	NOUN
dpc-1935	206	15	screening	screen	VERB
dpc-1935	206	16	for	for	ADP
dpc-1935	206	17	women	woman	NOUN
dpc-1935	206	18	at	at	ADP
dpc-1935	206	19	average	average	ADJ
dpc-1935	206	20	risk	risk	NOUN
dpc-1935	206	21	:	:	PUNCT
dpc-1935	206	22	2015	2015	NUM
dpc-1935	206	23	guideline	guideline	NOUN
dpc-1935	206	24	update	update	NOUN
dpc-1935	206	25	from	from	ADP
dpc-1935	206	26	the	the	DET
dpc-1935	206	27	american	american	ADJ
dpc-1935	206	28	cancer	cancer	NOUN
dpc-1935	206	29	society	society	NOUN
dpc-1935	206	30	.	.	PUNCT
dpc-1935	207	1	jama	jama	PROPN
dpc-1935	207	2	.	.	PUNCT
dpc-1935	208	1	2015;314(15):1599	2015;314(15):1599	NUM
dpc-1935	208	2	-	-	SYM
dpc-1935	208	3	1614	1614	NUM
dpc-1935	208	4	.	.	PUNCT
dpc-1935	209	1	doi	doi	NOUN
dpc-1935	209	2	:	:	PUNCT
dpc-1935	209	3	10.1001	10.1001	NUM
dpc-1935	209	4	/	/	SYM
dpc-1935	209	5	jama.2015.12783	jama.2015.12783	PROPN
dpc-1935	209	6	.	.	PUNCT
dpc-1935	210	1	pmid	pmid	NOUN
dpc-1935	210	2	:	:	PUNCT
dpc-1935	210	3	26501536	26501536	NUM
dpc-1935	210	4	.	.	PUNCT
dpc-1935	211	1	pmcid	pmcid	NOUN
dpc-1935	211	2	:	:	PUNCT
dpc-1935	211	3	pmc4831582	pmc4831582	NOUN
dpc-1935	211	4	.	.	PUNCT
dpc-1935	212	1	15	15	NUM
dpc-1935	212	2	.	.	PUNCT
dpc-1935	212	3	practice	practice	NOUN
dpc-1935	212	4	bulletin	bulletin	NOUN
dpc-1935	212	5	number	number	NOUN
dpc-1935	212	6	179	179	NUM
dpc-1935	212	7	:	:	PUNCT
dpc-1935	212	8	breast	breast	NOUN
dpc-1935	212	9	cancer	cancer	NOUN
dpc-1935	212	10	risk	risk	NOUN
dpc-1935	212	11	assessment	assessment	NOUN
dpc-1935	212	12	and	and	CCONJ
dpc-1935	212	13	screening	screen	VERB
dpc-1935	212	14	in	in	ADP
dpc-1935	212	15	average	average	ADJ
dpc-1935	212	16	-	-	PUNCT
dpc-1935	212	17	risk	risk	NOUN
dpc-1935	212	18	women	woman	NOUN
dpc-1935	212	19	.	.	PUNCT
dpc-1935	213	1	obstet	obstet	PROPN
dpc-1935	213	2	gynecol	gynecol	PROPN
dpc-1935	213	3	.	.	PUNCT
dpc-1935	214	1	2017;130(1):116	2017;130(1):116	X
dpc-1935	214	2	.	.	PUNCT
dpc-1935	215	1	doi	doi	NOUN
dpc-1935	215	2	:	:	PUNCT
dpc-1935	215	3	10.1097	10.1097	NUM
dpc-1935	215	4	/	/	SYM
dpc-1935	215	5	aog.0000000000002158	aog.0000000000002158	NOUN
dpc-1935	215	6	.	.	PUNCT
dpc-1935	216	1	pmid	pmid	NOUN
dpc-1935	216	2	:	:	PUNCT
dpc-1935	216	3	28644335	28644335	NUM
dpc-1935	216	4	.	.	PUNCT
dpc-1935	217	1	16	16	NUM
dpc-1935	217	2	.	.	PUNCT
dpc-1935	218	1	us	we	PRON
dpc-1935	218	2	preventive	preventive	ADJ
dpc-1935	218	3	services	service	NOUN
dpc-1935	218	4	task	task	NOUN
dpc-1935	218	5	force	force	NOUN
dpc-1935	218	6	.	.	PUNCT
dpc-1935	219	1	screening	screen	VERB
dpc-1935	219	2	for	for	ADP
dpc-1935	219	3	breast	breast	NOUN
dpc-1935	219	4	cancer	cancer	NOUN
dpc-1935	219	5	:	:	PUNCT
dpc-1935	219	6	u.s	u.s	PROPN
dpc-1935	219	7	.	.	PROPN
dpc-1935	219	8	preventive	preventive	ADJ
dpc-1935	219	9	services	service	NOUN
dpc-1935	219	10	task	task	PROPN
dpc-1935	219	11	force	force	PROPN
dpc-1935	219	12	recommendation	recommendation	NOUN
dpc-1935	219	13	statement	statement	NOUN
dpc-1935	219	14	.	.	PUNCT
dpc-1935	220	1	ann	ann	PROPN
dpc-1935	220	2	intern	intern	PROPN
dpc-1935	220	3	med	me	VERB
dpc-1935	220	4	.	.	PUNCT
dpc-1935	221	1	2009;151(10):716	2009;151(10):716	NUM
dpc-1935	221	2	-	-	SYM
dpc-1935	221	3	726	726	NUM
dpc-1935	221	4	,	,	PUNCT
dpc-1935	221	5	w-236	w-236	PROPN
dpc-1935	221	6	.	.	PUNCT
dpc-1935	221	7	doi	doi	PROPN
dpc-1935	221	8	:	:	PUNCT
dpc-1935	221	9	10.7326/00034819	10.7326/00034819	NUM
dpc-1935	221	10	-	-	SYM
dpc-1935	221	11	151	151	NUM
dpc-1935	221	12	-	-	PUNCT
dpc-1935	221	13	10	10	NUM
dpc-1935	221	14	-	-	PUNCT
dpc-1935	221	15	200911170	200911170	NUM
dpc-1935	221	16	-	-	PUNCT
dpc-1935	221	17	00008	00008	NUM
dpc-1935	221	18	.	.	PUNCT
dpc-1935	222	1	pmid	pmid	NOUN
dpc-1935	222	2	:	:	PUNCT
dpc-1935	222	3	19920272	19920272	NUM
dpc-1935	222	4	.	.	PUNCT
dpc-1935	223	1	17	17	NUM
dpc-1935	223	2	.	.	PUNCT
dpc-1935	224	1	siu	siu	PROPN
dpc-1935	224	2	al	al	PROPN
dpc-1935	224	3	.	.	PROPN
dpc-1935	224	4	screening	screen	VERB
dpc-1935	224	5	for	for	ADP
dpc-1935	224	6	breast	breast	NOUN
dpc-1935	224	7	cancer	cancer	NOUN
dpc-1935	224	8	:	:	PUNCT
dpc-1935	224	9	u.s	u.s	PROPN
dpc-1935	224	10	.	.	PROPN
dpc-1935	224	11	preventive	preventive	ADJ
dpc-1935	224	12	services	service	NOUN
dpc-1935	224	13	task	task	PROPN
dpc-1935	224	14	force	force	PROPN
dpc-1935	224	15	recommendation	recommendation	NOUN
dpc-1935	224	16	statement	statement	NOUN
dpc-1935	224	17	.	.	PUNCT
dpc-1935	225	1	ann	ann	PROPN
dpc-1935	225	2	intern	intern	PROPN
dpc-1935	225	3	med	me	VERB
dpc-1935	225	4	.	.	PUNCT
dpc-1935	226	1	2016;164(4	2016;164(4	NUM
dpc-1935	226	2	):	):	PUNCT
dpc-1935	226	3	279	279	NUM
dpc-1935	226	4	-	-	SYM
dpc-1935	226	5	296	296	NUM
dpc-1935	226	6	.	.	PUNCT
dpc-1935	227	1	doi	doi	NOUN
dpc-1935	227	2	:	:	PUNCT
dpc-1935	227	3	10.7326	10.7326	NUM
dpc-1935	227	4	/	/	SYM
dpc-1935	227	5	m15	m15	NOUN
dpc-1935	227	6	-	-	PUNCT
dpc-1935	227	7	2886	2886	NUM
dpc-1935	227	8	.	.	PUNCT
dpc-1935	228	1	pmid	pmid	NOUN
dpc-1935	228	2	:	:	PUNCT
dpc-1935	228	3	26757170	26757170	NUM
dpc-1935	228	4	.	.	PUNCT
dpc-1935	229	1	cancer	cancer	NOUN
dpc-1935	229	2	screening	screen	VERB
dpc-1935	229	3	programmes	programme	NOUN
dpc-1935	229	4	[	[	X
dpc-1935	229	5	9	9	NUM
dpc-1935	229	6	]	]	PUNCT
dpc-1935	229	7	.	.	PUNCT
dpc-1935	230	1	concerning	concern	VERB
dpc-1935	230	2	with	with	ADP
dpc-1935	230	3	cancer	cancer	NOUN
dpc-1935	230	4	and	and	CCONJ
dpc-1935	230	5	biological	biological	ADJ
dpc-1935	230	6	agents	agent	NOUN
dpc-1935	230	7	,	,	PUNCT
dpc-1935	230	8	joint	joint	ADJ
dpc-1935	230	9	american	american	PROPN
dpc-1935	230	10	academy	academy	PROPN
dpc-1935	230	11	of	of	ADP
dpc-1935	230	12	dermatology	dermatology	NOUN
dpc-1935	230	13	-	-	PUNCT
dpc-1935	230	14	national	national	ADJ
dpc-1935	230	15	psoriasis	psoriasis	NOUN
dpc-1935	230	16	foundation	foundation	NOUN
dpc-1935	230	17	(	(	PUNCT
dpc-1935	230	18	aad	aad	INTJ
dpc-1935	230	19	-	-	PUNCT
dpc-1935	230	20	npf	npf	ADJ
dpc-1935	230	21	)	)	PUNCT
dpc-1935	230	22	guideline	guideline	NOUN
dpc-1935	230	23	recommends	recommend	VERB
dpc-1935	230	24	patients	patient	NOUN
dpc-1935	230	25	to	to	PART
dpc-1935	230	26	attend	attend	VERB
dpc-1935	230	27	current	current	ADJ
dpc-1935	230	28	and	and	CCONJ
dpc-1935	230	29	age	age	NOUN
dpc-1935	230	30	-	-	PUNCT
dpc-1935	230	31	appropriate	appropriate	ADJ
dpc-1935	230	32	cancer	cancer	NOUN
dpc-1935	230	33	screening	screening	NOUN
dpc-1935	231	1	[	[	X
dpc-1935	231	2	10,23	10,23	NUM
dpc-1935	231	3	]	]	PUNCT
dpc-1935	231	4	.	.	PUNCT
dpc-1935	232	1	european	european	PROPN
dpc-1935	232	2	s3	s3	PROPN
dpc-1935	232	3	-	-	PUNCT
dpc-1935	232	4	guideline	guideline	NOUN
dpc-1935	232	5	suggests	suggest	VERB
dpc-1935	232	6	to	to	PART
dpc-1935	232	7	perform	perform	VERB
dpc-1935	232	8	clinical	clinical	ADJ
dpc-1935	232	9	examination	examination	NOUN
dpc-1935	232	10	during	during	ADP
dpc-1935	232	11	the	the	DET
dpc-1935	232	12	treatment	treatment	NOUN
dpc-1935	232	13	of	of	ADP
dpc-1935	232	14	psoriasis	psoriasis	NOUN
dpc-1935	232	15	with	with	ADP
dpc-1935	232	16	adalimumab	adalimumab	NOUN
dpc-1935	232	17	,	,	PUNCT
dpc-1935	232	18	etanercept	etanercept	NOUN
dpc-1935	232	19	,	,	PUNCT
dpc-1935	232	20	infliximab	infliximab	NOUN
dpc-1935	232	21	and	and	CCONJ
dpc-1935	232	22	secukinumab	secukinumab	NOUN
dpc-1935	232	23	[	[	X
dpc-1935	232	24	24,25	24,25	NUM
dpc-1935	232	25	]	]	PUNCT
dpc-1935	232	26	.	.	PUNCT
dpc-1935	233	1	moreover	moreover	ADV
dpc-1935	233	2	,	,	PUNCT
dpc-1935	233	3	japanese	japanese	ADJ
dpc-1935	233	4	guidance	guidance	NOUN
dpc-1935	233	5	for	for	ADP
dpc-1935	233	6	use	use	NOUN
dpc-1935	233	7	of	of	ADP
dpc-1935	233	8	biologics	biologic	NOUN
dpc-1935	233	9	for	for	ADP
dpc-1935	233	10	psoriasis	psoriasis	NOUN
dpc-1935	233	11	recommends	recommend	VERB
dpc-1935	233	12	to	to	PART
dpc-1935	233	13	collect	collect	VERB
dpc-1935	233	14	medical	medical	ADJ
dpc-1935	233	15	history	history	NOUN
dpc-1935	233	16	of	of	ADP
dpc-1935	233	17	malignancy	malignancy	NOUN
dpc-1935	233	18	from	from	ADP
dpc-1935	233	19	patients	patient	NOUN
dpc-1935	233	20	with	with	ADP
dpc-1935	233	21	psoriasis	psoriasis	NOUN
dpc-1935	233	22	before	before	ADP
dpc-1935	233	23	the	the	DET
dpc-1935	233	24	initiation	initiation	NOUN
dpc-1935	233	25	of	of	ADP
dpc-1935	233	26	biological	biological	ADJ
dpc-1935	233	27	agent	agent	NOUN
dpc-1935	233	28	treatment	treatment	NOUN
dpc-1935	233	29	[	[	X
dpc-1935	233	30	26	26	NUM
dpc-1935	233	31	]	]	PUNCT
dpc-1935	233	32	.	.	PUNCT
dpc-1935	234	1	guidelines	guideline	NOUN
dpc-1935	234	2	for	for	ADP
dpc-1935	234	3	the	the	DET
dpc-1935	234	4	treatment	treatment	NOUN
dpc-1935	234	5	of	of	ADP
dpc-1935	234	6	psoriasis	psoriasis	NOUN
dpc-1935	234	7	with	with	ADP
dpc-1935	234	8	biological	biological	ADJ
dpc-1935	234	9	agents	agent	NOUN
dpc-1935	234	10	recommend	recommend	VERB
dpc-1935	234	11	to	to	PART
dpc-1935	234	12	assess	assess	VERB
dpc-1935	234	13	patients	patient	NOUN
dpc-1935	234	14	with	with	ADP
dpc-1935	234	15	medical	medical	ADJ
dpc-1935	234	16	history	history	NOUN
dpc-1935	234	17	and	and	CCONJ
dpc-1935	234	18	physical	physical	ADJ
dpc-1935	234	19	examination	examination	NOUN
dpc-1935	234	20	to	to	PART
dpc-1935	234	21	exclude	exclude	VERB
dpc-1935	234	22	malignancy	malignancy	NOUN
dpc-1935	234	23	[	[	X
dpc-1935	234	24	9,10,2426	9,10,2426	X
dpc-1935	234	25	]	]	X
dpc-1935	234	26	.	.	PUNCT
dpc-1935	235	1	however	however	ADV
dpc-1935	235	2	,	,	PUNCT
dpc-1935	235	3	british	british	ADJ
dpc-1935	235	4	association	association	PROPN
dpc-1935	235	5	of	of	ADP
dpc-1935	235	6	dermatologists	dermatologists	PROPN
dpc-1935	235	7	guidelines	guideline	NOUN
dpc-1935	235	8	for	for	ADP
dpc-1935	235	9	biologic	biologic	NOUN
dpc-1935	235	10	therapy	therapy	NOUN
dpc-1935	235	11	for	for	ADP
dpc-1935	235	12	psoriasis	psoriasis	NOUN
dpc-1935	235	13	and	and	CCONJ
dpc-1935	235	14	joint	joint	ADJ
dpc-1935	235	15	aad	aad	ADJ
dpc-1935	235	16	-	-	PUNCT
dpc-1935	235	17	npf	npf	NOUN
dpc-1935	235	18	point	point	NOUN
dpc-1935	235	19	out	out	ADP
dpc-1935	235	20	the	the	DET
dpc-1935	235	21	importance	importance	NOUN
dpc-1935	235	22	of	of	ADP
dpc-1935	235	23	the	the	DET
dpc-1935	235	24	attendance	attendance	NOUN
dpc-1935	235	25	of	of	ADP
dpc-1935	235	26	psoriasis	psoriasis	NOUN
dpc-1935	235	27	patients	patient	NOUN
dpc-1935	235	28	to	to	ADP
dpc-1935	235	29	the	the	DET
dpc-1935	235	30	national	national	ADJ
dpc-1935	235	31	cancer	cancer	NOUN
dpc-1935	235	32	screening	screen	VERB
dpc-1935	235	33	programmes	programme	NOUN
dpc-1935	235	34	[	[	X
dpc-1935	235	35	9,10	9,10	X
dpc-1935	235	36	]	]	PUNCT
dpc-1935	235	37	.	.	PUNCT
dpc-1935	236	1	in	in	ADP
dpc-1935	236	2	the	the	DET
dpc-1935	236	3	light	light	NOUN
dpc-1935	236	4	of	of	ADP
dpc-1935	236	5	this	this	DET
dpc-1935	236	6	information	information	NOUN
dpc-1935	236	7	,	,	PUNCT
dpc-1935	236	8	there	there	PRON
dpc-1935	236	9	is	be	VERB
dpc-1935	236	10	no	no	DET
dpc-1935	236	11	consensus	consensus	NOUN
dpc-1935	236	12	on	on	ADP
dpc-1935	236	13	breast	breast	NOUN
dpc-1935	236	14	cancer	cancer	NOUN
dpc-1935	236	15	screening	screen	VERB
dpc-1935	236	16	guidelines	guideline	NOUN
dpc-1935	236	17	regarding	regard	VERB
dpc-1935	236	18	the	the	DET
dpc-1935	236	19	necessity	necessity	NOUN
dpc-1935	236	20	of	of	ADP
dpc-1935	236	21	clinical	clinical	ADJ
dpc-1935	236	22	breast	breast	NOUN
dpc-1935	236	23	examination	examination	NOUN
dpc-1935	236	24	,	,	PUNCT
dpc-1935	236	25	initiation	initiation	NOUN
dpc-1935	236	26	or	or	CCONJ
dpc-1935	236	27	cessation	cessation	NOUN
dpc-1935	236	28	age	age	NOUN
dpc-1935	236	29	of	of	ADP
dpc-1935	236	30	mammography	mammography	NOUN
dpc-1935	236	31	and	and	CCONJ
dpc-1935	236	32	screening	screening	NOUN
dpc-1935	236	33	intervals	interval	NOUN
dpc-1935	236	34	[	[	X
dpc-1935	236	35	14	14	NUM
dpc-1935	236	36	-	-	SYM
dpc-1935	236	37	17	17	NUM
dpc-1935	236	38	]	]	PUNCT
dpc-1935	236	39	.	.	PUNCT
dpc-1935	237	1	interestingly	interestingly	ADV
dpc-1935	237	2	,	,	PUNCT
dpc-1935	237	3	the	the	DET
dpc-1935	237	4	american	american	PROPN
dpc-1935	237	5	cancer	cancer	NOUN
dpc-1935	237	6	society	society	NOUN
dpc-1935	237	7	does	do	AUX
dpc-1935	237	8	not	not	PART
dpc-1935	237	9	recommend	recommend	VERB
dpc-1935	237	10	clinical	clinical	ADJ
dpc-1935	237	11	breast	breast	NOUN
dpc-1935	237	12	examination	examination	NOUN
dpc-1935	237	13	.	.	PUNCT
dpc-1935	238	1	however	however	ADV
dpc-1935	238	2	,	,	PUNCT
dpc-1935	238	3	american	american	PROPN
dpc-1935	238	4	college	college	PROPN
dpc-1935	238	5	of	of	ADP
dpc-1935	238	6	obstetricians	obstetrician	NOUN
dpc-1935	238	7	and	and	CCONJ
dpc-1935	238	8	gynecologists	gynecologist	NOUN
dpc-1935	238	9	and	and	CCONJ
dpc-1935	238	10	national	national	ADJ
dpc-1935	238	11	comprehensive	comprehensive	ADJ
dpc-1935	238	12	cancer	cancer	NOUN
dpc-1935	238	13	network	network	NOUN
dpc-1935	238	14	recommend	recommend	VERB
dpc-1935	238	15	clinical	clinical	ADJ
dpc-1935	238	16	breast	breast	NOUN
dpc-1935	238	17	examination	examination	NOUN
dpc-1935	238	18	every	every	DET
dpc-1935	238	19	1	1	NUM
dpc-1935	238	20	to	to	PART
dpc-1935	238	21	3	3	NUM
dpc-1935	238	22	years	year	NOUN
dpc-1935	238	23	in	in	ADP
dpc-1935	238	24	women	woman	NOUN
dpc-1935	238	25	aged	age	VERB
dpc-1935	238	26	25	25	NUM
dpc-1935	238	27	-	-	SYM
dpc-1935	238	28	39	39	NUM
dpc-1935	238	29	years	year	NOUN
dpc-1935	238	30	and	and	CCONJ
dpc-1935	238	31	every	every	DET
dpc-1935	238	32	year	year	NOUN
dpc-1935	238	33	in	in	ADP
dpc-1935	238	34	women	woman	NOUN
dpc-1935	238	35	aged	age	VERB
dpc-1935	238	36	over	over	ADP
dpc-1935	238	37	40	40	NUM
dpc-1935	238	38	years	year	NOUN
dpc-1935	239	1	[	[	X
dpc-1935	239	2	14,15	14,15	NUM
dpc-1935	239	3	]	]	PUNCT
dpc-1935	239	4	.	.	PUNCT
dpc-1935	240	1	moreover	moreover	ADV
dpc-1935	240	2	,	,	PUNCT
dpc-1935	240	3	the	the	DET
dpc-1935	240	4	american	american	ADJ
dpc-1935	240	5	cancer	cancer	NOUN
dpc-1935	240	6	society	society	PROPN
dpc-1935	240	7	and	and	CCONJ
dpc-1935	240	8	american	american	PROPN
dpc-1935	240	9	college	college	PROPN
dpc-1935	240	10	of	of	ADP
dpc-1935	240	11	obstetricians	obstetrician	NOUN
dpc-1935	240	12	and	and	CCONJ
dpc-1935	240	13	gynecologists	gynecologist	NOUN
dpc-1935	240	14	stated	state	VERB
dpc-1935	240	15	that	that	SCONJ
dpc-1935	240	16	initiation	initiation	NOUN
dpc-1935	240	17	or	or	CCONJ
dpc-1935	240	18	cessation	cessation	NOUN
dpc-1935	240	19	age	age	NOUN
dpc-1935	240	20	and	and	CCONJ
dpc-1935	240	21	screening	screen	VERB
dpc-1935	240	22	intervals	interval	NOUN
dpc-1935	240	23	of	of	ADP
dpc-1935	240	24	mammography	mammography	NOUN
dpc-1935	240	25	might	might	AUX
dpc-1935	240	26	be	be	AUX
dpc-1935	240	27	determined	determine	VERB
dpc-1935	240	28	based	base	VERB
dpc-1935	240	29	on	on	ADP
dpc-1935	240	30	the	the	DET
dpc-1935	240	31	preference	preference	NOUN
dpc-1935	240	32	of	of	ADP
dpc-1935	240	33	patients	patient	NOUN
dpc-1935	240	34	who	who	PRON
dpc-1935	240	35	had	have	VERB
dpc-1935	240	36	an	an	DET
dpc-1935	240	37	average	average	ADJ
dpc-1935	240	38	risk	risk	NOUN
dpc-1935	240	39	for	for	ADP
dpc-1935	240	40	breast	breast	NOUN
dpc-1935	240	41	cancer	cancer	NOUN
dpc-1935	240	42	[	[	X
dpc-1935	240	43	14,15	14,15	NUM
dpc-1935	240	44	]	]	PUNCT
dpc-1935	240	45	.	.	PUNCT
dpc-1935	241	1	since	since	SCONJ
dpc-1935	241	2	breast	breast	NOUN
dpc-1935	241	3	cancer	cancer	NOUN
dpc-1935	241	4	is	be	AUX
dpc-1935	241	5	the	the	DET
dpc-1935	241	6	most	most	ADV
dpc-1935	241	7	common	common	ADJ
dpc-1935	241	8	malignancy	malignancy	NOUN
dpc-1935	241	9	in	in	ADP
dpc-1935	241	10	women	woman	NOUN
dpc-1935	241	11	,	,	PUNCT
dpc-1935	241	12	mammography	mammography	NOUN
dpc-1935	241	13	should	should	AUX
dpc-1935	241	14	be	be	AUX
dpc-1935	241	15	considered	consider	VERB
dpc-1935	241	16	as	as	ADP
dpc-1935	241	17	a	a	DET
dpc-1935	241	18	prerequisite	prerequisite	NOUN
dpc-1935	241	19	prior	prior	ADV
dpc-1935	241	20	to	to	ADP
dpc-1935	241	21	initiation	initiation	NOUN
dpc-1935	241	22	of	of	ADP
dpc-1935	241	23	biological	biological	ADJ
dpc-1935	241	24	agents	agent	NOUN
dpc-1935	241	25	in	in	ADP
dpc-1935	241	26	female	female	ADJ
dpc-1935	241	27	patients	patient	NOUN
dpc-1935	241	28	with	with	ADP
dpc-1935	241	29	psoriasis	psoriasis	NOUN
dpc-1935	241	30	.	.	PUNCT
dpc-1935	242	1	discrepancies	discrepancy	NOUN
dpc-1935	242	2	between	between	ADP
dpc-1935	242	3	breast	breast	NOUN
dpc-1935	242	4	cancer	cancer	NOUN
dpc-1935	242	5	screening	screen	VERB
dpc-1935	242	6	guidelines	guideline	NOUN
dpc-1935	242	7	may	may	AUX
dpc-1935	242	8	lead	lead	VERB
dpc-1935	242	9	psoriasis	psoriasis	NOUN
dpc-1935	242	10	patients	patient	NOUN
dpc-1935	242	11	to	to	ADP
dpc-1935	242	12	non	non	ADJ
dpc-1935	242	13	-	-	NOUN
dpc-1935	242	14	adherence	adherence	NOUN
dpc-1935	242	15	with	with	ADP
dpc-1935	242	16	cancer	cancer	NOUN
dpc-1935	242	17	screening	screening	NOUN
dpc-1935	242	18	recommendations	recommendation	NOUN
dpc-1935	242	19	.	.	PUNCT
dpc-1935	243	1	therefore	therefore	ADV
dpc-1935	243	2	,	,	PUNCT
dpc-1935	243	3	patients	patient	NOUN
dpc-1935	243	4	with	with	ADP
dpc-1935	243	5	psoriasis	psoriasis	NOUN
dpc-1935	243	6	who	who	PRON
dpc-1935	243	7	undergo	undergo	VERB
dpc-1935	243	8	treatment	treatment	NOUN
dpc-1935	243	9	with	with	ADP
dpc-1935	243	10	biological	biological	ADJ
dpc-1935	243	11	agents	agent	NOUN
dpc-1935	243	12	should	should	AUX
dpc-1935	243	13	be	be	AUX
dpc-1935	243	14	informed	inform	VERB
dpc-1935	243	15	in	in	ADP
dpc-1935	243	16	detail	detail	NOUN
dpc-1935	243	17	about	about	ADP
dpc-1935	243	18	mamography	mamography	NOUN
dpc-1935	243	19	screening	screening	NOUN
dpc-1935	243	20	intervals	interval	NOUN
dpc-1935	243	21	,	,	PUNCT
dpc-1935	243	22	which	which	PRON
dpc-1935	243	23	should	should	AUX
dpc-1935	243	24	also	also	ADV
dpc-1935	243	25	be	be	AUX
dpc-1935	243	26	included	include	VERB
dpc-1935	243	27	within	within	ADP
dpc-1935	243	28	psoriasis	psoriasis	NOUN
dpc-1935	243	29	treatment	treatment	NOUN
dpc-1935	243	30	guidelines	guideline	NOUN
dpc-1935	243	31	.	.	PUNCT
dpc-1935	244	1	references	reference	NOUN
dpc-1935	244	2	1	1	NUM
dpc-1935	244	3	.	.	PUNCT
dpc-1935	244	4	kovitwanichkanont	kovitwanichkanont	PROPN
dpc-1935	244	5	t	t	PROPN
dpc-1935	244	6	,	,	PUNCT
dpc-1935	244	7	chong	chong	PROPN
dpc-1935	244	8	ah	ah	INTJ
dpc-1935	244	9	,	,	PUNCT
dpc-1935	244	10	foley	foley	PROPN
dpc-1935	244	11	p.	p.	PROPN
dpc-1935	244	12	beyond	beyond	ADP
dpc-1935	244	13	skin	skin	NOUN
dpc-1935	244	14	deep	deep	ADJ
dpc-1935	244	15	:	:	PUNCT
dpc-1935	244	16	addressing	address	VERB
dpc-1935	244	17	comorbidities	comorbiditie	NOUN
dpc-1935	244	18	in	in	ADP
dpc-1935	244	19	psoriasis	psoriasis	NOUN
dpc-1935	244	20	.	.	PUNCT
dpc-1935	245	1	med	med	PROPN
dpc-1935	245	2	j	j	PROPN
dpc-1935	245	3	aust	aust	PROPN
dpc-1935	245	4	.	.	PUNCT
dpc-1935	246	1	2020;212(11):528	2020;212(11):528	NUM
dpc-1935	246	2	-	-	SYM
dpc-1935	246	3	534	534	NUM
dpc-1935	246	4	.	.	PUNCT
dpc-1935	247	1	doi	doi	NOUN
dpc-1935	247	2	:	:	PUNCT
dpc-1935	247	3	10.5694	10.5694	NUM
dpc-1935	247	4	/	/	SYM
dpc-1935	247	5	mja2.50591	mja2.50591	NOUN
dpc-1935	247	6	.	.	PUNCT
dpc-1935	248	1	10	10	NUM
dpc-1935	248	2	.	.	PUNCT
dpc-1935	249	1	pmid	pmid	NOUN
dpc-1935	249	2	:	:	PUNCT
dpc-1935	249	3	32388913	32388913	NUM
dpc-1935	249	4	.	.	PUNCT
dpc-1935	250	1	2	2	X
dpc-1935	250	2	.	.	X
dpc-1935	250	3	trafford	trafford	PROPN
dpc-1935	250	4	am	am	PROPN
dpc-1935	250	5	,	,	PUNCT
dpc-1935	250	6	parisi	parisi	PROPN
dpc-1935	250	7	r	r	PROPN
dpc-1935	250	8	,	,	PUNCT
dpc-1935	250	9	kontopantelis	kontopantelis	X
dpc-1935	250	10	e	e	PROPN
dpc-1935	250	11	,	,	PUNCT
dpc-1935	250	12	griffiths	griffiths	PROPN
dpc-1935	250	13	cem	cem	PROPN
dpc-1935	250	14	,	,	PUNCT
dpc-1935	250	15	ashcroft	ashcroft	PROPN
dpc-1935	250	16	dm	dm	PROPN
dpc-1935	250	17	.	.	PUNCT
dpc-1935	250	18	association	association	NOUN
dpc-1935	250	19	of	of	ADP
dpc-1935	250	20	psoriasis	psoriasis	NOUN
dpc-1935	250	21	with	with	ADP
dpc-1935	250	22	the	the	DET
dpc-1935	250	23	risk	risk	NOUN
dpc-1935	250	24	of	of	ADP
dpc-1935	250	25	developing	develop	VERB
dpc-1935	250	26	or	or	CCONJ
dpc-1935	250	27	dying	die	VERB
dpc-1935	250	28	of	of	ADP
dpc-1935	250	29	cancer	cancer	NOUN
dpc-1935	250	30	:	:	PUNCT
dpc-1935	250	31	a	a	DET
dpc-1935	250	32	systematic	systematic	ADJ
dpc-1935	250	33	review	review	NOUN
dpc-1935	250	34	and	and	CCONJ
dpc-1935	250	35	meta	meta	ADJ
dpc-1935	250	36	-	-	PUNCT
dpc-1935	250	37	analysis	analysis	NOUN
dpc-1935	250	38	.	.	PUNCT
dpc-1935	251	1	jama	jama	PROPN
dpc-1935	251	2	6	6	NUM
dpc-1935	251	3	original	original	ADJ
dpc-1935	251	4	article	article	NOUN
dpc-1935	251	5	|	|	ADV
dpc-1935	251	6	dermatol	dermatol	ADJ
dpc-1935	251	7	pract	pract	NOUN
dpc-1935	251	8	concept	concept	NOUN
dpc-1935	251	9	.	.	PUNCT
dpc-1935	252	1	2022;12(2):e2022081	2022;12(2):e2022081	NUM
dpc-1935	252	2	18	18	NUM
dpc-1935	252	3	.	.	PUNCT
dpc-1935	253	1	rademaker	rademaker	PROPN
dpc-1935	253	2	m	m	PROPN
dpc-1935	253	3	,	,	PUNCT
dpc-1935	253	4	rubel	rubel	PROPN
dpc-1935	253	5	dm	dm	PROPN
dpc-1935	253	6	,	,	PUNCT
dpc-1935	253	7	agnew	agnew	PROPN
dpc-1935	253	8	k	k	PROPN
dpc-1935	253	9	,	,	PUNCT
dpc-1935	253	10	et	et	PROPN
dpc-1935	253	11	al	al	PROPN
dpc-1935	253	12	.	.	PUNCT
dpc-1935	253	13	psoriasis	psoriasis	NOUN
dpc-1935	253	14	and	and	CCONJ
dpc-1935	253	15	cancer	cancer	NOUN
dpc-1935	253	16	.	.	PUNCT
dpc-1935	254	1	an	an	DET
dpc-1935	254	2	australian	australian	ADJ
dpc-1935	254	3	/	/	SYM
dpc-1935	254	4	new	new	ADJ
dpc-1935	254	5	zealand	zealand	PROPN
dpc-1935	254	6	narrative	narrative	NOUN
dpc-1935	254	7	.	.	PUNCT
dpc-1935	255	1	australas	australas	PROPN
dpc-1935	255	2	j	j	PROPN
dpc-1935	255	3	dermatol	dermatol	NOUN
dpc-1935	255	4	.	.	PUNCT
dpc-1935	256	1	2019;60(1):12	2019;60(1):12	NUM
dpc-1935	256	2	-	-	SYM
dpc-1935	256	3	18	18	NUM
dpc-1935	256	4	.	.	PUNCT
dpc-1935	256	5	doi	doi	NOUN
dpc-1935	256	6	:	:	PUNCT
dpc-1935	256	7	10.1111	10.1111	NUM
dpc-1935	256	8	/	/	SYM
dpc-1935	256	9	ajd.12889	ajd.12889	PROPN
dpc-1935	256	10	.	.	PUNCT
dpc-1935	257	1	pmid	pmid	NOUN
dpc-1935	257	2	:	:	PUNCT
dpc-1935	257	3	29992535	29992535	NUM
dpc-1935	257	4	.	.	PUNCT
dpc-1935	258	1	19	19	NUM
dpc-1935	258	2	.	.	X
dpc-1935	259	1	chiesa	chiesa	PROPN
dpc-1935	259	2	fuxench	fuxench	PROPN
dpc-1935	259	3	zc	zc	PROPN
dpc-1935	259	4	,	,	PUNCT
dpc-1935	259	5	shin	shin	PROPN
dpc-1935	259	6	db	db	PROPN
dpc-1935	259	7	,	,	PUNCT
dpc-1935	259	8	ogdie	ogdie	PROPN
dpc-1935	259	9	beatty	beatty	PROPN
dpc-1935	259	10	a	a	PROPN
dpc-1935	259	11	,	,	PUNCT
dpc-1935	259	12	gelfand	gelfand	PROPN
dpc-1935	259	13	jm	jm	PROPN
dpc-1935	259	14	.	.	PUNCT
dpc-1935	260	1	the	the	DET
dpc-1935	260	2	risk	risk	NOUN
dpc-1935	260	3	of	of	ADP
dpc-1935	260	4	cancer	cancer	NOUN
dpc-1935	260	5	in	in	ADP
dpc-1935	260	6	patients	patient	NOUN
dpc-1935	260	7	with	with	ADP
dpc-1935	260	8	psoriasis	psoriasis	NOUN
dpc-1935	260	9	:	:	PUNCT
dpc-1935	260	10	a	a	DET
dpc-1935	260	11	population	population	NOUN
dpc-1935	260	12	-	-	PUNCT
dpc-1935	260	13	based	base	VERB
dpc-1935	260	14	cohort	cohort	NOUN
dpc-1935	260	15	study	study	NOUN
dpc-1935	260	16	in	in	ADP
dpc-1935	260	17	the	the	DET
dpc-1935	260	18	health	health	NOUN
dpc-1935	260	19	improvement	improvement	NOUN
dpc-1935	260	20	network	network	NOUN
dpc-1935	260	21	.	.	PUNCT
dpc-1935	261	1	jama	jama	PROPN
dpc-1935	261	2	dermatol	dermatol	NOUN
dpc-1935	261	3	.	.	PUNCT
dpc-1935	262	1	2016;152(3):282	2016;152(3):282	NUM
dpc-1935	262	2	-	-	SYM
dpc-1935	262	3	920	920	NUM
dpc-1935	262	4	.	.	PUNCT
dpc-1935	263	1	doi	doi	NOUN
dpc-1935	263	2	:	:	PUNCT
dpc-1935	263	3	10.1001	10.1001	NUM
dpc-1935	263	4	/	/	SYM
dpc-1935	263	5	jamadermatol.2015.4847	jamadermatol.2015.4847	PROPN
dpc-1935	263	6	.	.	PUNCT
dpc-1935	264	1	pmid	pmid	NOUN
dpc-1935	264	2	:	:	PUNCT
dpc-1935	264	3	26676102	26676102	NUM
dpc-1935	264	4	.	.	PUNCT
dpc-1935	265	1	pmcid	pmcid	NOUN
dpc-1935	265	2	:	:	PUNCT
dpc-1935	265	3	pmc5273859.20	pmc5273859.20	PROPN
dpc-1935	265	4	.	.	PUNCT
dpc-1935	266	1	20	20	NUM
dpc-1935	266	2	.	.	PUNCT
dpc-1935	267	1	yang	yang	PROPN
dpc-1935	267	2	h	h	PROPN
dpc-1935	267	3	,	,	PUNCT
dpc-1935	267	4	brand	brand	NOUN
dpc-1935	267	5	js	js	PROPN
dpc-1935	267	6	,	,	PUNCT
dpc-1935	267	7	li	li	PROPN
dpc-1935	267	8	j	j	PROPN
dpc-1935	267	9	,	,	PUNCT
dpc-1935	267	10	et	et	PROPN
dpc-1935	267	11	al	al	PROPN
dpc-1935	267	12	.	.	PROPN
dpc-1935	267	13	risk	risk	NOUN
dpc-1935	267	14	and	and	CCONJ
dpc-1935	267	15	predictors	predictor	NOUN
dpc-1935	267	16	of	of	ADP
dpc-1935	267	17	psoriasis	psoriasis	NOUN
dpc-1935	267	18	in	in	ADP
dpc-1935	267	19	patients	patient	NOUN
dpc-1935	267	20	with	with	ADP
dpc-1935	267	21	breast	breast	NOUN
dpc-1935	267	22	cancer	cancer	NOUN
dpc-1935	267	23	:	:	PUNCT
dpc-1935	267	24	a	a	DET
dpc-1935	267	25	swedish	swedish	ADJ
dpc-1935	267	26	population	population	NOUN
dpc-1935	267	27	-	-	PUNCT
dpc-1935	267	28	based	base	VERB
dpc-1935	267	29	cohort	cohort	NOUN
dpc-1935	267	30	study	study	NOUN
dpc-1935	267	31	.	.	PUNCT
dpc-1935	268	1	bmc	bmc	PROPN
dpc-1935	268	2	med	med	PROPN
dpc-1935	268	3	.	.	PUNCT
dpc-1935	269	1	2017;15(1):154	2017;15(1):154	PROPN
dpc-1935	269	2	.	.	PUNCT
dpc-1935	270	1	doi	doi	NOUN
dpc-1935	270	2	:	:	PUNCT
dpc-1935	270	3	10.1186	10.1186	NUM
dpc-1935	270	4	/	/	SYM
dpc-1935	270	5	s12916	s12916	PROPN
dpc-1935	270	6	-	-	PUNCT
dpc-1935	270	7	0170915	0170915	NUM
dpc-1935	270	8	-	-	SYM
dpc-1935	270	9	4	4	NUM
dpc-1935	270	10	.	.	PUNCT
dpc-1935	271	1	pmid	pmid	NOUN
dpc-1935	271	2	:	:	PUNCT
dpc-1935	271	3	28797265	28797265	NUM
dpc-1935	271	4	.	.	PUNCT
dpc-1935	272	1	pmcid	pmcid	NOUN
dpc-1935	272	2	:	:	PUNCT
dpc-1935	272	3	pmc5553678	pmc5553678	PROPN
dpc-1935	272	4	.	.	PUNCT
dpc-1935	273	1	21	21	NUM
dpc-1935	273	2	.	.	X
dpc-1935	274	1	peleva	peleva	PROPN
dpc-1935	274	2	e	e	PROPN
dpc-1935	274	3	,	,	PUNCT
dpc-1935	274	4	exton	exton	PROPN
dpc-1935	274	5	ls	ls	PROPN
dpc-1935	274	6	,	,	PUNCT
dpc-1935	274	7	kelley	kelley	PROPN
dpc-1935	274	8	k	k	PROPN
dpc-1935	274	9	,	,	PUNCT
dpc-1935	274	10	kleyn	kleyn	PROPN
dpc-1935	274	11	ce	ce	PROPN
dpc-1935	274	12	,	,	PUNCT
dpc-1935	274	13	mason	mason	PROPN
dpc-1935	274	14	kj	kj	PROPN
dpc-1935	274	15	,	,	PUNCT
dpc-1935	274	16	smith	smith	PROPN
dpc-1935	274	17	ch	ch	PROPN
dpc-1935	274	18	.	.	PROPN
dpc-1935	274	19	risk	risk	NOUN
dpc-1935	274	20	of	of	ADP
dpc-1935	274	21	cancer	cancer	NOUN
dpc-1935	274	22	in	in	ADP
dpc-1935	274	23	patients	patient	NOUN
dpc-1935	274	24	with	with	ADP
dpc-1935	274	25	psoriasis	psoriasis	NOUN
dpc-1935	274	26	on	on	ADP
dpc-1935	274	27	biological	biological	ADJ
dpc-1935	274	28	therapies	therapy	NOUN
dpc-1935	274	29	:	:	PUNCT
dpc-1935	274	30	a	a	DET
dpc-1935	274	31	systematic	systematic	ADJ
dpc-1935	274	32	review	review	NOUN
dpc-1935	274	33	.	.	PUNCT
dpc-1935	275	1	br	br	PROPN
dpc-1935	275	2	j	j	PROPN
dpc-1935	275	3	dermatol	dermatol	NOUN
dpc-1935	275	4	.	.	PUNCT
dpc-1935	276	1	2018;178(1):103	2018;178(1):103	NUM
dpc-1935	276	2	-	-	SYM
dpc-1935	276	3	113	113	NUM
dpc-1935	276	4	.	.	PUNCT
dpc-1935	277	1	doi	doi	NOUN
dpc-1935	277	2	:	:	PUNCT
dpc-1935	277	3	10.1111	10.1111	NUM
dpc-1935	277	4	/	/	SYM
dpc-1935	277	5	bjd.15830	bjd.15830	X
dpc-1935	277	6	.	.	PUNCT
dpc-1935	278	1	pmid	pmid	NOUN
dpc-1935	278	2	:	:	PUNCT
dpc-1935	278	3	28722163	28722163	NUM
dpc-1935	278	4	.	.	PUNCT
dpc-1935	279	1	22	22	NUM
dpc-1935	279	2	.	.	PUNCT
dpc-1935	280	1	wolinsky	wolinsky	PROPN
dpc-1935	280	2	c	c	X
dpc-1935	280	3	,	,	PUNCT
dpc-1935	280	4	lebwohl	lebwohl	VERB
dpc-1935	280	5	m.	m.	NOUN
dpc-1935	280	6	biologic	biologic	NOUN
dpc-1935	280	7	therapy	therapy	NOUN
dpc-1935	280	8	and	and	CCONJ
dpc-1935	280	9	the	the	DET
dpc-1935	280	10	risk	risk	NOUN
dpc-1935	280	11	of	of	ADP
dpc-1935	280	12	malignancy	malignancy	NOUN
dpc-1935	280	13	in	in	ADP
dpc-1935	280	14	psoriasis	psoriasis	NOUN
dpc-1935	280	15	.	.	PUNCT
dpc-1935	281	1	psoriasis	psoriasis	NOUN
dpc-1935	281	2	forum	forum	NOUN
dpc-1935	281	3	.	.	PUNCT
dpc-1935	282	1	2011;17(4):238	2011;17(4):238	NUM
dpc-1935	282	2	-	-	PUNCT
dpc-1935	282	3	253	253	NUM
dpc-1935	282	4	.	.	PUNCT
dpc-1935	283	1	doi	doi	NOUN
dpc-1935	283	2	:	:	PUNCT
dpc-1935	283	3	10.1177/247553031117a00401	10.1177/247553031117a00401	NUM
dpc-1935	283	4	.	.	NOUN
dpc-1935	283	5	23	23	NUM
dpc-1935	283	6	.	.	PUNCT
dpc-1935	284	1	menter	menter	PROPN
dpc-1935	284	2	a	a	PROPN
dpc-1935	284	3	,	,	PUNCT
dpc-1935	284	4	gelfand	gelfand	PROPN
dpc-1935	284	5	jm	jm	PROPN
dpc-1935	284	6	,	,	PUNCT
dpc-1935	284	7	connor	connor	PROPN
dpc-1935	284	8	c	c	PROPN
dpc-1935	284	9	,	,	PUNCT
dpc-1935	284	10	et	et	PROPN
dpc-1935	284	11	al	al	PROPN
dpc-1935	284	12	.	.	PUNCT
dpc-1935	284	13	joint	joint	PROPN
dpc-1935	284	14	american	american	PROPN
dpc-1935	284	15	academy	academy	PROPN
dpc-1935	284	16	of	of	ADP
dpc-1935	284	17	dermatology	dermatology	NOUN
dpc-1935	284	18	-	-	PUNCT
dpc-1935	284	19	national	national	ADJ
dpc-1935	284	20	psoriasis	psoriasis	NOUN
dpc-1935	284	21	foundation	foundation	NOUN
dpc-1935	284	22	guidelines	guideline	NOUN
dpc-1935	284	23	of	of	ADP
dpc-1935	284	24	care	care	NOUN
dpc-1935	284	25	for	for	ADP
dpc-1935	284	26	the	the	DET
dpc-1935	284	27	management	management	NOUN
dpc-1935	284	28	of	of	ADP
dpc-1935	284	29	psoriasis	psoriasis	NOUN
dpc-1935	284	30	with	with	ADP
dpc-1935	284	31	systemic	systemic	ADJ
dpc-1935	284	32	nonbiologic	nonbiologic	ADJ
dpc-1935	284	33	therapies	therapy	NOUN
dpc-1935	284	34	.	.	PUNCT
dpc-1935	285	1	j	j	PROPN
dpc-1935	285	2	am	be	AUX
dpc-1935	285	3	acad	acad	ADJ
dpc-1935	285	4	dermatol	dermatol	NOUN
dpc-1935	285	5	.	.	PUNCT
dpc-1935	286	1	2020;82(6):1445	2020;82(6):1445	NOUN
dpc-1935	286	2	-	-	PUNCT
dpc-1935	286	3	1486	1486	NUM
dpc-1935	286	4	.	.	PUNCT
dpc-1935	287	1	doi	doi	NOUN
dpc-1935	287	2	:	:	PUNCT
dpc-1935	287	3	10.1016	10.1016	NUM
dpc-1935	287	4	/	/	SYM
dpc-1935	287	5	j.jaad.2020.02.044	j.jaad.2020.02.044	PROPN
dpc-1935	287	6	.	.	PUNCT
dpc-1935	288	1	pmid	pmid	NOUN
dpc-1935	288	2	:	:	PUNCT
dpc-1935	288	3	32119894	32119894	NUM
dpc-1935	288	4	.	.	PUNCT
dpc-1935	289	1	24	24	NUM
dpc-1935	289	2	.	.	PUNCT
dpc-1935	290	1	nast	nast	PROPN
dpc-1935	290	2	a	a	PRON
dpc-1935	290	3	,	,	PUNCT
dpc-1935	290	4	spuls	spuls	PROPN
dpc-1935	290	5	pi	pi	PROPN
dpc-1935	290	6	,	,	PUNCT
dpc-1935	290	7	van	van	PROPN
dpc-1935	290	8	der	der	NOUN
dpc-1935	290	9	kraaij	kraaij	VERB
dpc-1935	290	10	g	g	PROPN
dpc-1935	290	11	,	,	PUNCT
dpc-1935	290	12	et	et	PROPN
dpc-1935	290	13	al	al	PROPN
dpc-1935	290	14	.	.	PROPN
dpc-1935	290	15	european	european	PROPN
dpc-1935	290	16	s3	s3	PROPN
dpc-1935	290	17	-	-	PUNCT
dpc-1935	290	18	guideline	guideline	NOUN
dpc-1935	290	19	on	on	ADP
dpc-1935	290	20	the	the	DET
dpc-1935	290	21	systemic	systemic	ADJ
dpc-1935	290	22	treatment	treatment	NOUN
dpc-1935	290	23	of	of	ADP
dpc-1935	290	24	psoriasis	psoriasis	NOUN
dpc-1935	290	25	vulgaris	vulgaris	NOUN
dpc-1935	290	26	update	update	NOUN
dpc-1935	290	27	apremilast	apremilast	NOUN
dpc-1935	290	28	and	and	CCONJ
dpc-1935	290	29	secukinumab	secukinumab	PROPN
dpc-1935	290	30	edf	edf	PROPN
dpc-1935	290	31	in	in	ADP
dpc-1935	290	32	cooperation	cooperation	NOUN
dpc-1935	290	33	with	with	ADP
dpc-1935	290	34	eadv	eadv	PROPN
dpc-1935	290	35	and	and	CCONJ
dpc-1935	290	36	ipc	ipc	PROPN
dpc-1935	290	37	.	.	PUNCT
dpc-1935	291	1	j	j	PROPN
dpc-1935	291	2	eur	eur	PROPN
dpc-1935	291	3	acad	acad	PROPN
dpc-1935	291	4	dermatol	dermatol	NOUN
dpc-1935	291	5	venereol	venereol	NOUN
dpc-1935	291	6	.	.	PUNCT
dpc-1935	292	1	2017;31(12):1951	2017;31(12):1951	NUM
dpc-1935	292	2	-	-	SYM
dpc-1935	292	3	1963	1963	NUM
dpc-1935	292	4	.	.	PUNCT
dpc-1935	293	1	doi	doi	NOUN
dpc-1935	293	2	:	:	PUNCT
dpc-1935	293	3	10.1111	10.1111	NUM
dpc-1935	293	4	/	/	SYM
dpc-1935	293	5	jdv.14454	jdv.14454	PROPN
dpc-1935	293	6	.	.	PUNCT
dpc-1935	294	1	pmid	pmid	NOUN
dpc-1935	294	2	:	:	PUNCT
dpc-1935	294	3	28895202	28895202	NUM
dpc-1935	294	4	.	.	PUNCT
dpc-1935	295	1	25	25	NUM
dpc-1935	295	2	.	.	PUNCT
dpc-1935	296	1	pathirana	pathirana	PROPN
dpc-1935	296	2	d	d	PROPN
dpc-1935	296	3	,	,	PUNCT
dpc-1935	296	4	ormerod	ormerod	VERB
dpc-1935	296	5	ad	ad	NOUN
dpc-1935	296	6	,	,	PUNCT
dpc-1935	296	7	saiag	saiag	ADP
dpc-1935	296	8	p	p	X
dpc-1935	296	9	,	,	PUNCT
dpc-1935	296	10	et	et	PROPN
dpc-1935	296	11	al	al	PROPN
dpc-1935	296	12	.	.	PROPN
dpc-1935	296	13	european	european	PROPN
dpc-1935	296	14	s3	s3	PROPN
dpc-1935	296	15	-	-	PUNCT
dpc-1935	296	16	guidelines	guideline	NOUN
dpc-1935	296	17	on	on	ADP
dpc-1935	296	18	the	the	DET
dpc-1935	296	19	systemic	systemic	ADJ
dpc-1935	296	20	treatment	treatment	NOUN
dpc-1935	296	21	of	of	ADP
dpc-1935	296	22	psoriasis	psoriasis	NOUN
dpc-1935	296	23	vulgaris	vulgaris	NOUN
dpc-1935	296	24	.	.	PUNCT
dpc-1935	297	1	j	j	PROPN
dpc-1935	297	2	eur	eur	PROPN
dpc-1935	297	3	acad	acad	PROPN
dpc-1935	297	4	dermatol	dermatol	NOUN
dpc-1935	297	5	venereol	venereol	NOUN
dpc-1935	297	6	.	.	PUNCT
dpc-1935	298	1	2009(suppl	2009(suppl	NUM
dpc-1935	299	1	2);23:1	2);23:1	NUM
dpc-1935	299	2	-	-	SYM
dpc-1935	299	3	70	70	NUM
dpc-1935	299	4	.	.	PUNCT
dpc-1935	300	1	doi	doi	NOUN
dpc-1935	300	2	:	:	PUNCT
dpc-1935	300	3	10.1111	10.1111	NUM
dpc-1935	300	4	/	/	SYM
dpc-1935	300	5	j.14683083.2009.03389.x	j.14683083.2009.03389.x	PROPN
dpc-1935	300	6	.	.	PUNCT
dpc-1935	301	1	pmid	pmid	NOUN
dpc-1935	301	2	:	:	PUNCT
dpc-1935	301	3	19712190	19712190	NUM
dpc-1935	301	4	.	.	PUNCT
dpc-1935	302	1	26	26	NUM
dpc-1935	302	2	.	.	PUNCT
dpc-1935	303	1	saeki	saeki	PROPN
dpc-1935	303	2	h	h	PROPN
dpc-1935	303	3	,	,	PUNCT
dpc-1935	303	4	terui	terui	PROPN
dpc-1935	303	5	t	t	PROPN
dpc-1935	303	6	,	,	PUNCT
dpc-1935	303	7	morita	morita	PROPN
dpc-1935	303	8	a	a	PROPN
dpc-1935	303	9	,	,	PUNCT
dpc-1935	303	10	et	et	PROPN
dpc-1935	303	11	al	al	PROPN
dpc-1935	303	12	.	.	PUNCT
dpc-1935	304	1	japanese	japanese	ADJ
dpc-1935	304	2	guidance	guidance	NOUN
dpc-1935	304	3	for	for	ADP
dpc-1935	304	4	use	use	NOUN
dpc-1935	304	5	of	of	ADP
dpc-1935	304	6	biologics	biologic	NOUN
dpc-1935	304	7	for	for	ADP
dpc-1935	304	8	psoriasis	psoriasis	NOUN
dpc-1935	304	9	(	(	PUNCT
dpc-1935	304	10	the	the	DET
dpc-1935	304	11	2019	2019	NUM
dpc-1935	304	12	version	version	NOUN
dpc-1935	304	13	)	)	PUNCT
dpc-1935	304	14	.	.	PUNCT
dpc-1935	305	1	j	j	PROPN
dpc-1935	305	2	dermatol	dermatol	NOUN
dpc-1935	305	3	.	.	PUNCT
dpc-1935	306	1	2020;47(3):201	2020;47(3):201	NUM
dpc-1935	306	2	-	-	PUNCT
dpc-1935	306	3	222	222	NUM
dpc-1935	306	4	.	.	PUNCT
dpc-1935	307	1	doi	doi	NOUN
dpc-1935	307	2	:	:	PUNCT
dpc-1935	307	3	10.1111/1346	10.1111/1346	NUM
dpc-1935	307	4	-	-	SYM
dpc-1935	307	5	8138.15196	8138.15196	NUM
dpc-1935	307	6	.	.	PUNCT
dpc-1935	308	1	pmid	pmid	NOUN
dpc-1935	308	2	:	:	PUNCT
dpc-1935	308	3	31916326	31916326	NUM
dpc-1935	308	4	.	.	PUNCT